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Recent imaging studies suggest that there are changes in the anatomy and
function of limbic and subcortical structures in depression. However,
the evidence is conflicting, possibly reflecting differing symptoms,
illness duration, sample ages and aetiologies of depression. The
experiments described here provide evidence explaining some of this
variability.
The striatum shows anatomical and functional changes associated with
depression, suggesting the involvement of dopamine. Using IBZM, a
SPET ligand with high dopamine D2/3 receptor selectivity, in-vivo striatal
D2/3 receptor availability was examined in 15 depressed in-patients and
15 matched controls. Depressed patients had increased receptor
availability, implying reduced striatal dopaminergic activity in
depressed patients. Increased receptor availability was related to
objectively measured motor slowing in the depressed group.
Inter-individual variation in IBZM binding may be due to a combination of state
and trait effects. Two trait effects were found in controls- sexual
dimorphism, with women showing higher receptor availability, and a
large effect related to specific personality traits.
Evidence for structural change in depression is conflicting, the strongest being
for striatal and frontal lobe volume reductions in unipolar depression.
Patients with chronic treatment resistant unipolar depression were
examined, as they may be most likely to have structural brain changes.
IV
Voxel based analysis was used to compare the high resolution MRI
images of twenty patients with chronic, treatment resistant unipolar
depression, with 20 individually matched patients who had recovered
and 20 individually matched healthy controls. Only chronically
depressed patients exhibited MRI differences. Chronically depressed
patients had frontal lobe and right striatal atrophy found using both
VBA and conventional volumetry, and also reduced grey matter density
in left temporal lobe and left anterior hippocampi. Neocortical changes
correlated with the cumulative severity of illness. Medial frontal grey
matter reductions correlated with age, psychomotor retardation as well
as current and past illness severity in patient groups. Left hippocampal
grey matter reductions correlated with reduced episodic verbal
memory. Voxel based analysis was a sensitive and complete analysis of
MRIs providing results consistent with contemporary hypotheses.
Further studies need to examine if these changes represent pre-existing
trait or state change, to what extent do they represent biochemical
change as opposed to anatomical change, and to what extent they are
irreversible. The results challenge the notion of depression being a fully
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1.0 This thesis presents work carried out at the MRC Brain
Metabolism Unit and University of Edinburgh Department
of Psychiatry between 1995 and 1998. Two main imaging
experiments were carried out to investigate limbic and
subcortical structures in vivo in depression. In the first,
dopamine D2/3 receptor availability was examined in
fifteen depressed and fifteen healthy controls. In the second
experiment, the MRIs of twenty chronic, treatment resistant
depressed patients were compared with two individually
matched reference groups- twenty healthy volunteers, and
twenty patients who had fully recovered from depression.
1.1 Depression is the "common cold" of psychiatry, with a
lifetime incidence in community surveys of about 20%
(Rorsman et al, 1990). It is commonly regarded as a wholly
reversible psychiatric illness associated with no lasting
neurological change. Its apparent reversibility makes it an
ideal experimental paradigm for imaging studies, as it
allows within subject comparisons of a condition with no
apparent structural change.
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1.2 For over 100 years, it has been thought that the regulation
of emotions involves limbic and subcortical structures
(Broca, 1878). The evidence for this view has largely been
based on serendipitous lesion experiments in humans or
from experimental animal models, where there have been
gross disturbances in cerebral structure and function
(Brown & Schlaepfer, 1888; Kluver & Bucy, 1938; Kluver &
Bucy, 1939). Logically, it follows that pathological mood
changes, such as those found in clinical depression, should
be associated with functional and anatomical changes in
these areas. However, most mood-disordered patients do
not have clearly visible cerebral differences in these areas
using conventional structural imaging techniques. This and
the natural history of the illness have led to the view that
mood disorders are "functional" in nature.
This view has been challenged recently by findings from studies
examining the metabolic or perfusion changes in vivo during
and after recovery from depression. Such studies have
found that the perfusion changes in depression may not
wholly normalise on recovery (Goodwin et al, 1993; Dolan
& Goodwin, 1995), suggesting that a structural change may
be present. As a result, interest has been rekindled in the
quantitative neuroanatomy of limbic and subcortical
structures. A number of technological advancements have
been central to this renaissance of interest. First, increasing
resolution of structural imaging using MRI has allowed the
detection of subtle anatomical change in small structures
such as the hippocampus (Sheline et al, 1996), which
previously could not have been measured with meaningful
accuracy. Secondly, more sophisticated methods of image
analysis, such as voxel based analysis (VBA), have recently
been applied to structural imaging data (Wright et al, 1995).
VBA has already revolutionised the approach to analysing
functional imaging data (Friston, 1994). It has a number of
advantages over traditional quantitative region of interest
analysis, such as allowing the full use of all imaging data and
promises to have a significant impact in the way structural
imaging data are analysed and interpreted.
These initial functional imaging studies have also confirmed
that spatially distributed cerebral areas are normally
organised into functional networks, and that mood
disorders may involve changes in a number of such
networks. Symptoms would then arise as a result of
disturbed function in these networks. Hence, one approach
to understanding the neurobiology of depression is to
identify symptoms or clusters of symptoms which may
map to specific neuronal systems.
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Matching symptoms with networks may be difficult. The syndrome
of depression includes many widely diverging symptoms,
including anxiety, apathy, psychotic symptoms, and the so-
called "biological" symptoms of depression, such as sleep
disturbance, appetite change and diurnal variation in mood.
Despite this, psychomotor retardation, or slowing of
cognitive and motor functions, has been demonstrated
repeatedly in severe depression. In fact, some authors
regard psychomotor retardation as a core feature of
melancholic depression (Widlocher, 1983; Parker et al, 1993).
Evidence from perfusion imaging studies provides a
candidate system that may be involved in the production of
motor retardation. Depressed patients show reduced
perfusion in frontal and striatal regions that may correlate
with the degree of motor retardation (Austin et al, 1992b;
Curran et al, 1993; Mayberg et al, 1994). Fronto-striatal
regions are heavily innervated by dopaminergic neurones.
Hence, with the availability of dopamine receptor binding
SPET ligands, it is now possible to directly test the
hypothesis that striatal dopamine may reflect motor
retardation in depression.
1.4 Thesis overview
As a starting point, therefore, the neuroanatomy of the brain regions
thought to be involved in mood regulation is reviewed in
chapter 2. Then, evidence from recent SPET and PET
functional imaging studies examining subjects during an
induced mood change and examining patients with primary
depression are reviewed (Chapter 2). These studies of
cerebral perfusion or metabolism are indirect measures of
actual change in synaptic neurochemistry, but provide
supportive evidence that dopamine may be involved in
some of the symptoms of depression. The chapter also
summarises the clinical and symptom correlates of
perfusion changes during depression and examines whether
all perfusion and metabolic changes normalise on recovery.
Chapter 3 describes the first experiment comparing the striatal
dopamine D2/3 receptor availability in fifteen clinically
depressed in-patients with that in fifteen matched healthy
controls. An index of striatal D2/3 receptor availability was
derived using 123I-IBZM, a D2/3 receptor SPET ligand with
high specificity and moderate affinity. IBZM binding is
dependant on the density of striatal D2/3 receptors and on
the active competition for binding from the endogenous
receptor ligand, dopamine. It was hypothesised that
melancholically depressed patients with motor slowing
7
would show increased receptor availability compared to
controls, suggesting reduced endogenous dopamine
release. The further hypothesis that receptor availability in
the depressed patients reflects psychomotor retardation
was tested by correlating objective measures of
psychomotor slowing with the binding of IBZM. Finally,
personality correlates of receptor availability were
examined in the controls, supporting the notion that the
striatum, particularly striatal dopaminergic neurones is
involved in the regulation of complex human behaviours.
In chapter 4, the evidence for structural change in depression is
reviewed. The factors associated with structural change are
examined, such as age, age of onset and vascular disease.
The argument is developed that treatment resistance and
chronicity in depression may be expected to be associated
with structural changes.
Chapter five describes the second experiment where the MRI images
of twenty patients with chronic, treatment resistant
depression (CTRD) were compared with the images from
twenty closely matched patients who had recovered and
with twenty matched controls. High resolution MRI images
were compared using SPM (statistical parametric mapping),
a form of voxel based analysis previously used for
functional imaging, but modified to analyse structural MRI
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images. All three tissue compartments were analysed (grey
matter, white matter and CSF) and provided a
comprehensive view of brain changes in patients with
CTRD. The chapter also examines the clinical correlates of
the brain changes in patients with CTRD in an attempt to
define if these changes were acquired or pre-existent.
Chapter six examines the profile of cognitive change in patients with
CTRD and recovered patients compared to controls from
experiment two. Cognitive impairments may reflect the
brain changes in those with CTRD. A further aim was to
investigate if recovered patients had achieved full cognitive
recovery. If there was residual impairment in the recovered
group, this may reflect cerebral structural change. Thus, the
results from the cognitive tests were correlated with grey
matter in the CTRD group, predicting that episodic verbal
memory would correlate with left hippocampus, and that
measures of motor retardation would correlate with fronto-
striatal regions.
Finally, chapter 7 summarises the findings of the experiments and
puts forwards suggestions for further future investigations.
CHAPTER 2:
A REVIEW OF FUNCTIONAL IMAGING STUDIES
IN PRIMARY DEPRESSION
CHAPTER 2: A REVIEW OF FUNCTIONAL IMAGING STUDIES
IN DEPRESSION
2.1 An overview of the functional neuroanatomy of the limbic system
Broca in 1878 (Broca, 1878) first described the ring of tissue comprising the
cingulate gyrus, anterior olfactory region, hippocampus and
parahippocampal gyrus as "le grand lobe limbique" describing its
function as olfactory. Lesion studies by Brown and Schlaepfer (Brown
& Schlaepfer, 1888), and by Kluver and Bucy (Kluver & Bucy, 1938)
(Kluver & Bucy, 1939) helped establish an emotional role for limbic
structures. Ramon y Cajal (Ramon y Cajal, 1900) established the
connection of other structures with the limbic lobe, including the
amygdala, septal nuclei, hypothalamus, epithalamus, anterior
thalamus and the basal ganglia, particularly the ventro-medial
portions.
Papez (Papez, 1937) integrated the evidence from anatomical and clinical studies
to propose a mechanism for emotion involving a limbic loop. He
proposed that sensory information was relayed to the hippocampus
via the primary sensory cortex. Via the fornix, information was
passed to the mamillary bodies and then the hypothalamus, where
(external) emotional expression, or affect, was initiated. Information
then passed through the mamillo-thalamic tract to the thalamus and
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then through the internal capsule to the cingulate gyrus where mood
was consciously perceived as an internal state. The loop was
completed by feedback to the hippocampus via the retrosplenic cortex.
Table 2.1












Interestingly, Papez regarded the cingulate cortex as the area that performed
the integration between emotional response and (dorsolateral frontal)
executive functions. Yakolev (Yakolev, 1948) independently proposed
that the orbito-frontal cortex, amygdala, temporal lobe, insula and
dorsal medial thalamus were important in mediating motivation and
emotional expression. Finally, MacLean linked Papez' circuit with the
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structures identified by Yakolev, referring to this network, for the first
time, as the limbic system (McLean, 1952) (table 2.1).
Since then, the anatomical organisation of these components has revealed
specific organisations within structures. For example, the anterior
cingulate is recognised to have at least three functionally different
subdivisions- a ventral affective, a cognitive and a motor division
(Devinsky et al, 1995). The affective component includes Brodmanns'
areas 33, 25, rostral 32 and 24 and have projections to lateral orbito-
frontal cortex, limbic striatum and brainstem. These areas are
activated during mood induction (George et al, 1995) and show
increases during recovery from depression (Goodwin et al, 1993). The
cognitive and motor divisions comprise Brodmanns' areas caudal 24
and 32 are activated with attentional and response selection tasks
(Frith et al, 1991; Pardo et al, 1991), and have reduced activity in
depression (Bench et al, 1992; Ring et al, 1994).
With increasing image resolution and spatial localisation of focal differences in
brain activity, there has been a shift in the view of the neuroanatomy
of depression- the limbic system is regarded as a number of
component cerebral areas organised into discrete parallel loops with
differing functions, which may be disturbed in depression. Alexander
and colleagues (Alexander et al, 1986) suggest at least five segregated
basal ganglia- thalamocortical loops, involving different parts of the
frontal and cingulate cortex, striatum and thalamus. Three of these are
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of particular relevance- the dorsolateral prefrontal, lateral orbitofrontal
and anterior cingulate loops, the components of which are outlined in
table 2.2. These have also been called the dorsal cognitive, ventral
cognitive and affective-emotional circuits (Rauch & Savage, 1997),
respectively, on the basis of function. The first is thought to play a role
in complex cognitive processes including working memory and
shifting mental sets, and the second in cognitive processes related to
response inhibition for social or emotional material. The affective/
motivational loop, also heavily innervated by the amygdala, is
involved in emotional or reward-based information processing (Rauch
& Savage, 1997).
In summary, it is currently thought that the limbic system, together with
subcortical brain regions;
"mediate fundamental functions such as memory, emotion, motivation
and mood. Limbic and subcortical systems also play a key
neurobiological role in other aspects of human experience, such as
substance abuse and reward systems."

















































It therefore follows that pathological mood states, such as depression,
should involve dysfunction in these limbic and subcortical networks,
specifically, that disturbances in the loops described above should
produce specific cognitive and emotional change which map to discrete
cortical areas showing change in activity.
2.2 Functional imaging of the human limbic system in vivo
The majority of recent functional (using PET or SPET) imaging studies compare
regional blood flow or glucose metabolism either between different
groups or between resting and active states. The central assumption
(for pathological states) is that the normal condition of a tight coupling
between regional metabolism and blood flow/ glucose metabolism
holds during pathological states. If true, differences in local blood flow
or glucose metabolism between groups or during activation should
reflect the net difference in summed metabolic activity associated with
terminal field synaptic transmission (Raichle, 1987; DiRocco et al, 1989).
Further, because of functional segregation of brain regions,
symptoms, mood or cognitive change should map to the specific
regions involved in their production or regulation.
However, measuring metabolism is a second derivative of net regional
neuronal activity. Within a region, there may be both inhibitory and
excitatory influence which influence metabolism. Thus, it is not
possible to attribute change in metabolism to a change in a single
neurochemical systems are involved in depression, but, taken with
15
neuroanatomical studies, these studies provide indicators to candidate
neurotransmitter systems.
2.3 Considerations in interpreting functional imaging studies
There are a number of factors that need consideration in interpreting functional
imaging studies
First, many studies examine small samples of heterogeneous depressed patients.
Clinical, aetiological and biological heterogeneity within and between
samples increases variance and allows divergent or negative results
dependent on the particular admixture of depressed patients. Regional
metabolism may be expected to differ, for example, between a patient
exhibiting prominent anxiety, psychomotor agitation and insomnia,
from one showing avolition, motor retardation and hypersomnia.
Thus samples have included mixtures of unipolar and bipolar patients,
medicated and unmedicated patients, patients with/ without
melancholic features, or psychotic symptoms, with/ without cognitive
impairment, a mixture of in and out patients, patients with varying
treatment responsiveness, and elderly patients with both late and early
onset depression. Most of these dichotomies may be associated with
particular patterns of perfusion or metabolism. Thus, it is important
that samples are selected to have some degree of homogeneity over
and above that of meeting criteria for a depressive episode, to limit the
variance in the data, especially as the size of difference in regional
activity is small.
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Second, most studies have used region of interest (ROI) analysis methods. In
this, the activity within a number of bounding boxes represents the
activity from specific anatomical areas. The bounding boxes can be
constructed using neuroanatomical templates (e.g. (Baxter et al, 1985;
Ebert et al, 1991; Austin et al, 1992b)), or be an arbitrary shape (e.g.
rectangle) distributed through the image (e.g. (Cohen et al, 1982;
Cohen, 1988)). It assumes functional homogeneity within an ROI and
that expected changes occur throughout the whole ROI or a majority
part. Additionally, as ROIs are identified on a priori hypotheses, only a
part of the data set (or image) is analysed. Further, the orientation of
the brain during imaging, the positioning of ROIs and measurements
are operator dependent. These considerations increase the variability
in the data, and produce reduced spatial precision for any differences
found.
Third, these small cross-sectional studies cannot allow the separation of state
dependent from pre-existing trait or long term resultant changes.
Detected differences may reflect, for example, the presence of
cerebrovascular or thyroid disorder, gray matter atrophy or
hypoplasia, or the effects of ageing, which may produce changes
predisposing to, or resultant from depression. Longitudinal studies
are required for this purpose.
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2.4 The limbic system and mood in health
The normal physiology function of the limbic system can be examined by
observing cerebral blood flow or metabolic changes with induced
mood change in healthy volunteers. These studies find activation and
attenuation of activity in different parts of the limbic network when
mood is normally lowered. In a first study, Pardo and co-workers
(Pardo etal, 1993) examined seven male and female volunteers whilst
they remembered a sad event and found activation of bilateral inferior
and orbitofrontal cortex. George et al (George etal, 1995) examined
eleven healthy women during transient sadness, and found extensive
limbic and paralimbic activation, specifically in right medial frontal
gyrus, left dorsolateral prefrontal cortex, bilateral cingulate gyrus,
basal ganglia, thalamus, fornix, left insula and left cerebellum.
Mayberg and colleagues (Mayberg etal, 1995) examined healthy
volunteers during maintained sadness. Activation was seen in insular
and subgenual anterior cingulate regions, with reductions in
prefrontal, inferior parietal, dorsal anterior and posterior cingulate.
Baker et al (Baker etal, 1997) examined the effects of inducing a
depressed mood analogous to retarded depression in nine controls.
They found increases in lateral orbitofrontal and midbrain blood flow,
with reductions in rostral medial frontal cortex. Thus, inducing a sad/
depressed mood in healthy controls initially produces both activation
in orbitofrontal cortex, insular cortex and ventral parts of the anterior
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cingulate, and attenuation in some prefrontal areas and parts of the
anterior cingulate.
2.5 Resting state functional studies during primary depression
Table 2.3 reviews the SPET and PET studies of patients with primary depression.
There is also considerable literature on functional imaging in
secondary depression, which is not reviewed here, since, although
there may be similarities in the findings, it is difficult to ultimately
exclude the effects of the primary illness on activity.
Although the same limbic and subcortical areas are repeatedly found to be
different in depression, there is considerable variance in the direction
of change. The most consistent findings are of reduced flow or
metabolism in bilateral dorsolateral prefrontal cortex and in the basal
ganglia in unipolar depression. There is also some evidence for
reduced temporal lobe perfusion, perhaps in treatment resistant
patients and the elderly, as well as activity changes in the basal ganglia,
amygdala and thalamus. Orbitofrontal perfusion appears to increase
in depression, in contrast to dorsolateral prefrontal cortex. Most
studies have had difficulty visualising or detecting change in medial
temporal structures, partially contributed to by the limits in resolution
of PET and SPET and because of the ROI method analysis. With VBA,
increased perfusion has been detected in the amygdala that may, or
may not normalise on recovery. Finally, the anterior cingulate, a
structure of particular interest in affective disorders, is consistently
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found to have changes in activity in depression. However, the
direction of change ranges from increases, no change, to decreases in
perfusion during depression. This may partially be attributable to the
spatial blunting inherent in ROI analysis. The cingulate, like most
other cerebral structures, is not functionally heterogeneous, having at
least three subdivisions. It is possible that there are opposing changes
occurring within a small area, producing a variable effect on ROI
analysis. A number of hypotheses have been proposed incorporating
the divergent changes in cingulate as well as orbitomedial frontal
hyperperfusion (Ebert & Ebmeier, 1996; Mayberg, 1997; Drevets,
1998). It is interesting to note that these more spatially refined
hypotheses of the neural substrate of depression have been enabled
by voxel based analysis.
2.6 Clinical correlates of perfusion changes and changes with recovery.
Table 2.4 summarises the correlation of activity changes during depression with
a number of clinical variables, and the changes that occur on recovery
from depression using physical (ECT, light, sleep deprivation) and
pharmacological methods.
Most studies have used the Hamilton Rating Scale for Depression (HRSD) to
measure global severity of depression. Consistently, severity
negatively correlates with lateral prefrontal metabolism or perfusion.
Depression can be characterised along the neurotic/ endogenous
continuum, the endogenous pattern corresponding to a melancholic
20
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type of depression. The few studies that have examined this, found an
endogenous pattern on the Newcastle scale (Carney et al, 1965) was
associated with a higher anterior cingulate perfusion (Austin et al, 1992b)
in middle aged patients, but with a lower perfusion in lower frontal
areas in the elderly (Curran et al, 1993). Motor retardation is regarded
by some authors as a key symptom of depression (Widlocher, 1983;
Parker et al, 1993)- activity in prefrontal cortex, cingulate and striatum
appear to correlate with clinically and objectively measured motor
retardation. Finally, cognitive impairment, which is often seen in
hospitalised depressed patients, correlated with anterior medial frontal
areas, and temporal areas.
One night of total sleep deprivation (TSD) can improve depressive symptoms in
about 60% of patients (Wu & Bunney, 1990). Consistently, studies have
shown that patients who respond to TSD initially have high orbito-
cingulate perfusion (Ebert et al, 1991; Wu et al, 1992; Wu et al, 1994;
Ebert et al, 1994b) which decreased on recovery, and that the
improvement in depression after TSD correlated with reductions in
orbitofrontal perfusion (Volk et al, 1993). It is possible that orbito-
cingulate hyperperfusion characterised TSD responders only (Wu et al,
1992; Volk et al, 1993). In contrast, with pharmacotherapy a number
of research groups have found some degree of reversibility in
perfusion deficits in dorsolateral and medial prefrontal cortex as well as
anterior cingulate (Goodwin et al, 1993; Dolan & Goodwin, 1995) in
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patients matched for medication status, as well as in frontal
metabolism in patients not matched for medication (Baxter et al, 1989;
Hurwitz et al, 1990; Martinot et al, 1990) although there may not have
been complete restitution in frontal and temporal areas (Goodwin et al,
1993). The short-term (45 minutes after treatment) effects of ECT
(Scott et al, 1994) include reduction in anterior and inferior cingulate,
whereas the longer term effect (Lerer et al, 1994) was for anterior and
posterior cingulate perfusion increases in ECT responders.
In summary, diverse results have been obtained for activity changes on
recovery, particularly anterior cingulate. This may be since different
areas of the anterior cingulate were sampled, with hyperperfusion
seen in more ventral parts and hypo-perfusion in dorsal parts during
depression (Ebert & Ebmeier, 1996), or that sample groups had
differing symptom profiles which have been found to be associated
with different cingulate perfusion patterns (Austin et al, 1992b;
Goodwin etal, 1993). Alternatively, Mayberg (Mayberg, 1997) has
suggested that perfusion in rostral anterior cingulate (Brodmann area
24) predicts treatment response. Patients who respond have pre-
treatment hyper-perfusion, with non-responders being hypo-perfused.
Also, not all areas showing perfusion change during depression return to
normal on recovery (e.g. basal ganglia, temporal and frontal cortex),
suggesting that there may be trait differences in depressed patients.
This, together with neuropsychological changes that occur with
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depression, give support to the notion of depression as a "fronto-
subcortical" or "fronto-striatal" dementia (Robbins et al, 1992).
2.7 Summary
The pattern of cerebral perfusion and metabolic change in primary depression is
complex, but involves a network of limbic and subcortical structures,
specifically orbito-frontal, medial frontal and dorsolateral prefrontal
cortex, several anterior cingulate regions, the striatum, amygdala and
temporal cortex. The pattern of change in discrete areas may be a
correlate of overall depression severity, symptom profile, cognitive
impairment or motor slowing.
The prominent involvement of the striatum, anterior cingulate and prefrontal
areas strongly suggest the contribution of the dopaminergic system in
the pathophysiology of depression, these areas having the greatest
density of dopaminergic innervation (Graybiel, 1990). This provides
some of the rationale in investigating striatal dopamine D2/3 receptor
availability in depression (Chapter 3).
Not all perfusion changes in depression appear to reverse on recovery,
suggesting a trait effect, possibly secondary to structural differences.
Chapters 4, 5 and 6 lay out an investigation of MRI changes in patients
with chronic treatment resistant depression, a group of patients who, it
will be argued, may have a greater likelihood of exhibiting structural
brain changes.
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CHAPTER 3 : CLINICAL AND PSYCHOMETRIC
CORRELATES OF DOPAMINE D2 BINDING IN
DEPRESSION
3.0 ABSTRACT
Single photon emission tomography (SPET) with the dopamine D2/3 ligand
123I-IBZM gives a semi-quantitative estimate of receptor
availability. We predicted evidence of reduced function, i.e.
increased binding, particularly in more motor retarded patients.
15 patients with major depressive illness and 15 healthy, age and sex
matched volunteers were examined with a clinical and
neuropsychological test battery and high resolution IBZM-SPET.
Estimates for specific binding were computed by averaging
striatum to whole slice uptake ratios over 8-10 scans acquired from
70 minutes after tracer injection.
IBZM binding was higher in the right striatum in depressed patients
compared to controls, with no difference in left striatal binding
ratios. There were significant correlations between IBZM binding
in left and right striatum, and measures of reaction time and verbal
fluency. Increased IBZM binding in striatum probably reflects
reduced dopamine function, whether due to reduced tonic release
of dopamine, or secondary receptors up-regulation. The difference
in the depressed group may be trait or state related, reversible or
irreversible. This can only be addressed by longitudinal studies.
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The possible confounding effect of medication requires further
exploration.
The variation in specific binding in healthy controls was examined. Women
exhibited increased binding compared to men, an effect size of 0.8.
Specific personality dimensions were strongly correlated with
IBZM binding in controls, suggesting a trait effect on binding,
adding to the weight of evidence implicating the basal ganglia in
complex behaviours.
3.1 INTRODUCTION
3.1.1 Limbic dopamine and depression
It will be evident from the preceding section that the basal ganglia, anterior
cingulate and prefrontal cortex are key components of the limbic
system showing changes during normal mood change, pathological
depression and on recovery using associated with
pharmacotherapy (Goodwin et al, 1993), ECT (Lerer et al, 1994;
Scott et al, 1994), sleep deprivation (Ebert et al, 1991; Wu et al, 1992;
Volk et al, 1993; Wu et al, 1994; Ebert et al, 1994a). No single
neurotransmitter can fully explain the range of mood, motor,
cognitive and somatic symptom found in depression. However,
since dopaminergic neurones heavily innervate many of the
cerebral areas involved in depression, it is likely that dopamine
does play a role in the neurochemistry of depression. This
potentially challenges conventional theory that dopamine
transmission is related to schizophrenia, with serotonin and
noradrenalin being related to depression..
The mesolimbic dopaminergic neurones are of importance here, originating
in the ventral tegmental area (VTA) which specifically projects to
orbito/ ventral prefrontal cortex, anterior cingulate and ventral
striatum (Graybiel, 1990). They have been implicated in depressive
behaviour in humans and in animal models of reward seeking
behaviour (Fibiger, 1993). In fact, animal models of depression
suggest the mesolimbic system, including the ventral striatum/
nucleus accumbens is involved in the pathophysiology of
depression (Willner, 1995). Although dopaminergic innervation is
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more widespread in humans, the greatest projections are to
anterior cingulate and motor cortex (Berger et al, 1991).
Consequently, it is not surprising that apomorphine, a dopamine
agonist, has been found to increase medial prefrontal, particularly
anterior cingulate perfusion, in normal subjects using PET (Grasby
etal, 1993; Kapur et al, 1994).
Further evidence of dopaminergic involvement in depression comes from
patients with Parkinson's disease (PD) who exhibit an associated
(anterior cingulate) dopaminergic depletion and have exhibit high
rates of depression (Cummings, 1992). Depressed patients with PD
had reductions in perfusion in antero-medial prefrontal cortex and
anterior cingulate compared to non-depressed PD patients and
controls (Ring et al, 1994).
Additionally, many antidepressants, such as tricyclics, monoamine oxidase
inhibitors, nomifensine, bupropion and electro-convulsive
treatment, exhibit direct or indirect dopamine enhancing effects,
although these actions are not ordinarily postulated to be the
primary mechanism of action. Moreover, some agents with
mainly dopaminergic effects, amphetamine, pirebidil and
bromocriptine, may have antidepressant action (Diehl & Gershon,
1992). Additionally, a reduced turnover of dopamine, determined
by the measurement of homovanillic acid in cerebrospinal fluid, has
been demonstrated in depressed patients, particularly if motor
retardation is present, (van Praag & Korf, 1975); (Jimerson, 1987).
Despite the above evidence, it is not altogether clear how dopaminergic
activity interacts with the network of limbic structures found to
have altered activity during depression. One hypothesis is that
reduced dopaminergic neurotransmission may result in
disinhibition of the amygdala leading to activation of other limbic
structures "in the loop" and inhibition of the basal ganglia (Ebmeier
& Ebert, 1996). A first step, therefore, is to establish what happens
with the dopaminergic system, in vivo during depression.
Three single photon emission tomography (SPET) studies have examined
dopamine function more directly in depression, by using 123I-IBZM
(123I-3-iodo- methoxybenzamide), a benzamide derivative with
high D2/3 receptor selectivity (Verhoeff et al, 1992), but moderate
affinity to dopamine receptors. Its specific binding, therefore,
reflects receptor binding and any partial displacement by
endogenous ligand (Laruelle et al, 1995). Specific IBZM binding in
the striatal regions of interest (ROIs) has been found to be
increased in the depressed group compared with controls,
suggesting either a reduction in competition from endogenous
dopamine or an up-regulation or increased affinity of IBZM to D2/3
receptors (D'haenen & Bossuyt, 1994). A second study could not
confirm this effect for all depressed patients examined, but found
IBZM binding to be specifically higher in patients with
psychomotor retardation (Ebert et al, 1996). IBZM binding was
reduced after successful pharmacological treatment and a
concomitant improvement in motor retardation (Ebert et al, 1996).
The same pattern of change in IBZM binding was found in
depressed patients with a successful antidepressant response to
total sleep deprivation (Ebert etal, 1994a).
3.1.2 Correlates of variation in normal striatal dopamine function
In humans, PET imaging studies have found considerable variation in basal
ganglia D2 receptor density in normal healthy subjects, a finding
confirmed by post-mortem studies (Farde etal, 1995). The
correlates of this normal variation are yet to be established.
Although it has not been convincingly demonstrated that striatal
dopamine D2/3 receptors in humans are causally related to
persistent behaviour patterns or personality traits, animal studies
suggest that the basal ganglia, particularly the ventral striatum and
nucleus accumbens, is involved in behaviours related to reward
and motivation (Salomone, 1992), (Robbins & Everitt, 1996).
Dopamine D2 receptor density is greatest in the caudate/ putamen
and nucleus accumbens/ ventral striatum as well as on
dopaminergic cell bodies within the substanstia nigra and VTA. D2
receptors are also present on cholinergic interneurones and thus
may be involved in reward -based learning (Mello & Villares, 1997).
VTA dopaminergic neurones fire in relation to reward stimuli and
reward conditioned and direct stimulation of the VTA in rodents
inhibits cingulate neurones either through D2 receptors directly or
by dopaminergic stimulation of cortical inhibitory cells (Finch,
1993). D3 receptors are particularly found in the nucleus
accumbens/ ventral striatum as well as hippocampus and
mammilary nuclei, forming part of a system with several diverse
inputs from several limbic structures, suggesting a role for them in
cognitive and emotional functions (Palermo-Neto, 1997)..
Neurones in the ventral striatum discharge in relation to the
reward properties of unconditional stimuli and may be involved in
the motivational aspects of behaviour (Schultz et al, 1992).
Laboratory rats, for example, dichotomised on the basis of
behaviour in novel environments into high and low responders,
differ in their predisposition to drug taking, in their sensitivity to
the reinforcing properties of food and in the basal activity of the
dopamine system in the nucleus accumbens (Dellu et al, 1996).
Thus, these structures may form part of the "neural mechanism by
which motivation gets translated into action" (Robbins & Everitt,
1996).
Two imaging studies have found a relationship between personality traits
and striatal dopamine receptor availability. Gray et al (Gray et al,
1994) found strong negative correlations between both left and
right basal ganglia IBZM binding and Psychoticism. Farde et al
(Farde et al, 1997), in a quantitative PET study using [nC] raclopride
found a strong negative correlation between scores of
"detachment" and D2 receptor density in the putamen, specifically
excluding the D3 dopamine receptor rich ventral striatum. The
detachment scale is one of fifteen from the self-reported
"Karolinska Scales of Personality", a personality inventory thought
to measure biologically based dimensions, with no apparent
correlation with any of Eysenck's dimensions (Schalling et al, 1987).
However, there is descriptive similarity between these dimensions.
High "detachment" appears to characterise subjects who avoid
involvement with other people, and avoid giving and taking
confidences (Schalling et al, 1987), high Psychoticism scorers
characterise people who are cold, impersonal, unempathic and
tough-minded (Eysenck & Eysenck, 1975) and low scorers of
reward dependence are characterised by being socially detached,
avoiding personal confidences and preferring to be independent
(Cloninger, 1987).
3.1.3 Aims of study
Depressed patients: Ebert et al (Ebert et al, 1996) dichotomised patients by
the presence or absence of retardation, but did not specifically
investigate the cross-sectional relationship between IBZM binding
in depression and more objective measures of psychomotor speed,
reflecting varying degrees of psychomotor retardation. This study
was designed to compare IBZM binding in the striatum between a
depressed group and matched healthy volunteers, predicting a
significant excess of binding in the patients, which was likely to be
correlated with objective measures of motor and cognitive speed.
Controls: One of the tasks in investigating the biological basis of personality
is to establish the external or criterion validity of personality
dimensions. The external validity of Psychoticism In the Eysenck
Personality Questionnaire (EPQ) (Eysenck & Eysenck, 1975), has
attracted the greatest degree of criticism (Block, 1977) as it has a
non-normal distribution in control populations, and since it was
initially thought to measure psychosis-proneness. External validity
is also limited for newer personality models. The Tridimensional
Personality Questionnaire (TPQ) (Cloninger, 1987), is based on a
model of personality proposing that the dimensions of harm
avoidance, reward dependence and novelty seeking reflect
genetically heritable trait behaviours dependent on the function of
central serotonin, noradrenalin and dopamine, respectively.
Although an extension of the evidence from animal studies, direct
confirmation from human control population studies is lacking.
Personality inventories not based on biological models, such as the
currently popular NEO-5 inventory (Costa & McCrae, 1992) also do
not have established external validity for their constituent
dimensions.
Thus, this study was designed to replicate the findings of Gray et al (Gray et
al, 1994) as well as examine correlations between specific striatal
binding and personality dimensions from the TPQ and NEO-5
inventories. In theory, striatal IBZM binding should correlate with
scores of novelty seeking in the TPQ. Elowever, since a comparison
of inventories (Zuckerman & Cloninger, 1996) suggests that
reward dependence, and not novelty seeking, has a closer
correlation with Psychoticism on the EPQ, reward dependence
scores may correlate with specific IBZM binding. There was no a
priori hypothesis about which dimension(s) from the NEO-5 would
correlate with IBZM activity. However, since scores of
agreeableness and conscientiousness in the NEO-5 weight the most
towards scores of Psychoticism (McCrae & Costa, 1985), it may be





The design of the study was approved by the local research ethics committee
and the appropriate committee at the Department of Health
(ARSAC). Written informed consent was obtained from all
participating subjects. 15 in-patients (9 males, 6 females) from the
Royal Edinburgh Hospital fulfilling DSM-EI-R criteria
(American Psychiatric Association, 1987) for a current major
depressive episode with or without melancholic or mood-
congruent psychotic features and fifteen healthy volunteers were
entered into the study. The groups were matched for age, sex, and
premorbid IQ.
Two of the depressed patients had a bipolar affective disorder. Four
patients were free of all medication at the time of scanning, seven
were free of antidepressant medication. Eight patients were on
antidepressant medication (including lithium) only, three on
benzodiazepines only (appendix 3.1). The remaining four were
free of all medication at time of scanning. For at least three months
prior to the investigation, patients had not received any medication
acting directly on the dopamine system, such as neuroleptics.
None had received depot neuroleptics previously. The severity of
symptoms was assessed using the 17-item Hamilton Depression
Rating Scale (Hamilton, 1960), and the patient's position on the
neurotic / endogenous continuum was measured by the Newcastle
scale (Carney etal, 1965).
Controls were screened for the presence of psychiatric disorders using the
Schedule for Affective Disorders and Schizophrenia (SADS)
(Endicott & Spitzer, 1978), and were free of any medication. Both
patients and controls were required to be in good physical health,
particularly with no evidence of alcohol or substance misuse,
significant neurological illnesses or brain trauma. All patients were
right-handed, two of the controls were predominantly left-handed.
3.2.2 Imaging Protocol
Subjects were imaged using a single slice twelve-detector head scanner, with
an in-slice and z-axis resolution of approximately 8.5mm (full width
half maximum), and a sensitivity of 520 counts per second in a
head-sized phantom filled with IkBq/ml (Ebmeier et al, 1991).
All subjects took oral doses of potassium iodate to ensure thyroid saturation
with iodine and to prevent its excess exposure to radiation, 170mg
each on the night before and the morning of the scan, 85mg the
day after the scan. All scans were performed in the morning. An
indwelling catheter was inserted into an arm vein 15-30 minutes
before the injection of 185 MBq of 123I-IBZM over 30 seconds.
During and for 5 minutes after injection, patients were required to
lie still and silent wearing eye patches with ears unplugged, with
background noise kept to a minimum. The subject's head was
then placed in a moulded headrest, positioned with the help of two
crossed light beams, and fixed with two pressure pads over the
zygomatic arches.
Slices were acquired parallel to the orbito-meatal line (OML). During the
first hour, a full scan of the brain was carried out, followed by a
short sequence of scans around the level of the basal ganglia,
allowing the operator to choose the slice position with maximum
activity from the striatum, approximately 4 cm above the OML.
Single slices were then acquired at this level in a time series from 80
minutes to 140 minutes post injection. IBZM studies in healthy
volunteers have found specific activity to be at a steady state
during this period (Verhoeff et al, 1992).
3.2.3 Image Analysis
Analyses of the scans were carried out by a physics technician who was blind
to the clinical details. Regions of interest (ROIs) were drawn in
advance from a standard brain atlas (Talairach et al, 1988), outlining
left and right frontal cortex, striata and brain slice hemispheres.
The complete templates were linearly re-positioned, re-sized and
deformed, so that the outlines of the hemisphere ROIs fit over the
cortical rim, defined by the 20% isocontour line (Ebmeier et al,
1991). The striatal ROIs were then manually re-positioned and
centred over maximal striatal activity if necessary, but were not re¬
sized. Once the template position had been determined for each
subject, no further adjustment of the template was permitted.
Following the previous studies, a regional uptake ratio was
calculated as the ratio of the striatal ROI activity to reference ROI.
With this approach, striatal activity (presumed to represent specific
+ non-specific binding + free ligand) is compared to a background
region (non-specific binding + free ligand), providing a functional
index of specific binding of IBZM to D2/ 3 receptors. The choice of
reference region is critical, as different reference regions may affect
results (Ebmeier & Ebert, 1996), especially if it includes the basal
ganglia. For example, the use of whole slice activity as a reference
region may reduce the power of comparison by including areas
with high specific binding in both numerator and denominator
(Ebert & Ebmeier, 1996). On the other hand, using a smaller
reference region may increase variability of the uptake ratios
(Ebmeier et al, 1991) Finally, it has to be considered that non-specific
binding may not be the same for different subjects and thus may
confound group comparisons (Laruelle et al, 1995). For
comparison, we chose two reference regions - whole slice and
frontal cortex. Regional uptake ratios were calculated for each
scan in the time series and were then averaged across 8-10 scans
to remove noise. The mean time of the scans was well matched
for the two groups (118 (SD=5) minutes in controls vs. 121 (SD=8)
minutes in patients post-injection).
3.2.4 Neuropsychological testing
All subjects were tested under standardised conditions. On the morning
prior to the scan subjects performed the National Adult Reading
Test revised (Nelson & Willison, 1991) to measure premorbid IQ,
the auditory verbal learning test (AVLT; (Rey, 1964); (Lezak, 1983)),
the Digit Symbol Substitution Test (DSST; (Wechsler, 1981)), Trail-
making A and B from the Army Individual Test Battery
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(Army Individual Test Battery, 1944), the F.A.S.-Verbal Fluency test
(Borkowski et al, 1967), and the reaction time tasks from the
CANTAB, computerised psychometric testing battery (Sahakian &
Owen, 1992), which allow for a separate determination of the
response initiation and movement times. This battery was chosen
as the tests were thought to measure differing aspects of motor
and cognitive speed.
On the morning of the scan, subjects performed a maximum voluntary
contraction (MVC) task. Each subject was asked to squeeze a
dynamometer as hard as they could, and the average of three trials
with the right hand was used for analysis. This follows the work
of Cohen et al. (Cohen et al, 1982) who demonstrated that deficits in
motor performance in depressed patients was proportionate to
their level of depression, and also Moffoot et al (Moffoot et al, 1994)
who found a reduction in performance in melancholically
depressed patients sensitive to diurnal variations in mood. It has
been suggested that a reduced performance may reflect a
generalised reduction in central motivational state or in effort.
Subjects also completed the Befindlichskeitskala (BFS; (von Zerssen
et al, 1974)), an adjective check list of 28 word-pairs reflecting their
present state of mind. The scale has two sub-scores, one for the
degree of fatigue experienced, the other for the degree of
depression felt. Finally, the Alderly Park State Anxiety
Questionnaire (APSAQ; (Walker, 1990)) was used to assess the
subject's level of state anxiety just after the injection of the ligand.
Al
Eleven of the healthy volunteers completed the Eysenck Personality
Questionnaire to determine scores of extroversion, neuroticism
and psychoticism (Eysenck & Eysenck, 1975). All the volunteers
were posted the Tridimensional Personality Questionnaire (TPQ)
(Cloninger, 1987) and the NEO-5 (Costa & McCrae, 1992)
questionnaires at least six months after having been scanned, after
preliminary investigations of the associations with the EPQ. Ten
subjects returned completed TPQ and NEO-5 questionnaires.
3.2.5 Statistics
Data were analysed with SPSS (version 4) for the Apple Macintosh. Since
clear hypotheses existed for the direction of group differences,
comparisons were made by one-tailed Mann-Whitney U-Tests.
For correlations between Hamilton scores, psychometric tests and
striatal tracer uptake, Spearman's one-tailed correlation coefficients
were computed. Non-parametric tests were used consistently,
because some variables were not normally distributed.
Exploratory correlations are descriptive, or at best, hypothesis
generating. Univariate 95% confidence intervals (CI) were
computed for correlation coefficients to provide a more practical
description of the effect. However, correlations of measures of
psychomotor retardation with striatal IBZM uptake were planned,




and controls were well matched for age and sex (table 3.1, appendix
3.1). The average 17-item Hamilton score was 23.5 (SD = 7.6, range
= 8 to 45) in the depressed group, the mean Newcastle score 6.9 (SD
= 2.28, range = 2 to 11). Four of the 15 patients had obvious
retardation (Hamilton score of 2+). One patient was not able to co¬
operate with the whole scanning sequence, and was, therefore, not
included in the analysis of imaging data.
3.3.2. Psychometric testing
As expected, patients reported more depression and fatigue than controls
(Table 3.1, appendix 3.2 and 3.3). Patients were weaker than
controls in the hand grip task, were slower in reaction movement
time and tended to be slower for total reaction time, response
initiation time and tended to have poorer verbal fluency. There
were no differences between patients and controls for state anxiety
and for other neuropsychological tests.
3.3.3. IBZM binding and diagnosis
Depressed patients had higher right striatal activity than controls (figure 3.1
and 3.2, table 3.2, appendix 3.1), using whole slice as a reference
region (mean= 1.68 (SD= 0.08) v. 1.62 (0.07), Cohen's d = 0.8, Mann-
Whitney U-Test: Z= 1.8, p=0.03) (Figure 3.1). Using whole slice





Table 3.1: Clinical and neuropsychological differences between fifteen
depressed patients and fifteen controls.
Variable Depressed Controls Mann-Whitney li¬
(n=14) (n=15) test (p)
Age (Years) 45 (14) 41 (10) 0.54*
Sex (M\F) 9 \ 6 9\6
NARTIQ 112 (10) 116 (7) 0.24*
Education (Years) 13 (3) 15 (2) 0.07*
APSAQ 9(8) 5(4) 0.24
BFS Total 26 (14) 9(8) 0.002
BFS Mood 6(5) 1(2) 0.01
BFS Fatigue 6(5) 2(3) 0.004
Isometric contraction (kg) 34 (15) 45 (14) 0.03
Total reaction time (msec) 684 (227) 571 (63) 0.06
Response initiation time 524 (168) 449 (47) 0.09
(msec)
Movement time (msec) 488 (353) 330 (58) 0.05
Digit symbol substitution 10 (2) 11(2) 0.15
test
Trails A (seconds) 32(7) 32 (9) 0.49
Trails B (seconds) 90(108) 54 (17) 0.25
Verbal Fluency (words/ 3 39 (20) 48 (10) 0.09
mins)
AVLT total (5 trials) 49 (15) 55 (8) 0.24
Delayed recall (no. words) 10(4) 12 (3) 0.31
Delayed recognition (no. 12 (6) 13 (3) 0.29
words)










Table 3.2: Comparison of regional activity indices between groups,











1.621 (0.074) 1.683 (0.08) 1.8 (0.03) 0.8
Left striatum/
whole slice (SD)







1.71 (0.053) 1.61 (0.10) -1.56 (0.12) 0.95
Left striatum/
whole slice (SD)









1.72 (0.049) 1.64 (0.09) -1.45 (0.14) 0.99
Left striatum/
whole slice (SD)
1.69 (0.055) 1.63 (0.087) -1.34 (0.18) 0.8
Males (n=18) Females (n=ll)
Right striatum/
whole slice (SD)
1.625 (0.086) 1.687 (0.062) 4.9 (0.03) 0.9
Left striatum/
whole slice (SD)
1.617 (0.084) 1.682 (0.067) 4.87 (0.03) 0.87
(1.66 (0.08) v. 1.63 (0.09), Cohen's d = 0.4, Mann-Whitney U-Test:
Z=0.7, p=0.23). Ratios using the frontal region (figure 3.2) as
reference produced essentially identical, albeit slightly more
pronounced, group effects, (right: 1.88 (0.13) v. 1.7 (0.1), Cohen's
as
d= 1.0, Mann-Whitney U-Test: Z= 2.3, p=0.01; left: 1.88 (0.18) v. 1.80
(0.12), Cohen's d= 0.5, Mann-Whitney U-Test: Z= 1.6, p=0.05). The
significant group difference for left striatal uptake ratios with a
frontal reference region, together with the increase in effect size for
both sides when using frontal reference regions, suggests a real
effect in left striatum requiring larger samples to be statistically
confirmed.
3.3.4. IBZM binding and medication
We examined the effect of concomitant medication that could potentially
decrease dopaminergic activity in an indirect fashion, such as
antidepressants and benzodiazepines, by comparing ten medicated
patients against the four on no medication (table 3.2). No
significant effect was found, although the observed effect sizes
were large (d= 0.85- 0.95), with higher binding ratios in medicated
patients. Further investigation is therefore merited as medication
being a confounder. Not surprisingly, similar results were found
comparing patients on (n= 7) and off (n= 7) antidepressants (d=
0.80- 0.99)
IBZM binding and gender
both groups, women had higher striatal (whole slice) uptake ratios
compared with men (table 3.2) for both the left (1.68 (SD:0.07) vs.
1.61 (SD:0.08), d = 0.90) and the right side (1.69 (SD:0.06) vs. 1.62
(SD:0.09), d = 0.87). Although this effect of sex appeared greater in




there was no significant diagnosis by sex interaction (F4;22= 0.49,
p=0.75) Since both groups had equal ratios of males to females, sex
was ignored as a confounding variable for the group comparison.
Female patients were more retarded than male patients (1.8
(SD:0.98) vs. 0.75 (SD:0.71; Mann-Whitney U test, p - 0.04), but
otherwise male and female patients were well matched for the
items and the total score of the Hamilton scale, the Newcastle scale,
and age.
3.3.6 Correlations between clinical and neuropsychological scales
There were positive correlations of total reaction time (r = 0.77, p = 0.001,
95% CI= 0.50 to 0.90), response initiation time (r - 0.74, p = 0.001,
95% CI= 0.44 to 0.89), and movement time (r = 0.48, p = 0.04, 95%
CI= 0.05 to 0.76) with endogenicity of the depressive illness, as
measured by the Newcastle scale. Reaction times did not correlate
with depression severity, as estimated by the Hamilton scale total.
Total reaction time (r = 0.47, p = 0.04, 95% CI= 0.03 to 0.76) and
response initiation time (r = 0.51, p = 0.03, 95% CI= 0.09 to 0.78)
however, positively correlated with the retardation item on the
Hamilton scale. Maximal isometric contraction also correlated with
the Newcastle scale (r = -0.56, p = 0.02, 95% CI= -0.80 to -0.16).
Finally, performance on the verbal fluency task showed a trend
towards negative correlation with retardation on the Hamilton
scale (r = -0.39, p = 0.08, 95% CI= -0.71 to 0.06).
so
3.3.7 Correlation between IBZM uptake and neuropsychological test
scores in depressed patients.
Table 3.3 shows the correlations of clinical and psychometric variables with
striatal regional uptake ratios. Consistent with our hypothesis, we
found positive correlations between movement time and regional
uptake ratios, as well as negative correlations between verbal
fluency and regional uptake ratios in the depressed group. Other
measures of clinical retardation, such as the Hamilton-retardation
score, response initiation time, and other timed neuropsychological
tests were not significantly correlated with IBZM uptake in
depressed patients. Notably, there were no correlations between
uptake and severity of depression as measured by the Hamilton
scale, type of depression as measured by the Newcastle scale, or
age of the patient. An exploratory analysis of the Hamilton items
showed that there was a strong negative correlation between the
suicide item and IBZM uptake (right: r = -0.70, p = 0.002, 95% CI= -
0.88 to -0.35; left: r = -0.63, p = 0.008, 95% CI= -0.85 to -0.24),
suggesting that high suicidality was associated with more normal
striatal IBZM uptake.
Table 3.3: Correlation of RAIs with clinical and neuropsychological scores
Right striatal binding ratio
rho 95% c.-i.
Left striatal binding ratio
rho 95% c.-i.
Age -0.22 -0.62 to 0.27 -0.24 -0.63 to 0.25
NARTIQ 0.15 -0.33 to 0.57 0.13 -0.35 to 0.56
HRSD score -0.2 -0.60 to 0.29 -0.18 -0.59 to 0.31
Newcastle scale
score
0.03 -0.44 to 0.48 0 -0.46 to 0.46
APSAQ 0 -0.46 to 0.46 -0.07 -0.51 to 0.40
BFS total -0.09 -0.53 to 0.39 -0.11 -0.54 to 0.37
BFS mood -0.05 -0.50 to 0.42 -0.11 -0.54 to 0.37
BFS fatigue -0.12 -0.55 to 0.36 -0.06 -0.51 to 0.41
Isometric
contraction
0 -0.46 to 0.46 0.01 -0.45 to 0.47
Retardation item
from HRSD



















DSST -0.04 -0.49 to 0.43 -0.04 -0.49 to 0.43
Trails-A -0.08 -0.52 to 0.39 -0.04 -0.49 to 0.43
Trails-B -0.05 -0.50 to 0.42 -0.07 -0.51 to 0.40
Verbal fluency -0.56** -0.81 to -0.13 -0.52* -0.80 to -0.09
AVLT (total) 0.14 -0.34 to 0.56 0.18 -0.31 to 0.59
Delayed recall 0.24 -0.25 to 0.63 0.3 -0.19 to 0.67
Delayed
recognition
0.01 -0.45 to 0.47 -0.01 -0.74 to 0.45
Table 3.4: Scores on the three personality questionnaires in the control
group
EPQ n=ll TPQ n=10 NEO-5 n=10
Neuroticism 7.73 (5.85) Harm 7.1 (5.5) Neuroticism 70.3 (18.1)
Avoidance
Psychoticism 2.64 (1.91) Reward 15.8 Openness 120.7 (12.6)
Dependence (7.9)





3.3.8 Correlation between IBZM uptake and personality dimensions in
controls.
Initially, eleven of the controls completed the EPQ prior to the scan. After
having examined the correlations between specific binding and
EPQ personality dimension scores, control subjects were
re-contacted in writing requesting the completion of the TPQ and
NEO-5 inventories. Ten controls returned these completed
questionnaires. Table 3.4 presents the mean scores for each of the
inventories. Controls showed a range of Psychoticism scores on
the EPQ from 0 to 8.
Table 3.5 summarises the correlation of personality dimensions with IBZM
binding. There were negative correlations with psychoticism
(right: r = -0.48, p = 0.06, 95% CI= -0.80 to 0.06; left: r = -0.75, p =
0.004, 95% CI= -0.91 to -0.37, figure 3.3) and positive correlations
Table 3.5: Correlations between scores on personality inventories
and regional activity indices.
Inventory Left Striatal Right Striatal






Harm Avoidance 0.41 0.48
Reward 0.57* 0.60*
Dependence








p< 0.05 ** p< 0.005
between neuroticism and striatal IBZM uptake (right: r = 0.56, p =
0.035, 95% CI= 0.05 to 0.84; left: r = 0.22, p = 0.26, 95% CI= -0.34 to
0.67), but no correlations with extroversion in the EPQ (Eysenck &
Eysenck 1975). This partially confirms results previously published
by Gray and co-workers (Gray etal, 1994). The same correlations
were found when repeated using frontal regions as reference. In
the TPQ, reward dependence correlated positively with striatal
binding (right: r = 0.60, p < 0.05; left: r =0.57, p <0.05) (figure 3.4 and
3.5), but not with novelty seeking or harm avoidance.
Figure 3.3 Graph of left striatal IBZM binding ratio and psychoticism score
from the EPQ in 11 control subjects
Left striatal binding of IBZM
Figure 3.4 Graph of Reward Dependence and right striatal binding ratio in
10 control subjects
Right striatal binding ratio
Figure 3.5- Graph of Reward Dependence and left striatal binding ratio in
10 control subjects
30-i
y = 60.276x - 83.628














3.4.1 Group differences in IBZM binding
3.4.1.1. Influence of diagnosis
We were able to confirm that there is higher IBZM binding in the right
striatum of depressed patients compared with healthy volunteers.
There was a smaller difference in the left striatum, which did not
reach statistical significance, even if a frontal reference region was
used. Importantly, in depressed patients higher IBZM binding was
correlated with measures sensitive to reduced speed of motor
performance, such as movement time and verbal fluency, in which
they had some degree of impairment compared to controls.
Binding was not correlated with mood per se, grip strength or
memory function.
That IBZM binding is higher in the right striatum of depressed patients has
some support from Ebert's studies (Ebert et al, 1994a; Ebert et al,
1996), who showed that (retarded) patients had higher right-sided
specific activity during a depressive episode, which normalised with
drug treatment and with clinical response to sleep deprivation.
The effect size of the group comparison was very similar to that
reported in previous studies (Ebmeier & Ebert, 1996), suggesting a
moderate, but robust effect. This finding has interesting parallels
with SPET cerebral perfusion studies in depression. We have
found a 7.5% lower perfusion of basal ganglia in depressed patients
compared with controls (Austin et al, 1992b), which normalised on
recovery (Goodwin et al, 1993).
3.4.1.2 Influence of gender and medication
IBZM binding differed between the sexes, with women having higher
binding suggesting sexual dimorphism in the human striatal
dopamine system. This effect was statistically independent of
diagnosis and did not confound the comparison of sex- matched
diagnostic groups. Because the sex effect appeared at least as
pronounced within the controls, the main effect across diagnostic
groups was not caused by the chance inclusion of more female
retarded patients.
In previous studies of depression, the samples have either been all male
(D'haenen & Bossuyt, 1994) or of unequal sex ratios (Ebert et al,
1994a; Ebert et al, 1996). Sex will, therefore, have to be controlled
for as a confounder in future studies.
There is additional support for an effect of gender on dopamine function in
humans. Pilowski et al (Pilowski et al, 1994) found greater left than
right striatal IBZM binding in female, but not male controls. This
difference was absent in schizophrenic patients, who showed
greater left striatal uptake in both sexes. Plasma homovanillic acid
levels 10 -70% higher in female than in male schizophrenics and
controls have been reported (Koreen et al, 1994). This effect was
more pronounced in patients acutely after receiving fluphenazine.
Animal studies (Kazandjian et al, 1987); (Hafner et al, 1993) and
limited human investigations have suggested modulation of
dopamine function by oestrogen levels ((Wieck et al, 1991), (Best et
al, 1992)). The explanation of the findings in terms of reduced pre-
synaptic release of dopamine or increased post-synaptic expression
of receptors must remain tentative but merits further study.
None of the subjects received medication directly acting on dopaminergic
receptors. However, there is some evidence that other
neurotransmitter systems interact with dopaminergic function.
Serotonergic agonism reduces extrastriatal dopamine
concentrations, while acute serotonergic blockade increases
concentrations (Dewey et al, 1995). Acute antidepressant treatment
with a serotonergic reuptake inhibitor or a less specific drug, could,
therefore be responsible for increased IBZM binding in patients.
Similar effects on dopamine ligand binding have been
demonstrated using drugs specifically acting on cholinergic and
GABA-ergic transmission (Schloesserg et al, 1996). Although there
were no significant difference in IBZM binding between medicated
and unmedicated patients, and an initial investigation of the effects
of antidepressant treatments showed a decrease rather than the
predicted increase in IBZM binding (Ebert et al, 1996), we cannot
exclude, at this stage, that the diagnosis effect may be confounded
by the influences of sertonergic, benzodiazepine or anti-cholinergic
indirectly on dopaminergic activity.
The difference between depressed patients and controls could be, equally,
related to state or trait differences between the groups, or a
combination of both. There is previous evidence that striatal IBZM
uptake in depression may be state dependent (Ebert et al, 1994a;
Ebert et al, 1996). A state effect on the occupancy of D2/3 sites by
AO
IBZM could be due to reduced striatal dopamine release or to an
up-regulation of D2 receptor density. A number of in vivo binding
studies with benzamides have shown that decreased dopamine D2
receptor occupancy can be the acute result of increased dopamine
release or turnover (Hall et al, 1990; Logan et al, 1991; Laruelle et al,
1995) and the evidence from sleep deprivation suggests a similarly
acute effect not likely to be produced by change in receptor
number.
In contrast, there is indirect evidence suggesting a degree of irreversible
change in the neurophysiological substrate, possibly dopaminergic,
underlying psychomotor function in depression. Firstly, there is
evidence that motor slowing persists even after treatment and
recovery from depression (Beats, 1996) (O'Brien et al, 1993) (Abas et
al, 1990). Second, the most consistent finding from structural
studies in depressed patients is of reduced basal ganglia and frontal
lobe volumes (Soares & Mann, 1997), also implying changes in the
fronto-striatal dopaminergic system.
3.4.2 Correlations of striatal IBZM binding
3.4.2.1 IBZM uptake in depressed patients
Only four of the patients were clinically clearly retarded, but there were still
measurable psychomotor differences between depressed and
control patients, most prominently in movement time and
isometric contraction. There were trends (p<0.1) also in other
reaction time measures and verbal fluency. Maximal isometric
contraction, response initiation and movement times were
correlated with endogenicity and clinically rated retardation
correlated with reaction time, and weakly with fluency. These
findings accord with the view that motor signs and, specifically,
measures of performance may be more discriminating than
subjective symptoms for identifying endogenous patterns of
illness. It concords with a long standing tradition that places clinical
retardation as a core symptom in depressive illness (Widlocher,
1983; Parker et al, 1993; Rush & Weissenburger, 1993). The results
do not, however, account for patients with the presence of
agitation in endogenously depressed patients.
IBZM uptake correlated most strongly with relatively pure measures of
motor function (speed of movement in the reaction time task)
rather than clinical measures of mood, fatigue, grip strength or
even retardation. This was despite the much greater group
difference and within group variance for the patients compared
with controls in the latter measures. This finding provides the first
direct evidence suggesting that reduced receptor occupancy by
endogenous dopamine in the basal ganglia has a primary effect on
motor function in depression, although some limited evidence
already exists to suggest acute reversibility of IBZM binding in
depression (Ebert et al, 1996), IBZM uptake also correlated with
verbal fluency and showed a trend with DSST performance. These
are also tests that depend upon speed of motor performance and
showed trends towards impairment in the depressed group.
Performance of Trails A and B was neither impaired in the patient
group nor correlated with IBZM binding. Since the patients in this
study did not on average display major psychomotor impairment,
the correlations that did emerge were striking. Significant
correlations could only be expected for the most sensitive of the
measures or for those most directly related to striatal function In
this regard the failure of mood to correlate with striatal IBZM
binding is very interesting. Although this may have been due to
small sample size, it could also suggest that IBZM might reflect
motor slowing, regardless of cause. In support of this is evidence
that striatal D2 receptors are associated with neuropsychological
tasks involving psychomotor speed. Volkow et al (Volkow et al,
1998) using raclopride found an age dependent decline in striatal D2
receptor availability which most strongly correlated with a motor
neuropsychological task (Finger Tapping Test) but also with most
tasks involving frontal brain regions, involving tasks of abstraction
and mental flexibility, and attention and response inhibition.
The strong negative correlation of IBZM uptake with suicidality could not be
explained by sex differences and was otherwise unexpected. It
could reflect the anecdotal clinical observation that activated
depressed patients are at increased risk of suicide; this occurs
classically after alleviation of psychomotor retardation by
treatment, without an improvement of affect.
3.4.2.2 Correlations of IBZM uptake in healthy controls
The results suggest that the EPQ and TPQ may both have dimensions
measuring behaviours related to striatal dopamine D2/3 receptor
availability at rest. A lower IBZM binding ratio, corresponding to
higher tonic striatal dopamine release and/ or lower striatal
dopamine D2/3 receptor density correlated with lower reward
dependence on Cloninger's Tridimensional Personality
Questionnaire and correlated with higher Psychoticism scores (i.e.
more tough-minded) on Eysenck's Personality Questionnaire (left
striatum particularly). Novelty seeking as well as all of the
dimensions from the NEO-5 inventory did not correlate with IBZM
binding.
There was also a positive correlation between neuroticism and the right
striatal binding ratio. This is of particular interest, as neuroticism is
a strong predictor of later depressive breakdown (Hirschfeld &
Klerman, 1979; Angst & Clayton, 1986; Hirschfeld et al, 1986) and
psychiatric morbidity (Duggan et al, 1995; Young et al, 1995;
Krueger et al, 1996). As yet, no convincing biological correlate of
neuroticism has been found to provide external validity, but it is
interesting that other personality inventories often identify a
dimension similar to neuroticism (e.g. neuroticism dimension in the
NEO-5, (Costa & McCrae, 1992) and harm avoidance dimension in
the TPQ, (Cloninger, 1987). It is also interesting that higher
neuroticism is associated with higher right striatal IBZM binding.
Increased right striatal binding was also found in the depressed
patients. Neuroticism has been found to be high in patients when
depressed and reduces on recovery. Thus, the potential
contribution of trait differences to increased IBZM binding should
not yet be discounted for depressive illness.
The lack of correlation with novelty seeking merits comment. Although
Cloninger suggests that novelty seeking is a dopamine related
dimension, evidence is equivocal. Studies of alcohol or drug
misusers have suggested that novelty seeking may be related to
dopamine activity (Cloninger, 1995). However, patients do not
represent physiological normality, making it difficult to generalise
to the healthy population. Genetic studies linking dopamine
receptor subtypes and novelty seeking have also yielded diverging
evidence (Benjamin et al, 1996; Ebstein et al, 1996; Malhotra et al,
1996). Finally, Psychoticism may be more closely correlated with
reward dependence than novelty seeking (Zuckerman &
Cloninger, 1996). It is therefore not surprising that novelty seeking
did not correlate with IBZM binding.
3.4.3 Limitations and methodological considerations
The major limitation of the study is the small sample sizes. The main effect
would be to reduce the power of the study, making it more likely
to produce a false negative result. Power calculations suggest that
to detect an effect size of 1.0 (or 0.5) in 80% of equal sized samples
using a 2-tailed $ of 0.05, seventeen (64) subjects would need to be
examined in each group (Cohen, 1988). It seems likely that there
may be an effect of diagnosis on left striatal uptake which is missed
due to lack of power. To counter this, there were a large number
of tests. Thus, significant results could have been detected because
of the large number of comparisons made. Similarly, the
correlations between motor speed and uptake, and personality
dimensions and uptake, being dependent on a small data set are
notable. Further studies with larger samples are thus required to
confirm these results.
Unlike PET imaging, SPET receptor imaging can yield only semi-quantative
measures of receptor availability and requires the choice of a
reference region. Specific striatal binding ratios were calculated
using whole slice activity as the reference region. As is
demonstrated, using a frontal reference produces essentially the
same results with a slightly greater effect size, but with greater
variability. Whole slice references thus provides a more
conservative estimate of striatal IBZM binding and makes it more
likely that any effect may be missed. Frontal activity which is low,
may also be subject to the effect of changes in frontal perfusion
which is known to decrease in patients with depression. The use of
reference regions within the same brain assumes that non-specific
binding is the same for different subjects. However, this is not
necessarily correct (Laruelle et al, 1995), thus leading to a greater
difficulty in detecting between subject differences. Specific binding
during the plateau phase after an i.v. bolus injection is further
dependent on tracer washout from plasma, Plasma washout rates
may vary in different groups of subjects, again affecting results
(Laruelle et al, 1995).
The striatum was measured as a single region of interest, despite it being
known that it is functionally heterogeneous. Moreover, the
distribution of D2 and D3 receptors is know not to be
homogeneous within the striatum. However, the spatial
resolution of SPET precludes the division of the striatum into even
caudate and putamen unlike PET imaging. The effect would be to
reduce the effect size if changes occurred only in a part of the
striatum. Correlations with neuropsychological measures may also
be expected to be wide-ranging, relating to the striatum's diverse
range of functions. Thus, it is not surprising that striatal activity
reflects motor slowing in depression, reflects gender differences
and reflects personality traits.
3.5 Summaiy
There are four main findings:
1. Depressed patients have higher, particularly right, striatal IBZM binding
than controls. Acute medication effects cannot be ultimately
discounted in this study.
2. Increased striatal IBZM binding in the depressed patients was correlated
with objectively measured motor slowing and not with mood,
fatigue or hand grip.
3. Women had higher IBZM binding bilaterally, independent of diagnosis.
4. Psychoticism and neuroticism from the EPQ, and reward dependence
from the TPQ correlated with IBZM binding, implying that the
normal variation in limbic striatal receptors may be associated with
normal variation in personality.
IBZM binding at striatal D2/3 is dependent on two factors; receptor density
and basal intrinsic dopamine release. Depression could be
associated with reversible or irreversible differences in either of
these. A cross-sectional study such as this using SPET imaging
cannot definitively distinguish between these effects. However,
from the currently available evidence, it would seem likely that
increased binding is associated with a reduction in dopaminergic
function either reflected in reduced dopamine release and/or
dopamine receptor up-regulation. The observed associations
between dopamine receptor binding and the motor slowing of the
depressed state may, at least in part, reflect a more stable trait of
depressed patients. Furthermore, the available evidence would
^8
suggest that the effect personality probably represent normal
variance in receptor density. The explanation of the sex difference
in terms of reduced pre-synaptic release of dopamine or increased
post-synaptic expression of receptors must remain tentative but
merits further study. If these results were to be confirmed, future
imaging studies would need to control for variation in D2/3
receptor density and/or baseline dopamine release, as both gender
and personality were strong effects and could act as confounders
especially in studies with small samples.
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CHAPTER 4: STRUCTURAL AND FUNCTIONAL BRAIN MARKERS OF
TREATMENT RESISTANCE AND CHRONICITY IN MAJOR
DEPRESSION
Parts of the chapter have been published together with K.P. Ebmeier as a book
chapter in (Shah & Ebmeier, 1998)
4.1 Introduction
One challenge to the present day nosology of depression is to find differences in
aetiology, pathology and prognosis within an apparently clinically
homogeneous syndrome. For this purpose, modern imaging
techniques may be able to define brain differences associated with
differences in outcomes.
Recent functional imaging studies suggest that the perfusion and metabolic
changes associated with depression may not fully reverse in some
groups of patients. Accordingly, high resolution structural studies also
find differences in some groups of depressed patients. In the following
chapter, it is first argued that treatment resistance defines a group of
patients who may have structural brain differences compared to those
with a good outcome. Then, the preliminary evidence of functional
and structural abnormalities associated with a poorer prognosis is
examined.
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4.2 Using treatment outcome to define a homogeneous group
It is surprising that treatment outcome has not been used more often to define
subgroups of patients with depression. This may partially stem from
traditional psychiatric wisdom, which contends that mood disorders
have a good outcome, in contrast to the poor prognosis of dementia
praecox (Kraepelin, 1912). However, accumulating epidemiological
evidence suggests that a significant proportion of patients has a
chronic course and suggests that they form a distinct group:
a. Of depressed patients attending psychiatrists, up to 20% develop a chronic,
treatment resistant illness (Keller et al, 1982; Kiloh et al, 1988; Lee &
Murray, 1988; Scott, 1988), i.e. an illness that fulfils diagnostic criteria
for at least two consecutive years. Although the NIMH Psychobiology
study was carried out with predominantly inpatients (Keller et al, 1982;
Keller et al, 1984) referred to a tertiary referral centre, other studies
have found similar rates of chronicity in out patients and community
based samples in non-elderly age groups (Weissman & Klerman,
1977). Further, these seminal studies were carried out prior to the
modern treatment era. However, two more recent studies have
indicated that the long term outcome from depression still remains
poor in up to 20% ((Kiloh et al, 1988; Lee & Murray, 1988)). Although
recovery does continue after two years of illness, the rate of recovery
slows substantially after the first twelve to eighteen months (Keller et
al, 1982; Keller et al, 1984), suggesting that patients with chronic illness
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may, by their very nature, form a distinct subgroup, possibly with
associated irreversible, i.e. structural brain changes.
b. Poor outcome from depression is associated with a number of factors, the
best established being advanced age, and increased duration of the
illness episode prior to treatment (Scott, 1988). Each of these suggest
distinct aetiological mechanisms:
1. Advancing age: The bad prognosis in terms of both continuing
morbidity and mortality of depression in the elderly was strikingly
observed initially by Murphy and co-workers (Murphy, 1983; Murphy
etal, 1988). Since then, evidence suggests that late onset depression
(first episode after the age of 65) is associated with an excess of
vascular risk factors (Fujikawa et al, 1994), with brain changes,
particularly white matter hyperintensities (WMHs), and possibly with
greater treatment resistance, mortality and morbidity (Hickie et al,
1995; Lesser et al, 1996; O'Brien et al, 1996; Krishnan et al, 1997;
Videbech, 1997; Yanai et al, 1998) but with the absence of a family
history of affective disorder, with fewer other predisposing
aetiological factors found in younger age groups (Post, 1968;
Alexopoulos et al, 1992; Fujikawa et al, 1996). In fact, it has been
suggested that late onset depression may include a large proportion of
patients with depression secondary to cerebrovascular disease
(Krishnan et al, 1997). A central finding associated with treatment
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resistance is that of cerebral WMHs. A review of the aetiology and
clinical correlates of WMHs is therefore presented later.
2. Illness duration: At worst, longer illness periods without
remission may result in a progressive, maybe permanent damage to
the neural systems needed for recovery. One potential mediator of
such damage is Cortisol. Patients with depression show dysregulation
of the hypothalamic-pituitary-adrenal axis. Up to 70% of patients have
raised Cortisol, which is generally not suppressed by dexamethasone
(Dinan, 1994). A persistent positive dexamethasone suppression test,
despite apparent clinical improvement, may predict rapid relapse and
possibly chronicity (Amsterdam et al, 1983; Targum, 1983). Animal
work further suggests that chronically raised Cortisol can cause
hippocampal neuronal death, which in turn may result in
dysregulation of the HPA-axis (Sapolsky et al, 1986; Jacobson &
Sapolsky, 1991). Despite this circumstantial evidence, there has been
very little direct clinical testing of this hypothesis. The functional and
structural imaging studies providing indirect evidence for
neuroanatomical change in treatment resistant patients is reviewed in
section 4.4.
4.3 White matter hyperintensities and late onset depression
4.3.1 Pathological correlates of WMHs
A great deal of interest has been taken in periventricular and subcortical white
matter hyperintensities (WMHs) on MRIs. Originally called "unknown
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bright objects", the aetiology of these discrete areas of signal
hyperintensity on T\- or T2-weighted images is not clearly
understood. There has been a tendency to attribute all such lesions to
vascular causes, but it is probably better to follow Hachinski
(Hachinski et al, 1986) in describing WMHs as "leuko-araiosis", i.e.
rarefied white matter without implying cause.
WMHs can be subdivided on the basis of their distribution and their spatial
extent. Fazekas et al. (Fazekas et al, 1993) compared the in vivo and in
vitro MRI appearances of WMHs with pathological findings and
showed that ventricular cap and smooth ventricular halo WMHs were
closely associated with subependymal gliosis and were probably due
to altered CSF dynamics. In contrast, irregular periventricular
hyperintensities (PVHs) and more severe, confluent deep white matter
hyperintensities (DWMHs) corresponded to areas of arteriolar
thickening, lacunar infarction and reactive gliosis, with early confluent
DWMHs associated with perivascular myelin rarefaction, gliosis and
fibre loss. Similar results were found in two other studies (van Swieten
et al, 1991), (Chimowitz et al, 1992) making it likely that severe PVHs
and DWMHs are related to atherosclerosis. Whether milder PVHs are
independent of atherosclerosis, but related to physiological changes
occurring with advancing age, is yet to be determined.
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4.3.2 Risk factors for WMHs
Epidemiological studies suggest that WMHs are found with increasing age, with
vascular risk factors and risk factors for stroke. The Rotterdam study
for example, a prospective study of 111 subjects aged 55 years or
more, found that WMHs were more pronounced in people with
carotid atherosclerosis (Bots et al, 1993). People with WMHs also
showed greater evidence of peripheral vascular disease, possibly of
coronary artery disease and were older than people without lesions.
In the Helsinki Ageing Brain Study (Ylikoski et al, 1995), most subjects
(n=128, general population neurologically non-diseased cohorts taken
at five year intervals from 55 years old) showed only mild
hyperintensities on T2 weighted MRI sequences, most frequently in
the periventricular areas. They concluded that white matter
hyperintensities in normal cohorts were related especially to age, to
"silent infarcts" and atrophy and to some vascular risk factors. Hence,
there is strong evidence that these lesions are associated with
advancing age and vascular risk factors.
4.3.3. Functional effects of WMHs in non-patient populations
The functional effects of WMHs in healthy elderly subjects are still uncertain,
possibly since WMHs have been measured in a variety of ways. The
evidence suggests that there may be an association between WMHs
and measures of executive function, mental speed and attention.
Ylikoski et al. (Ylikoski et al, 1995) in a large community sample found
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that periventricular hyperintensities in particular were associated with
reductions in measures of mental speed and ability on complex tasks.
They suggested that such lesions might be an index of increasing brain
vulnerability. Schmidt et al. (Schmidt et al, 1993) examining a large
population sample (n= 150) found that subjects with WMLs, after
controlling for age, had deficits in complex tasks, suggesting reduced
mental speed. Further evidence from the Rotterdam study (n= 111)
also found healthy subjects with WMHs to be impaired in cognitive
tasks associated with executive function, mental speed and memory
(Breteler et al, 1994a; Breteler et al, 1994b), though this was not
significant after adjusting for age and education. This was similar to
Tupler et al. (Tupler et al, 1992) in a study of 66 healthy volunteers. An
interesting explanation has been offered by Boone et al. (Boone et al,
1992), who measured the total volume of tissue affected by WMHs in
100 normal subjects, and suggested that a threshold volume needed to
be affected for there to be a measurable effect on cognitive tasks. This
may be reasonable, since in most qualitative studies, cognitive
impairment is particularly associated with the severe end of the
spectrum of WMLs. However, it remains speculative since there have
not been any confirmatory studies. To summarise, population based
studies of the healthy elderly population with a total sample size of
nearly 500 subjects, suggest that WMHs may be associated with a
small but significant effect on executive function and mental speed
although it is not known if these lesions are causally related, are
77
markers of a generalised cerebral process, or an incidental
epiphenomenon to possible cognitive changes.
4.3.4 WMHs and affective disorder
A large number of studies have examined the relationship between WMHs and
affective disorder, particularly in older age (O'Brien et al, 1996).
Drawing firm conclusions from these studies is hampered by the
different methods of rating WMHs, by the selection of mixed (i.e.
bipolar vs. unipolar) depressions, and varied duration of illness.
Nevertheless, in comparison with elderly controls, elderly depressed
patients have more numerous or more extensive WMHs. In elderly
(>60 years) patients with depression severe enough to merit ECT,
Coffey et al. (Coffey et al, 1990) found that patients with depression
had more extensive DWMHs and PVHs compared to matched controls
and that these were related to vascular risk factors. Subsequent
studies suggest that DWHs (Coffey et al, 1990; Brown et al, 1992;
Greenwald et al, 1996) and PVHs (O'Brien & Ames, 1996) may be more
severe, but not more numerous in elderly depressed patients.
Few studies have directly examined the possible association between vascular
risk factors in patients with depression and WMHs. Studies either omit
to measure risk factors, measure them in a non-standardised way or
correlate them with merely the presence or absence of WMHs. Coffey
et al. (Coffey et al, 1990), for example, found that WMHs in the
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depressed group were associated with vascular risk factors. Miller et
al. (Miller et al, 1994) selected subjects and patients without vascular
risk factors, and found no significant difference in the presence, but
found a trend for more severe DWMHs in depressed patients. That
this difference was not significant was probably due to the relatively
small sample size. This perhaps indicates that other factors apart from
vascular pathology may contribute to DWMHs. O'Brien et al. (O'Brien
et al, 1996) also found that even controlling for vascular risk factors and
current blood pressure, depressed patients had more DWMHs than
controls. Therefore, although it is tempting to speculate that late onset
depression in particular is an illness with vascular aetiology (Krishnan
et al, 1997), there is presently not the balance of direct evidence that can
attribute the increased severity of DWMHs in old age depression
wholly to excess vascular risk factors.
The association between WMHs and age of onset of depression implies that late
onset depression differs in its aetiology from early onset depression.
A problem lies in the definition of "late onset", which ranges from 45 to
65 years. The likelihood of finding group differences will vary with the
assumptions made about underlying risk factor(s). If such a risk factor
was proportional to age, dichotomising at different ages could yield
significantly different results. However, if the relationship was non¬
linear, then different age cut-offs might generate similar results.
Krishnan et al. (Krishnan et al, 1988) defined late onset as being >45
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years and found increased DWMHs in late onset depression, although
the two depressed groups were not matched for age. Miller et al.
(Miller et al, 1994) and O'Brien et al. (O'Brien et al, 1996), defining late
onset as >65 years, Figiel et al. (Figiel et al, 1991) as >60 years and
Hickie et al. (Hickie et al, 1995) as >50 years also showed differences
between late and early onset depression in terms of the presence of
subcortical hyperintensities (Figiel et al, 1991) or in the extent of PVHs
and DWMHs (Miller et al, 1994; Hickie et al, 1995; O'Brien et al, 1996).
Also, two studies ((Lesser et al, 1996) (Salloway et al, 1996)) have
compared the volume of WMH tissue between early onset and late
onset depression. Both found that late onset depression was
associated with greater WMHs than early onset, even though the
definition of late onset differed between the two studies. It, therefore,
seems likely that late onset depression is associated with more
extensive areas of WMHs, particularly, DWMHs, above and beyond
the effects of age.
4.3.5 WMHs in depression and cognitive impairment
From the studies of healthy controls, it may be expected that WMHs in late
onset depression would be associated with greater cognitive
impairment. Two volumetric studies (Lesser et al, 1996) (Salloway et al,
1996) found that late onset patients who differed from early onset
patients in terms of DWMHs, also showed reduced performance on
executive tasks and tasks of mental speed. Ebmeier et al (Ebmeier et
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al, 1997) found that the severity of DWMHs correlated negatively with
the MMSE, a global measure of cognitive function. Further
preliminary evidence suggests that increasing WMHs characterise
patients with a poorer treatment response (Hickie et al, 1995), who are
functionally more impaired (Hickie et al, 1995). Thus, WMHs may be
involved in producing cognitive impairment, a risk factor for
(continuing) depression (Post, 1968).
4.3.6 Summary of WMHs in (late onset) depression
There is strong evidence that the presence of WMHs increase with age in
healthy controls, and that late onset depression is associated with
increased severity of these lesions. There is preliminary evidence that
an increase in the extent of these lesions is associated with treatment
resistance, poorer outcome and greater functional disability. There is
reasonable evidence that the presence of DWMHs is associated with a
small degrees of cognitive impairment in the asymptomatic elderly,
and that depressed patients with large volumes of DWMHs have
greater cognitive impairment. It is probable, though not yet
conclusively proven that vascular disease is a major cause of the
DWMHs and of late onset depression. Although there is some
evidence that WMHs are also found in younger age depression, it is
limited primarily to bipolar affective disorder; there is less convincing
evidence for unipolar affective disorder (Soares & Mann, 1997).
81
It is not known if the site of DWMHs are importance. It has been proposed, for
example, that particularly lesions of the basal ganglia or their
connections may be associated with depression (Swerdlow & Koob,
1987). On the other hand, the load of tissue affected by DWMHs may
be important for cognitive impairment (Boone et al, 1992; Lesser et al,
1996), which may act as a vulnerability factor for, and perpetuator of
continued depression (Post, 1968; Ebmeier etal, 1997). Thus, WMHs
may represent generalised age-related changes, vascular disease, or
other as yet unidentified pathological processes, that produce cognitive
impairment.
4.4 Evidence from perfusion and volumetric studies
4.4.1 Functional imaging studies and treatment resistance
There have been only a few functional studies directly examining treatment
resistant patients, usually in comparison to controls (Morinobu et al,
1991). Mayberg et al (Mayberg et al, 1994) found blood flow
reductions in bilateral frontal cortex, anterior temporal cortex, anterior
cingulate gyrus and caudate compared to controls. The greatest
decreases were seen in the inferior frontal and cingulate cortex. Bonne
et al (Bonne et al, 1996) describes patients with medication resistant
depression as having reduced perfusion in left superior temporal, right
parietal and bilateral occipital regions. The ideal comparison in such
studies is CTRD patients with patients who will eventually respond, to
identify metabolic or perfusion patterns that may be found only in
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non-responders. Thus, it is particularly interesting that Hornig et al
(Hornig et al, 1997) found an increase in hippocampus-amygdala
activity in CTRD patients compared with patients with treatment
responsive depression.
If depression is fully reversible, regional perfusion or metabolism changes
during depression should return to normal on recovery. This may not
be the case. Recovery may involve more focused increases of activity
in the basal ganglia and in fronto-cingulate cortex (Goodwin et al, 1993;
Bench et al, 1995) (table 2.1), but not in temporal cortex. Since
functional imaging may detect reduced activity of intact neurones,
normal activity in disrupted cortical neuroterminals, or a combination
of both, persistent reductions in perfusion may reflect grey matter
change. With the limited evidence available, therefore, it appears that
changes in temporal limbic structures may be associated with
treatment resistance and chronicity.
Further evidence for a role of temporal lobe structures comes from studies of
the elderly. In one study, periventricular high intensity signals,
discussed above, were correlated with reduced perfusion in a large
contiguous volume extending across both temporal lobes and around
the ventricles (Ebmeier et al, 1997) implicating temporal lobe
abnormalities in the development of depressive illness in late life. As
patients with such hyperintensities may be more treatment resistant
and may have a worse outcome (Hickie et al, 1995), it suggests
temporal lobe changes are associated with chronicity/ treatment
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resistance. As age of onset of depression was negatively correlated
with perfusion in bilateral temporal cortices, and with fewer MRI
abnormalities in patients with early onset depression, length of illness
and chronic hypercortisolism were unlikely to be responsible for these
perfusion changes. Changes at a molecular level, in functional and
structural imaging also suggest a link between temporal lobe changes
and increased vulnerability to continued depression (Sheline et al, 1996;
Hornig et al, 1997; McEwen, 1997).
4.4.2 Volumetric studies and treatment resistance
The considerations discussed previously, regarding sample selection and
methods of image analysis in functional imaging studies apply to
structural imaging studies. It is, therefore, not surprising that such
studies have also often had a diverse range of findings. There have
not been any studies that directly address if treatment resistance is
associated with structural brain differences. The evidence, therefore, is
indirect.
In terms of generalised tissue loss, a recent meta-analysis of both CT and MRI
studies (Elkis et al, 1995) concluded that patients with affective
disorders had small increases in the ventricle-to-brain ratio (VBR) and
indices of sulcal prominence (SP, a measure of focal cortical tissue loss),
and that patients with affective disorders did not differ from those
with schizophrenia (Elkis et al, 1996). Increased VBR and SP may be
present particularly in the elderly group, and may be associated with
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treatment resistance. It is perhaps not surprising that previous
conventional reviews have concluded that there is no increase in the
VBR in affective disorders, since the overall effect size is small, and the
power of studies is often not sufficient to yield significant results.
The most pervasive criticisms of the VBR are that it reflects both global and focal
tissue loss, and that increases are not diagnosis specific. Additionally,
most studies only analysed a single slice of the acquired image.
Together with the relatively subjective selection of the "right" slice in
the "correct" orientation, the measurement of a one-dimensional
variable obviously has many more spatial degrees of freedom than,
say the determinations of a volume and is thus, liable to have greater
measurement variability.
In terms of focal brain changes, a brief review is given here of findings in
unipolar depression. There are four previous MRI studies that have
rated or quantified frontal lobe volume. Reduced frontal brain width
has been found in middle aged unipolar depressives (Krishnan et al,
1992) and in elderly unipolar depressives prior to ECT (Coffey et al,
1993). This finding has not been replicated in younger bipolar mood
disorder patients (Coffman et al, 1990) (Schlaepfer et al, 1994). With
regards to the temporal lobe, most studies have been confined to
patients with bipolar affective disorder, where there is mixed evidence
of all, "no-change", increases or decreases in volume. Only one studies
(Coffey et al, 1993) had a large number of patients with unipolar
depression and showed no difference in temporal lobe volume. This
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latter study is of interest since it seems to suggest that elderly severely
depressed and possibly treatment resistant patients may not show
temporal lobe structural change.
The amygdala-hippocampal complex has been of intense interest because of its
role in memory (known to be impaired in depression), and because it
may be a structure vulnerable to the effects of corticosteroids, and thus
a candidate structure to be affected by chronicity. However, most
volumetric studies of unipolar patients have, so far, been negative.
Both Coffey et al. (Coffey etal, 1993), who examined mainly elderly
patients awaiting ECT, and Axelson et al. (Axelson et al, 1993),
examining younger inpatients, found no reduction in hippocampal
volume. Interestingly, Krishnan et al. (Krishnan et al, 1991) found a
reduction in relaxation time in this area in a sample of elderly
unipolar depressed patients. More recently, Sheline et al. (Sheline et al,
1996) reported a reduction in hippocampal volume in a small sample of
elderly women with recurrent unipolar depression, who were
asymptomatic at the time of imaging. There are a number of possible
explanations for this discrepancy. First, apart from the latter study, the
resolution of the MRI images may have been insufficient to detect
change in the hippocampus (typical slice thickness of 5mm vs. up to
1.25 mm presently). Second, as most studies use ROI analysis, localised
changes may not have been detected if the volume of the whole
amygdala/hippocampal complex was measured. Finally, samples may
have been heterogeneous: older patient samples may have included
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both late and early onset patients and younger samples both chronic
and non-chronic patients.
There is better evidence that patients with unipolar depression, particularly with
increasing age, have smaller basal ganglia. Husain et al. (Husain et al,
1991) examining 41 unipolar patients (mean age: 55.3) and Krishnan et
al. (Krishnan et al, 1992) examining 50 patients (mean age: 48.3) found
bilateral reduction in putamen and caudate volume, whilst Dupont et
al. (Dupont et al, 1995) examining 30 unipolar (mean age: 36.6) and 36
bipolar patients found a similar trend in only unipolar depression.
Reductions were also found in 25 elderly (mean age: 74.1) patients with
unipolar depression (Krishnan, 1993). Finally, two controlled MRI
studies have found reductions in cerebellar volume (Escalona et al,
1993) and cerebellar vermis (Shah et al, 1992) in relatively middle-aged
patients.
4.4.3 Conclusions
In summary, conventional volumetric analysis shows that patients with unipolar
depression may have reductions in frontal lobe and basal ganglia
(particularly in the elderly), and cerebellum. The evidence for thalamic
reductions is scant, and for the temporal lobe, equivocal. There is
uncertainty about changes in the amygdala/hippocampal complex
partially through reservations about image resolution and the patient
groups used. Nevertheless, there is some evidence that hippocampal
atrophy may be present, despite recovery from depression,
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supporting the notion that repeated exposure to depression has an
enduring structural effect.
Structural differences, at least in elderly depressed patients may be associated
with treatment resistance (Hickie et al, 1995). However, it is not known
if this extends to younger patients since the balance of causes of
depression may be age dependant: depression first presenting in old
age may involve less genetic predisposition, but may be related to
vascular disease or to age related degenerative processes (Alexopoulos
et al, 1992; Axelson et al, 1993; Hickie et al, 1995; Soares & Mann, 1997).
There are inconsistencies, between the evidence from structural studies
suggesting fronto-striatal volume reductions, and perfusion and
metabolic studies suggesting recovery in these areas on remission, but
enduring perfusion deficits in temporal regions. There is, therefore a
need to examine chronic, treatment resistant depression in middle-
aged patients, who would have been less subject to the age-related
degenerative and vascular pathologies found to be important in late
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5.0 ABSTRACT
Severe, chronic, treatment resistant depression (CTRD) is a condition
that is well recognised, but little understood. Though
apparent intractability may reflect brain abnormality, this
has not previously been specifically examined. The MRI
images of the brains of twenty patients with major
depression lasting for two years or more were compared
with twenty controls and twenty other patients showing
complete recovery from depression. Subjects were
individually matched for age, sex, years of education and
premorbid IQ. A fully automated, operator independent
voxel based method was used to segment grey, and white
matter and CSF allowing group comparisons and
correlations to be made. Patients with CTRD had altered
grey and white matter densities in the left hippocampus and
rostral anterior cingulate. There was evidence of right
putamen and right frontal lobe atrophy, confirmed on
conventional volumetric analysis, with smaller left frontal
reductions, concentrated more in white matter. Only grey
matter density was reduced in left temporal neocortex.
Neocortical reductions were related to the severity of illness
over time, and not duration of illness. Older age and
increasingly severe motor retardation was associated with
91
medial prefrontal grey matter reductions (Broadman areas
9 and 10) in the CTRD group. In the RD group, medial
prefrontal grey matter reductions also correlated with age
and age of onset. Hippocampal and anterior cingulate
changes were independant of illness duration and severity,
and from ECT treatment. The study is the first to report
localised tissue abnormalities in patients with CTRD using
voxel based analysis and broadly supports the notion of a
"fronto-subcortical" or "fronto-striatal" dementia. Voxel
based analysis provided a more sensitive and complete
analysis than conventional volumetry, allowing the
detection of a grade of MRI abnormalities. The results
challenge the accepted view of depression as a functional
and fully reversible illness, implying that more permanent
brain changes may be associated with chronicity.
Prospective studies are required to determine whether
these differences predate the onset of depression or are the




Depression is one of the most common clinical problems presenting
to psychiatrists, and has an estimated lifetime incidence of
25% in the general population (Rorsman et al, 1990). Of
those, about 10% present to psychiatrists, possibly on the
basis of depression severity or initial treatment non-
response. Up to one in five of these patients with unipolar
depression follow a chronic, treatment resistant course
(Keller et al, 1982), (Scott, 1988), i.e. an illness fulfilling
diagnostic criteria for at least two consecutive years.
Chronic treatment resistant depression (CTRD) is,
therefore, important for psychiatric practice, but little is
known of its specific aetiological characteristics. The
established clinical associations are with duration of
symptoms before treatment and with age (Scott, 1988). The
very nature of refractory illness suggests that some
permanent change in brain structure may have occurred,
but past neuroimaging studies have either ignored the issue
or provided only limited evidence for biological correlates
of treatment resistance or chronicity (Morinobu et al, 1991;
Mayberg et al, 1994). Studies which have found structural
differences in depressed patients associated with treatment
resistance have been in the elderly (Hickie et al, 1995).
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However, since the balance of causes of depression may
differ at different ages, these results may not apply to
younger age groups.
5.1.2 Previous neuroimaging studies
Until recently, neuro-imaging studies have identified the anatomical
substrates of depression in rather broad terms and have
often provided conflicting results. During depression,
regional perfusion is diffusely reduced in frontal and
temporo-limbic cortex, as well as in the basal ganglia, but
may be increased in some cingulate regions and
ventromedial prefrontal cortex in particular groups of
depressed patients (Mayberg et al, 1997; Drevets, 1998;
Ebert, 1998). Recovery may involve more focused reversals
of activity in the basal ganglia and in fronto-cingulate cortex
(Goodwin et al, 1993; Bench et al, 1995). Since functional
imaging may detect reduced activity of intact neurones,
normal activity in disrupted cortical neuroterminals, or a
combination of both, reductions in perfusion may
sometimes reflect structural changes in grey matter. In fact,
Mayberg et al (Mayberg et al, 1997) has recently suggested
that responders and non-responders to treatment can be
distinguished by the presence of hyper - and hypo -
perfusion in the rostral cingulate (Brodmanns' area 24).
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Similarly, Drevets et al (Drevets, 1998) proposes subgenual
anterior cingulate (Brodmann area 25) hypoperfusion may
be a trait marker for familial depression, partially explained
by grey matter reduction in this area. Both these findings
may be associated with structural changes.
Structural studies using CT or MRI have shown non-specific changes,
such as ventricular enlargement that may reflect cortical
atrophy or basal ganglia changes or a combination of both
(Soares & Mann, 1997). So far, localised frontal lobe
atrophy, especially in the elderly with severe depression
(Coffey et al, 1993), and reduced caudate nucleus volume in
unipolar patients (Soares & Mann, 1997; Krishnan et al,
1992), have been the most reliably reproduced results.
There is also one report of hippocampal atrophy found in a
small cohort of elderly depressed patients with recurrent
depression (Sheline et al, 1996), which may be important if
reproduced.
5.1.3 Methods of image analysis
The absence of spatial precision in neuroimaging studies, as well as
apparently contradictory findings are partially due to the
limitations of the region of interest (ROI) approach to image
analysis. For structural scans this involves laborious slice by
slice measurement of the volumes of local structures, and
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has a number of limitations. Anatomical boundaries are
usually arbitrary and assume functional homogeneity' for
the structure. Further, it assumes that any change occurs
throughout the whole volume of interest or a majority part.
Volumes are identified on a priori hypotheses, and
therefore only a part of the data set (or image) is analysed.
Measurements can be highly operator dependant, with
reliability becoming lower for small volumed structures
such as the hippocampus. Finally, only the volumetric
aspect of the data and not the signal intensity is analysed.
As an alternative, the use of voxel based analysis (VBA) has recently
been extended to analysing structural MRI (Wright et al,
1995), addressing some of the shortcomings of volumetric
analysis. It has already transformed the approach to
isotope based functional imaging (Friston, 1994; Friston et
al, 1995b), where region of interest analysis was previously
regarded as the "gold standard". With VBA, MRI scans of
patients are first spatially transformed into a standard brain
atlas space to remove variation in overall brain position,
size and shape. Images are then segmented into three
tissue compartments, grey matter, white matter and CSF,
each of which may be compared between groups on a voxel
by voxel basis. The technique for spatially transforming
and segmenting images into different tissue types is fully
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automated and operator independent (Wright et al, 1995).
Additionally, the whole (image) data set can be statistically
interrogated independent of hypotheses after appropriately
correcting for multiple comparisons. Where hypotheses
exist, these constraints can be relaxed. Tissue segments can
also be subject to correlational analysis, matching structure
with function or important clinical factors.
5.1.4 Aims of this study
In this study, voxel based analysis was used to compare the three
tissue compartments (grey matter, white matter and CSF)
between three subject groups- patients with chronic,
treatment resistant chronic depression (CTRD), recovered
(RD) patients, and normal healthy volunteers (C). If
previous studies can be generalised to younger patients, it
would be expected that the CTRD group would show grey
matter density reductions in bilateral frontal and temporal
regions, including the hippocampus and basal ganglia. It
would also be expected that there would be corresponding
white matter reductions and increases in CSF in appropriate
regions. Following Mayberg's (Mayberg, 1997) and
Drevet's (Drevets, 1998) studies, grey matter changes may
also be expected in anterior cingulate regions. Further, grey
matter density changes should correlate with clinical
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dimensions - specifically, depression severity should
correlate with medial frontal grey reductions and clinically
rated retardation with basal ganglia and prefrontal grey
matter on the basis of functional imaging studies(Austin et
al, 1992b; Curran et al, 1993; Mayberg et al, 1994). These
correlations in the chronic group would in effect confirm the
biological significance of any observed group differences, as
these differences would then be not only categorical, but
also related to the underlying dimensions of function.
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5.2 MATERIALS AND METHODS
5.2.1 Subjects
All subjects gave informed written consent following a protocol
approved by the local research ethics committee. Twenty
treatment resistant patients aged between 21 and 65 and
fulfilling DSMIV (American Psychiaric Association, 1994)
criteria for major depressive disorder (chronic) were
recruited from general adult in-patient units and from out¬
patient clinics in Lothian. Patients also fulfilled Research
Diagnostic Criteria for a primary major depressive disorder.
Chronicity was defined by a diagnosis of major depressive
episode (DSM IV) lasting for two or more continuous years
(American Psychiatric Association, 1994). Treatment
resistance was assumed if patients did not respond to at
least two treatments from four different pharmacological
regimes employed for at least four weeks:
1. > 150mg of imipramine or an equivalent tricyclic
antidepressant.
2. > 60mg of phenelzine or an equivalent
monoamine oxidase inhibitor.
3. ^ 40mg of fluoxetine or an equivalent selective
serotonin reuptake inhibitor.
4. 2:6 treatments with ECT, with seizures > 20
seconds each.
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In reality, all patients far exceeded the minimum criteria for
treatment resistance, many having been on multiple and / or
combination treatments (appendix 5.1). All patients were
on a stable medication for at least two weeks prior to the
study, as it was not possible to study patients medication
free. Patients had not received ECT for at least three
months. Twelve patients had required at least one
psychiatric admission.
Twenty patients who had recovered from depression previously
fulfilling DSMIV criteria for a major depressive disorder (16
requiring inpatient treatment), and twenty normal healthy
volunteers were also examined. Volunteers were recruited
from the paramedical and administrative staff from the
hospital, and from the community through infomal contact.
Subjects from both these groups were individually matched
for age, sex, intelligence and years of education with the
CTRD patients. Patients with recovered depression were
matched for age of onset, for onset of the index episode and
for total number of depressive episodes, with the CTRD
group. Recovery was defined as scoring five or less on the
Hamilton Rating Scale for Depression (HRSD) (Hamilton,
1960) for at least three months prior to the study.
Recovered patients were either on a stable medication (n=9)
for at least two weeks prior to the study, or were
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medication free (n=ll).
Healthy volunteers had no lifetime history of significant psychiatric
illness, using the SADS-L interview schedule (Endicott &
Spitzer, 1978). Exclusion criteria were previous manic
episodes, organic cerebral pathology, significant alcohol or
substance misuse, head injury associated with significant
loss of consciousness, or concurrent use of exogenous
steroids.
5.2.2 Neuropsychological and clinical assessment
All subjects were interviewed using the lifetime version of the
Schedule for Affective Disorders and Schizophrenia (SADS-
L) (Endicott & Spitzer, 1978). All available casenotes were
reviewed in detail, providing RDC diagnoses and allowing
lifetime histories of psychiatric illness to be determined.
Treatment and illness histories were re-constructed from
casenotes and from interview, allowing an estimation of
lifetime illness duration, age of onset and age at onset of last
episode. The number of hospitalisations, cumulative length
of psychiatric hospitalisation and cumulative number of
ECT treatments were ascertained from case notes and were
used as indices of cumulative illness severity (Appendix 5.1).
The presence of specific psychotic symptoms (delusions or
hallucinations) through the illness history was noted.
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All subjects underwent neuropsychological and clinical testing in a
standardised environment, within a two day period.
Symptom severity was measured using the HRSD
(Hamilton, 1960), the severity of psychomotor retardation
using the observer rated Widlocher scale (Widlocher, 1983)
and cerebral dominance using a handedness scale(Annett,
1970). Subjects also performed the National Adult Reading
Test-Revised(Nelson & Willison, 1991), to estimate pre¬
morbid IQ, and a battery of neuropsychological tests
described in the next chapter.
5.2.3 MR image acquisition and analysis
All subjects were scanned within one week of the clinical assessment.
MR images were acquired on a 1.0 Tesla Siemens
Magnetrom SPE system, with subjects undergoing a
magnetisation prepared rapid acquisition graded echo
(MPRAGE) sequence, acquired perpendicular to the
anterior-to-posterior commissure (AC-PC) line. This
sequence produces high resolution images with good
contrast between white and grey matter (TR = 10ms, TD =
500ms, TI = 200ms, flip angle = 12 degrees, block size =
240mm, 128 contiguous slices with an effective slice
thickness of 1.875mm). Image analysis was performed on a
SPARC workstation (Sun Microsystems Europe Inc.) using
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ANALYZE (CNS Software), and SPM'96 for spatial
normalisation and statistical parametric mapping (Friston et
al, 1995a; Friston et al, 1995b) running in MATLAB (The
Mathworks Inc.).
In ANALYZE, images were first corrected for field inhomogeneities
with a phantom image using image algebra, then converted
to 8-bit images and flipped to reverse right and left to
comply with the neurological convention. Within the
SPM'96 software, images were first spatially normalised into
standard space (Talairach et al, 1988) and then segmented
into grey matter, white matter, cerebro-spinal fluid and
skull/ scalp compartments, using an automated and
operator independent process. Spatial normalisation
involved reading image data in coronal orientation and
linearly deforming them using a 12-point affine
transformation to fit a Tl-weighted template image which
included skull and scalp. Nearest neighbour interpolation
was used to preserve tissue type boundaries and the
original intensity spectrum of the image. The normalised
image has a voxel resolution of 1 x 1 x 2mm. Images were
then segmented using a modified clustering algorithm
based on the maximum likelihood "mixture model"
(Elartigan, 1975) which allows classification of tissue type, as
well as tissue density. The algorithm uses a combination of
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the underlying multinomial distribution of T1 relaxation
times, and a series of a priori probability images for each
tissue type, where each voxel represents the prior
probability of tissue at a location belonging to a particular
compartment. The multinormal distribution reflects the
distinct T1 intensity clusters from different tissue types. The
essential assumption is that the range of T1 relaxation times
reflect different tissue types and, within each distribution,
different tissue densities. A priori segmented probability
images provide approximate spatial distributions of
different tissue types. These were derived from averaging
the spatially transformed segmented images of grey, white
matter and CSF from MRIs of healthy volunteers. The
intensity distribution of the probability image ranges
between 0 and 1. The algorithm is iterative and has the
effect of biasing voxel classification towards the a priori
distribution (Appendix 5.2). Prior to statistical comparison,
the spatially normalised segments were smoothed with a
12mm FWITM isotropic Gaussian kernel to remove
variation due to individual differences in sulcal and gyral
patterns. The segmentation procedure used in this study is
more sophisticated than the method previously applied by
Wright et al (Wright et al, 1995). Tissues are classified
having continuous values between 0 and 1 based on
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probability, whereas the earlier technique classified tissue
only as 0 or 1, in binary fashion. In addition, by smoothing
the data, the partial volume effect is used to convert
differences in the amount of grey matter locally into
differences in intensity.
5.2.4 Dexamethasone Suppression Test
A dexamethasone suppression test was given to all subjects within
the week after all clinical, and neuropsychological testing
and imaging were completed. Dexamethasone (lmg) was
taken at 10 pm, two blood samples were collected at 9.30
am and 4 pm the next day. An indwelling cannula was
inserted into a forearm vein thirty minutes before the first
sample, and was removed after the last sample. Samples
were immediately centrifuged and the serum promptly
frozen and stored at -400C. Total plasma Cortisol
concentrations were determined by RIA using a
modification of the method of Seth and Brown (Seth &
Brown, 1978), as described by Christie et al (Christie et al,
1986). All samples were measured in the same assay. The
sensitivity of the assay was 16 nmol/1. The intra-assay
coefficient of variance of a low quality sample (150 nmol/1)
was 6.1%, of a high quality sample (400nmol/l) was 8.9%.
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5.2.5 Statistical comparison
An ANCOVA model was applied which removed global tissue
density for each subject. This normalises the transformed
and segmented brain image to the same total amount of
tissue, whilst preserving regional differences in tissue
density. Age-effects were also removed by ANCOVA.
Differences between groups were displayed as statistical
parametric maps (SPMs), with a threshold probability7 of 1%.
Statistical clusters were projected on to a T1-weighted MRI
template to facilitate interpretation of the results. Corrected
probability values were computed which took into account
the whole volume examined, the smoothness of the data,
the size of the cluster with p < 0.01, and the peak effect (Z-
value). Group demographic and clinical data were
compared using univariate ANOVA and post-hoc t-tests to
identify specific group differences. Non-continuous
variables were compared using the Kruskal-Wallis, Mann-
Whitney U and chi-squared tests, as appropriate. Spearman
non-parametric correlations were also used, as appropriate.




5.3.1 Comparison of clinical data.
The three groups did not statistically differ in age, sex, cerebral
hemispheric laterality, years of education, estimated
premorbid 1Q and for the total number of years smoking
(table 5.1), although there was a tendency for the CTRD
patients to have a lower NARTIQ particularly in
comparison to control subjects, and to be right-lateralised to
a lesser degree. The mean age of onset of the first and most
recent, and lifetime number of depressive episodes did not
differ between the treatment resistant and recovered
groups. The CTRD group had a longer current episode and
total duration of illness, and had greater number and longer
total hospitalisations (table 5.1, appendix 5.1).
All CTRD patients were taking antidepressant drugs. Additionally,
twelve patients took regular neuroleptic medication, five
lithium and three benzodiazepines. Eleven of the RD group
were medication free. Nine of the recovered patients were
prescribed antidepressants, one also received neuroleptics
and one lithium.
Both the CTRD and RD patients had, or previously had melancholic
depressive episodes- the CTRD group had endogenous/
melancholic symptoms as measured by the Newcastle scale
(Carney et al, 1965) and fulfilled the DSM-IV criteria for a
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Table 5.1: Comparison of 20 CTRD patients, RD patients and













Mean age (SD) 48.9 (9.8) 47.7 (9.9) 49.3 (11.8) 0.89
Male: female ratio 13:7 13:7 13:7
Handedness score (SD) 13 (16) 16 (13) 19 (5) 0.27
Years Education (SD) 11.7(2.9) 13.4 (3.4) 13.5 (2.9) 0.12
Nart IQ (SD) 107 (12.7) 113 (10.2) 115 (8.7) 0.06 CTRD=RD
CTRD<C
HRSD score (SD) 20.6 (5.3) 2.6 (1.7) 0.2 (0.7) <0.0001 CTRD>RD>C
Widlocher score (SD) 26.1 (8.6) 2.2 (3.6) 0.3 (0.7) <0.0001 CTRD>RD>C
Total years smoking
(SD)








Age onset last episode
(SD)
45.8 (10.1) 44.8 (9.8) 0.76
Total number of episodes
(SD)
2.2 (1.4) 2.5 (1.9) 0.52
Longest duration of
episode in weeks (SD)
197 (125) 46(36) <0.001
Lifetime total illness
duration in weeks (SD)
263 (133) 76 (58) <0.001
Total number of
hospitalisation (SD)
3.8 (5.3) 1.3 (1.2) 2.06 (0.05)
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depressive episode with melancholic features
(American Psychiaric Association, 1994). The RD patients
also previously fulfilled DSM-IV criteria for having
depressive episodes with melancholic features.
The CTRD patients had moderately severe depressive symptoms (17-
item HRSD, mean: 20.6, sd: 5.3, range: 10 to 30) and
moderately severely psychomotor retardation (table 5.1).
Although not clinically depressed, scoring five or less on the
HRSD, and not fulfilling the criteria for a major depressive
episode, the recovered depressed patients had significantly
more depressive symptoms and more clinically observed
motor retardation than controls (table 5.1). This was not a
medication effect: there was no difference in either HRSD
score (3.3, (SD= 1.3) vs 2.0, (SD= 1.8); t= -1.82, p=0.9) or
Widlocher score (2.1, (2.7) vs 2.4, (4.3); t= 0.16, p= 0.88)
between medicated (n=9) and medication free (n=ll)
recovered patients.
Although not significant, the CTRD patients had a tendency to have
been smokers for longer than both controls (mean=20.4
years (SD= 13.6) vs 12.1 (16.6); t= 1.72, p-0.09) and the RD
patients (20.4 (13.6) vs 12.3 (13.7); t= 1.85, p= 0.07).
Post-dexamethasone morning and afternoon Cortisol values did not
differ between the three groups. Median values for chronic,
recovered patients and controls were 16.0, 21.6, and 24.0
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nmol/1 (c2 = 4.1, p=0.13, corrected for ties) and 16.5,21.1,
and 23.4 nmol/1 (c2 = 0.3, p=0.85), respectively. Values
ranged between 16.0 and 44.6 nmol/1 (0.58 -1.61 mg/dl) in
the morning, and 16.0 and 82.4 nmol/1 (0.58 - 2.97 mg/dl) in
the afternoon, i.e. all subjects were suppressors (Carroll et
al, 1981).
5.3.2 Regional differences in grey and white matter, and CSF
A three group comparison of increases and decreases in each of the
three tissue compartments yielding eighteen SPMs. There
were no significant differences in any of the tissue
compartments between the recovered patients and controls.
Tables 5.2, 5.3 and 5.4 show that only the CTRD group had
changes in all three tissue compartments in comparison to
the recovered and control group. Since there was almost
exact convergence of the areas of difference with CTRD
patients, and as there was no significant difference between
the recovered group and controls in any of the three tissue
compartments, the recovered and control groups were
combined and jointly compared against the remaining
twenty images from the chronically depressed patients. The
combination of resultant SPMs from this comparison is
illustrated in Figure 5.1.
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5.3.2.1 Limbic changes (table 5.2)
The CTRD group had reduced bilateral hippocampal and
parahippocampal grey matter density particularly
anteriorly and more marked on the left. There was an
overlapping increase in white matter density over bilateral
anterior hippocampi and medial temporal lobe. Similarly,
there was reduced grey matter density in the left Broadman
area 24 (rostral anterior cingulate) in only the CTRD
patients, with an associated increase in white matter density
in the same area, extending into the anterior corpus
callosum. Finally, right basal ganglia tissue density was
reduced, with a corresponding increase in the overlying
right lateral ventricular CSF in only the CTRD group,
suggesting an anatomical volume reduction in right
striatum.
5.3.2.2 Cortical and other changes (tables 5.3 and 5.4)
There were large grey matter density reductions in the left superior
and medial temporal gyri with white matter density
reductions in the right medial temporal gyrus. The right
superior frontal gyrus had small reductions in grey matter
density in the CTRD group, with the adjacent medial frontal
gyrus having grey matter increases. There were large
111
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reductions in white matter density in the right medial and
superior frontal gyri and a corresponding large increases in
CSF over the right frontal lobe, suggesting an anatomical
reduction in anterior frontal lobe. The changes were less
marked in the left frontal lobe- grey matter changes were
not seen, there were small white matter reductions in left
medial and supeior gyri, with a corresponding increase in
overlying CSF. Finally, grey matter density was increased
in the left cuneus, precuneus and lingual gyrus in the CTRD
group, with a milder increase in bilateral cerebellum.
Interestingly, grey matter decreased and white increased in
the right pecuneus and posterior cingulate.
5.3.2.3 Volumetric analysis
The above results predict that volumetric reductions would be
confined to right basal ganglia and right anterior (prefrontal
cortex) in only the CTRD group. Appendices 5.3 and 5.4(1-
5b) describes the methods and results of volumetric
analysis. Volumetric analysis confirmed the prediction that
CTRD patients had reduced volume of right prefrontal
tissue and right caudate, particularly in comparison to




5.3.3.1 Correlation between clinical variables
Table 5.5 shows the Spearman correlation co-efficients between
clinical variables. The number of past psychiatric
hospitalisations, the cumulative duration of in-patient
treatment and the cumulative number of ECT administered
were closely correlated. There was a close correlation
between the observed severity of psychomotor retardation
(Widlocher score) and current severity of depressive
symptoms (HRSD score) in both CTRD and RD groups, but
not in controls. In the CTRD group, both the current
severity of retardation and depression were associated with
cumulative severity of illness (cumulative number of ECT).
Both the Widlocher and HRSD scores had a tendency to
correlate with cumulative duration of in-patient stay. In
contrast, both the total duration of illness and apparent
premorbid IQ did not correlate with any of the measures.
Current age and age of onset of depression were positively
correlated in both the CTRD (Spearman's o= 0.57, p= 0.004)
and RD (cr= 0.52, p= 0.009) groups, suggesting the age of
onset was later in older patients. In the CTRD group, age
of onset positively correlated with Newcastle score and
negatively with total number of episodes, suggesting onset
of depression at an older age was associated with a more
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Table 5.5: Spearman correlations between clinical features of illness.
HRSD No. Past Total Total Total Premorbid
Score psychiatric number time in illness IQ
hospitalisations of ECT hospital duration
Widlocher 0.76 0.34 0.52 0.40 0.12 0.03
score (<0.001) (0.14) (0.018) (0.077) (0.62) (0.91)
Premorbid IQ 0.08 -0.17 -0.27 0.06 0.15
(0.74) (0.49) (0.26) (0.82) (0.54)
Total illness -0.12 0.40 (0.08) 0.35 0.34
duration (0.61) (0.13) (0.14)
Total time in 0.26 0.87 0.84
hospital (0.26) (<0.001) (<0.001)
Total number 0.42 0.87
of ECT (0.067) (cO.001)
No. Past 0.28 p- values in parentheses
psychiatric (0.22)
hospitalisations
melancholic type depression and fewer episodes (Table 5.6).
There was no correlation, however, between current age or
age of onset and number of ECT, number and duration of
hospitalisations. Thus older onset patients had not recieved
more or less ECT than younger patients. Current age
negatively correlated with total duration of illness.
In the RD group, current age and age of onset both positively
correlated with number of ECT received (Table 5.6). Age of
onset negatively correlated with total illness duration and
number of episodes. Thus, later onset recovered patients
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Table 5.6: Correlations between age and clinical variables in the
two patient groups
CTRD group RD group
Widlocher score -0.15 (0.25) 0.24 (0.16)
HRSD score 0.25 (0.14) 0.28 (0.11)
Tot. Duration of illness -0.4 (0.039) 0.08 (0.36)
Total number of episodes -0.46 (0.02) 0.13 (0.3)
Total duration of
hospitalisation
-0.35 (0.07) 0.14 (0.29)
Total lifetime ECT -0.31 (0.09) 0.52 (0.009)
No. of previous psychiatric
hospitalisations
-0.3 (0.099) 0.18 (0.22)
had received more ECT, suffered depression for shorter time and had
fewer episodes than younger recovered patients. There
were no other correlations with age of onset. Finally, there
was no correlation between clinically measured retardation
(Widlocher score) and age or age of onset in either of the
patient groups.
5.3.3.2 Grey density correlations with clinical features
A. Cumulative illness severity
As the total number of psychiatric hospitalisations, the cumulative
duration of hospitalisations and the cumulative number of
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Figure 5.3. Negative correlations between grey density and total number of ECT in CTRD patients
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Figure 5.4. Negative correlations between grey density and number of psychiatric hospitalisations
in CTRD.
Saggital Coronal Transverse
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Figure 5.5. Negative correlations between grey density and total duration of psychiatric
hospitalisations in CTRD patients
Saggital Coronal Transverse
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Figure 5.6. Negative correlations between grey density and total number of ECT in CTRD patients
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7159 <0.001 (0.006)
-33, 48, 24 (4.54)
-26, 49, 28 (4.35)




L medial frontal (9/ 10)
L. superior frontal (9)
L superior frontal (10)
4096 <0.001 (0.032)
57, -50, 40 (4.03)
54, -63,16 (3.83)




R. inferior parietal (40)
R medial temporal (39)




Figure 5.7. Negative correlations between grey density and total number of ECT in CTRD patients
controlling for age and type of depressive symptoms (Newcastle score).
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
11,15, -2 (5.04)






R caudate/ subgenual cing (25)
L caudate
1533 0.014 (0.028)
-19, -56, -14 (4.65)
-22, -66, -18 (4.05)






L. lingual (19)/ cerebellum
4512 <0.001 (0.025)
-60, -34, 32 (4.36)
-52, -55, 42 (4.01)




L inferior parietal (40)
L inferior parietal (40)
L medial temporal (21)
9179 <0.001 (0.003)
-19, 44, 44 (4.32)





L. superior frontal (8)
L medial frontal (9/ 10)
L. superior frontal (10)
3846 <0.001 (0.039)
37, 45, 26 (4.25)
12, 56, 32 (4.18)




R medial frontal (9/ 10)
R superior frontal (9)
R superior frontal (10)
5879 <0.001 (0.011)
23, -59, -8 (4.24)
22, -52, -12 (4.06)






R fusiform (19)/ cerebellum
3750 <0.001 (0.042)
55, -62,18 (4.10)
43, -83, 8 (3.58)




R medial temporal (39)
R occipital (19)




Figure 5.8.Reductions and increases in grey matter density in CTRD compared to RD patients,




Reductions in grey density in CTRD patients
Co-ordinates of peak uncorrected p-value Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) (corrected) (Broadmann area) (voxels) value (corrected)
-38, -16, -28 (3.63)
-25, -29, -8 (3.52)








Increases in grey density in CTRD patients
Co-ordinates of peak uncorrected p-value Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) (corrected) (Broadmann area) (voxels) value (corrected)
1, -67, 24 (4.21)
7, -89, -4 (4.02)










Figure 5.9. Negative correlations between grey matter density and total illness duration in CTRD
patients, controlling for age and sex.
Saggital Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
16, -31, 0 (4.49) <0.001 (0.05) R parahippocampal (30) 7095 <0.001 (0.007)
-13, -31, 0 (4.44) <0.001 (0.58) L parahippocampal (30)
-8, -24, 2 (3.71) <0.001 (0.29) L thalamus
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Figure 5.10. Negative correlations between grey matter density and current severity of depressive
symptoms (HRSD score) in CTRD patients.
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p-value Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) (corrected) (Broadmann area) (voxels) value (corrected)
8, 50, 26 (3.48) <0.001 (0.83) R. medial frontal (9) 3701 0.001 (0.045)
9, 58,18 (3.39) <0.001 (0.89) R. medial frontal (10)
-6, 49, 12 (3.26) <0.001 (0.96) L. medial frontal (10)
15, -68, 14 (3.30) <0.001 (0.94) Rcuneus 1261 0.025 (0.52)
19, -60, -4 (3.05) 0.001 (1) R lingual (19)/ cerebellum
19, -59, -20 (2.69) 0.004 (1) R cerebellum
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Figure 5.11. Negative correlations between grey matter density and clinically rated motor







Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
8, 51, 20 (4.62) <0.001 (0.03) R. medial frontal (9/10) 2719 0.002 (0.08)
6, 47, 8 (3.61) <0.001 (0.70) R. medial frontal (9)
-2, 60, -4 (3.35) <0.001 (0.92) L. medial frontal (10)
Positive correlations between grey matter density and clinically rated motor retardation (Widlocher
score) in CTRD patients, controlling for age.
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
64, -37, -12 (4.83)
65, -21, -18 (4.10)




R medial temporal (21)
R inferior temporal (20)
R medial temporal (21)
2657 0.002 (0.047)
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Figure 5.12. Negative correlation between grey matter density and age in CTRD.
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
-1, 48, 36 (5.61)
1,12, 54 (5.13)





R. superior frontal (6)
R Posterior cingulate (31)
20309 <0.001 (<0.001)
20,-63,14 (4.35)
-17, -81, -18 (4.22)




R posterior cingulate (31)
L fusiform (19)
R lingual gyrus (17)
15637 <0.001 (<0.001)
-24, 43, 34 (3.82)





L superior frontal (9)
L superior frontal (9)







Figure 5.13. Negative correlation between grey matter density and age in RD.
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-












65, -23, 32 (4.25)




R precentral gyrus (6)
R. postcentral gyrus (2)









L. postcentral gyrus (40)
L sup. medial temporal (38)
3861 <0.001 (0.04)
-2, -12,12 (3.74)
-26, -44, -14 (3.67)










Figure 5.14. Negative correlation between grey matter density and age of onset in
RDs.
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
-62, -28,16 (4.43)
-56, 5, -14 (4.06)




L. superior temporal (42)
L medial temporal (21)
L. insular cortex
4583 <0.001 (0.023)
52, -54, 40 (3.56)
57, -59,14 (3.31)




R. Lateral parietal (40)
R. superior temporal (22)
R. Lateral parietal (40)
2094 0.004 (0.19)
1,45, -20 (4.33)
5, 54, -18 (3.63)














L. medial frontal (10)
L. medial frontal (10)
L. medial frontal (10)
928 0.043 (0.53)
Figure 5.15. Positive correlations between grey matter density and duration of tobacco smoking
history in CTRD patients.
Saggital Coronal Transverse
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
-28, -33, -24 (4.10)
-29, -42, -26 (3.77)








37, 21, -40 (3.75)






R. supeior temporal (38)
R. supeior temporal (38)
R. supeior temporal (38)
1248 0.025 (0.52)
30, -58, -30 (3.42)
20, -36, -26 (3.30)








Negative correlations between grey matter density and duration of tobacco smoking history.
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
38, -82, -14 (4.36)
30, -84, -18 (3.60)









ECT received were closely correlated in the CTRD group, it
is not surprising that correlations between grey matter
density and these three variables were almost identical. As
figures 5.2, 5.3 and 5.4 show, cumulative ECT and total
number of hospitalisations were negatively correlated with
bilateral superior frontal and inferior parietal gyri, bilateral
medial and superior temporal gyri and bilateral caudate.
There were similar negative correlations between extensive
areas of bilateral temporal grey matter density and
cumulative hospital admissions, involving frontal regions to
a lesser degree (figure 5.5). Notably, all three variables did
not correlate with either hippocampal or rostral anterior
cingulate grey matter. The correlations with lifetime
numbers of ECT were unaffected after accounting for the
current severity of depression (using the HRSD score as a
co-variate, figure 5.6) or the degree of endogenicity (using
the Newcastle scale score as co-variate, figure 5.7). Hence,
increasing cumulative severity, and not current severity or
type of the illness, was associated with neocortical
reductions in grey matter density.
The group comparison of grey matter density between the CTRD
and RD groups was repeated, controlling for the number of
ECT administered as well as age. As expected, (figure 5.8)
the only significant reduction was in left hippocampal grey
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matter density, the neocortical reductions in the CTRD no
longer present. Thus, reduced left hippocampal grey matter
density in the CTRD group was unrelated to the cumulative
illness severity (or lifetime number of ECT). Interestingly,
the large increases in precuneal grey matter and the small
increases in bilateral cerebellar grey also remained,
suggesting that these too were unrelated to the cumulative
severity of depression.
There were no significant correlations between grey matter density
and number of ECT in the recovered group.
B. Estimated cumulative illness duration
In contrast, the estimated total duration of illness did not correlate
with neocortical grey density reductions but instead with
brain stem/ posterior cingulate grey matter reduction
(figure 5.9).
C. Clinical features of depressive illness
Both the severity of current depressive symptoms, measured with
the HRSD (figure 5.10), and clinically rated psychomotor
retardation, measured by the Widlocher scale (figure 5.11),
were significantly negatively correlated with bilateral
medial frontal gyrus (Brodmann areas 9 and 10). This is not
surprising as both clinical measures were highly inter-
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correlated. In contrast, there were no significant
correlations between grey density and Newcastle scale
score.
Finally, the nine patients with CTRD who had at some time in their
illness experienced hallucinations or delusions were
compared with the eleven who had not. Patients who had
had psychotic symptoms showed small grey density
reductions in right inferior and right superior frontal cortex,
before correction for multiple correction.
D. Current age and age of onset.
There was no correlation between age and grey matter density in the
controls. Both patient groups, however, showed highly
significant negative correlations between grey matter
density and age (figures 5.12 and 5.13) in bilateral fronto-
medial prefrontal cortex (Brodmann areas 9 and 10),
extending around the medial surface, including the cingulate
and extending posterior to the precentral gyrus. Brodmann
areas 9 and 10 grey matter also negatively correlated with
age of onset in the RD patients (figure 5. 14), but not the
CTRD group. There were no other significant correlations
with age of onset. Age was also positively correlated with
cerebellar grey matter, particularly in the RD group.
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E. Duration of smoking history
Surprisingly, there was a strong positive correlation between the
number of years a patient had smoked tobacco and bilateral
cerebellar grey matter, in the same regions in which there
were group differences in grey matter density (figure 5.15).
The correlation was significant even after correction for
multiple comparisons.
5.4 Discussion
5.4.1 General points on the group comparisons of MRIs
There are two broad points:
1. CTRD patients have MRIs which differ from two comparator
groups.
At its simplest, the results show that only CTRD patients had
differences in tissue density in comparison to healthy
controls and recovered patients. The pattern of differences
in the CTRD group compared with controls was almost
identical to the comparison with recovered patients. This is
particularly important when considering unpredicted
differences in tissue compartments- the argument for these
being chance findings is weakened, if found in two groups.
There was no difference between the recovered and control groups
in any tissue compartment and therefore they could be
formed into a single group. This had the effect of increasing
the power of the group comparison with the CTRD group.
It is interesting that the recovered patients had no tissue
differences compared to healthy controls. This contrasts
with the recent finding of hippocampal volume reductions
in recovered elderly women (Sheline etal, 1996).
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2. SPM analysis may be more sensitive and comprehensive than
conventional volumetric analysis.
Conventional volumetry simplifies the analysis of MRI data into
counting numbers of voxels, and therefore volume, in only
specific regions of interest formed by a priori hypotheses.
In contrast, VBA examines the intensity of all voxels and is
hypothesis free. The core assumption in traditional
volumetry is that the MRI reflects structure. However, this
is a simplified interpretation of MRI data- T1 weighted MRI
images are a "snapshot" of cerebral water distribution at a
point in time. The intensity of a single picture element,
representing the net signal from a block of tissue (a voxel)
depends on the water content of the voxel. In turn, the
voxel water content depends on the tissue characteristics (eg
lipid content) but may also depend on focal biochemistry
and blood flow, which may be a temporary, state
dependant change. Thus, Tl-weighted MRIs may reflect
both anatomical and state dependant effects.
Clearly, voxel intensity differences are important as these distinguish
the CTRD group- in fact, reductions of T1 intensity values in
depression has been previously found. However, as will be
illustrated later, the form of VBA used, SPM, may detect a
range of changes from gross structural atrophy, lesser
degrees of structural change with changes in tissue density
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only, to differences possibly representing local change in the
biochemical environment. This is made possible by
examining complimentary changes in all three tissue
compartments.
5.4.2 An interpretation of MRI changes in patients with CTRD
The results of SPM analysis suggest two areas of atrophy in the
CTRD group- right basal ganglia and bilateral, particularly
right, frontal lobes. This prediction was confirmed on
conventional volumetric analysis. In the SPM analysis, there
was both reduced right striatal tissue density and an
increase in overlying CSF. In the frontal lobes, there were
large reductions in prefrontal white matter, particularly on
the right, with a corresponding increase in bilateral CSF.
However, grey matter was spared in left prefrontal cortex,
with both increases and decreases in right grey matter. One
possiblilty is that the CTRD group mainly had white matter
atrophy, with relative grey matter preservation: with
shrinkage of the right frontal lobe, grey matter moved
away from the skull, producing apparent decreases in grey
matter on the cortical surface, but increases at the edge with
white matter.
Other volumetric studies support these findings- the most reliably
demonstrated structural difference found during depression
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is of frontal lobe and basal ganglia volume reductions
(Soares & Mann, 1997). Whether this represents state
dependant change or is irreversible cannot ultimately be
answered by this cross-sectional study, especially as
apparent atrophy on MRI has been found to reverse to
some extent with illness resolution in conditions such as
anorexia nervosa and alcohol dependence (Swayze et al,
1996) (Trabert et al, 1995). However, as will be discussed
below, the results suggest that neocortical change may be
related to the cumulative severity of illness, and thus,
acquired.
In contrast, focal changes in tissue water or biochemical composition
without volumetric change, may explain the reciprocal
decreases and increases in grey and white matter densities
respectively in Brodmann area 24). A consideration of MRI
signals and of the method of analysis may be useful at this
point. With atrophy, CSF replaces grey and white matter
and produces a darkening of the voxels. If, however, water
density or content diminishes without cell death, possibly
through focal biochemical change or sclerosis, the T1 signal
would appear brighter, with signal intensities resembling
white matter. As voxels are segmented by the approximate
spatial distributions of tissue and by voxel intensity, and as
hippocampal grey and white matter is closely intertwined,
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brighter voxels may be segmented into the white matter
compartment instead of grey, reducing grey matter density,
but increased white matter densities. Because of this, and as
there was no increase in CSF in the lateral ventricle abutting
on to the hippocampus, no volumetric change would be
expected on the basis of these results. This contrasts with
the results from Sheline et al. (Sheline et al, 1996) who found
reduced bilateral hippocampal volume, particularly left
sided, in recovered elderly women with a history of
recurrent depression, in a high resolution volumetric MRI
study. Hippocampal volume reduction was correlated with
total illness duration.
Similarly, biochemical and not volumetric change may explain the
changes in Brodmann area 24 (rostral anterior cingulate
cortex). This area is of particular interest as recent evidence
suggests that hypoperfusion in this area may predict
treatment non-response (Mayberg, 1997; Mayberg et al,
1997). The results are consistent with this hypothesis, but
do not support Drevet's hypothesis of volumetric change in
Brodmann area 25 (subcallosal anterior cingulate) as a
marker for familial affective disorder (Drevets et al, 1997).
However, both patient groups in this study were a mixture
of both familial and non-familial affective disorders, and so
this hypothesis could not be directly examined.
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Interestingly, change in both these areas was not related to
the cumulative severity or total duration of illness.
The large grey matter density reductions in the left temporal lobe
were not accompanied by reductions in white matter
density or an increase in CSF. Presumably this reflects
subtle structural change or a change in the biochemical
environment. There is a large body of evidence suggesting
reduced temporo-limbic perfusion or metabolism during
depression (Amsterdam & Mozley, 1992; Austin et al, 1992b;
Mayberg et al, 1994), but equivocal evidence for atrophy - in
elderly patients, chronicity may be associated with increased
ventricle to brain ratio (Roy-Byrne et al, 1988), with
decreased right temporal volume (Altshuler, 1993) and with
decreased amygdala-hippocampus volume (Axelson et al,
1993). The results of this study, however, would predict no
volumetric change, as was confirmed on volumetric
analysis.
There was increased white matter density in the anterior corpus
callosum in the CTRD group. There has been reports of
increases, decreases and no difference in callosal cross-
sectional area in the literature (Hauser et al, 1989; Coffman
et al, 1990; Wu et al, 1993), but their significance is unknown.
Interestingly, Wu et al (Wu et al, 1993) found increased
callosal size in unipolar patients. There was also evidence of
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increased cerebellar grey density in only the CTRD group.
There is some evidence that cerebellar structures may form
part of the network involved in emotional regulation, and
that metabolic differences exist in cerebellar vermis in those
with depression (Bench et al, 1992; Shah et al, 1992). The
increases in grey and white matter densities in the precuneal
region are more difficult to understand with current models
of depression.
5.4.3 An interpretation of the clinical correlates of MRI changes
By allowing correlational analysis, SPM may help identify some of the
influences in producing brain changes in CTRD. There were
three important clinical correlates of grey matter density
(cumulative severity of depression, psychomotor
retardation and age) and one unexpected correlate (tobacco
smoking).
A. Cumulative severity
Cumulative severity of illness (lifetime number of ECT) not
purely illness duration, was associated with neocortical
frontal and temporal grey matter density reductions in in
the CTRD group, suggesting that these changes were
acquired. The hippocampal and rostral anterior cingulate
reductions were not related to cumulative severity, which
was confirmed when the CTRD and RD groups were
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compared controlling for the number of ECT given- grey
matter density reductions in the left hippocampus were still
found in the CTRD group.
Although there are no studies directly comparable to this, there is
some evidence suggesting that chronicity, independent of
diagnosis, may be associated with temporal lobe changes in
a number of ways.
First, Ebmeier et al (Ebmeier et al, 1998) have shown that late onset
depression is associated with reduced temporal lobe
perfusion which is related to the severity of periventricular
hyperintensities. Such hyperintensities are associated with a
poorer prognosis and treatment resistance (Hickie et al,
1995). Greenwald et al (Greenwald et al, 1996) have also
demonstrated that patients with late-onset depression have
left medial temporal lobe atrophy. Thus it may be that
disrupting the function of the left temporal lobe acts as a
vulnerability factor in maintaining illness.
Second, it is well established that patients with depression
show a dysregulation of the hypothalamic-pituitary-adrenal
axis. Up to 70% of patients have raised levels of Cortisol,
which generally are not suppressed by dexamethasone
(Dinan, 1994). A continuing positive dexamethasone
suppression test, despite apparent clinical improvement,
may predict rapid relapse and possibly chronicity
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(Amsterdam etal, 1983; Targum, 1983). Animal work
suggests that chronically raised Cortisol can facilitate
hippocampal neuronal death, which in turn may cause
dysregulation of the HPA-axis (Sapolsky et al, 1986;
Jacobson & Sapolsky, 1991). Importantly, dysregulation of
the HPA axis is not diagnosis specific, and can also be found
in patients with schizophrenia, who have reduced
hippocampal volumes. Chronicity in schizophrenia also
appears to associate with reductions in left temporal lobe
volumes (DeLisi et al, 1991). However, since hippocampal
damage may disinhibit the HPA axis and cause
hypercortisolaemia, these associations do not establish the
direction of the effect. Interestingly, our chronic patients
did not exhibit dexamethasone non-suppression, suggesting
that hypercortisolaemia may not be an important factor
maintaining chronicity in this sample. However, since we
did not obtain baseline measures of Cortisol and this was a
cross-sectional study, the possibility of present or previous
HPA dysfunction cannot be discounted.
Third, grey matter change may be an antecedent to chronic
depressive symptoms or their treatment. Obstetric
complications may be more frequent in patients with early
onset depression or with bipolar disorder (Done et al, 1991;
Guth et al, 1993; Kinney et al, 1993). In schizophrenia, such
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complications have been linked to neurodevelopmental
brain abnormalities, in particular left temporal lobe volume
reduction (Waddington, 1993; O'Callaghan et al, 1995),
which may reflect reduced cerebral lateralisation. One
study (DeLisi et al, 1991) found that patients with chronic
schizophrenia had smaller left temporal lobe volumes than
a reference group of patients examined during their first
illness episode. Similarly, our patients with chronic
depression showed a tendency to less lateralisation, if
compared with recovered patients or healthy controls. It is,
therefore, possible that neurodevelopmental abnormalities
in patients with unipolar depression, particularly affecting
the left temporal lobe, may predispose to chronicity.
B. Age and psychomotor retardation
In both patient groups, older patients had later onset illness and had
fewer episodes of depression than younger patients. In
only the patient groups was older age associated with
reduced grey matter density in large areas in medial frontal
cortex, particularly Brodmann areas 9 and 10, as well as
parts of the cingulate cortex. This could not be attributable
to general ageing- controls did not exhibit such a
correlation.
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In the CTRD group, patients with later onset depression had more
melancholic features, measured by the Newcastle scale,
motor retardation being a feature of melancholia. Both
older age and increasing motor retardation correlated with
reduced medial prefrontal grey matter density, particularly
Broadman areas 9 and 10. Recovered patients had residual
psychomotor retardation, previously also had melancholic
depression and exhibited grey matter correlations with age
in the same way as CTRD patients. The RD patients also
showed a negative correlation between age of onset and
medial prefrontal grey matter density. Thus, these results
suggest that the later the onset of depression, the larger the
reduction in grey matter density in medial prefrontal
regions, regardless of outcome, and that this reduction was
a marker for increasing motor retardation found only in
those had depression. Further, as cumulative severity, or
number of ECT was related to the severity of retardation in
the CTRD patients, illness severity and age of onset may
interact- thus, patients with severe late onset depression
may be expected to have the greatest reduction in medial
prefrontal grey density. This conclusion has support from
existing literature. Functional imaging studies suggest that
prefrontal hypoperfusion may be associated with motor
slowing. Curran et al (Curran et al, 1993) for example, found
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an age effect in medial prefrontal perfusion in depressed
patients- older patients with melancholic depression showed
greater medial prefrontal hypoperfusion than younger
patients. Structural change during depression is most
commonly found in the elderly, particularly in those with
severe illness and particularly in frontal regions (Coffey et
al, 1993). Further, on recovery, residual motor slowing has
been found in both young (O'Brien et al, 1993) and elderly
(Abas et al, 1990) patients, although associated structural
change is found only in the elderly (Abas et al, 1990). Thus,
although it is acknowledged that late onset depression in
the elderly is associated with structural change (Krishnan et
al, 1997), the results presented here suggest that older age
and age of onset in non-elderly populations is also
associated with structural change. Taken with the findings
of fronto-striatal atrophy, a possible interpretation is that
motor retardation in melancholic depression is not fully
reversible, even on recovery, which suggests an enduring,
accumulative effect of depression associated with biological
change in fronto-striatal regions, and which becomes more
prominent with increasing age.
There are a number of interpretations of the association between age
and medial frontal grey matter reductions in the depressed
group. As age more than age of onset had greater
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correlation, it may be that depression, regardless of
outcome has a "premature ageing" effect in these areas. It
may also be that depression has an exaggerated effect in the
presumably more vulnerable, older brain. It is known, for
example, that medial frontal areas, particularly cingulate,
show age-related metabolic reductions in normal controls
(Martin et al, 1991). Although it is possible that the controls
in this study had age related changes, any such changes
were not of sufficient magnitude to produce focal changes
in T1 values. It may be that such an effect reflects a
neurotoxic effect of, for example, Cortisol. However, both
recovered and chronically depressed patients were
dexamethasone suppressors, suggesting no ongoing
hypercortisolaemia. Further, the hippocampus and not the
cingulate, is usually regarded as the structure most
susceptible to Cortisol induced damage (Sapolsky etal, 1986).
Alternatively, it may be that the balance of aetiologies for
depression changes with age, as is the case in old age
depression. The results of this study support the notion that
the increasing risk of severe depression with age (Eagles &
Whalley, 1985) may be mediated by structural brain
changes, suggesting that structural change in fronto-medial
cortex is a marker or vulnerability factor for depression in
older age, but not predictive of outcome. However, as this
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study was cross sectional, the causal relationship cannot
ultimately be resolved, requiring longitudinal studies.
The existing literature provides support for the involvement of a
striato-frontal system (Robbins et al, 1992) and, in particular,
inferior and medial frontal dysfunction in the biology of
depression and an association with psychomotor
retardation (Austin et al, 1992b; Curran et al, 1993; Mayberg
et al, 1994) (Bench et al, 1992; Dolan et al, 1994). In fact, some
authors regard motor retardation as a core feature of
depression, particularly in patients who exhibit melancholic
symptoms(Widlocher, 1983; Parker et al, 1993). This
concept has recently undergone a renaissance, strengthened
by the findings from neuroimaging and neuropsychological
studies. Functional imaging studies, for example, have
found reductions in blood flow in frontal areas, related to
increasing psychomotor retardation (Bench et al, 1993)
(Dolan et al, 1993) (Curran et al, 1993). Medial orbito-frontal
cortex activation has also been found in association with
reinforcement and reward (Rolls et al, 1997) and with
induction of different mood states in healthy volunteers
(Pardo et al, 1993; George et al, 1995; Baker et al, 1997).
Further, recent studies have found in vivo changes in right
striatal dopamine suggestive of reduced dopamine release
in depression, related to the severity of motor retardation
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(Ebert et al, 1994a; Ebert el al, 1996; Shah el al, 1998), again
implicating fronto-striatal pathways in depression.
Characterisation of cognitive deficits in depression also lend
support to a fronto-striatal deficit, which may be
irreversible, raising the possibility of a "fronto-striatal or
fronto-subcortical" dementia (reviewed in Robbins et al,
1992). Massman et al (Massman et al, 1992), for example
found that a subgroup of depressed patients exhibited a
"subcortical dementia" memory profile, a prominent feature
being difficulty with speed related tasks. Further, motor
speed, unlike most other cognitive measures, may not
normalise with recovery from depression (Abas et al, 1990)
(Beats, 1996) (O'Brien et al, 1993), is not sensitive to diurnal
variation during depression, unlike most other
psychometric measures (Moffoot et al, 1994), and correlates
negatively with the number of depressive episodes and
with measures of cerebral atrophy (Abas et al, 1990),
suggestive of an irreversible, cumulative effect.
As with hypercortisolism, temporal lobe changes and chronicity,
these psychomotor and structural changes may not be
diagnosis specific. There are, for example, parallels with
findings from schizophrenia where frontal lobe atrophy and
hypoperfusion has been associated with the negative
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symptoms of schizophrenia(Dolan etal, 1993) which are also
regarded as an expression of a reduced dopaminergic
function in the mesolimbic system. In another study (Chua
etal, 1997), the severity of left ventromedial prefrontal
atrophy correlated with the degree of psychomotor
poverty (ie poverty of speech, flattening of affect,
retardation of action) in schizophrenia. In fact, chronically
depressed patients have been found to have similar levels of
negative symptoms compared to patients with
schizophrenia (Harvey et al, 1997). Such converging
evidence raises the issue of the difficulty in separating
"negative symptoms" from some of the symptoms of
depression and may argue not only for a phenotypic
similarity between slowing in depression and negative
symptoms in schizophrenia, but a shared, final common
biological pathway, speculatively involving dopamine in
medial frontal regions.
C. Tobacco smoking
Unexpectedly, there was a strong positive correlation between the
duration the CTRD patients had smoked and grey matter
density in bilateral cerebellum. The CTRD patients had a
tendancy to have been smoking for longer than the other
two groups, and the cerebellar increases were unrelated to
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any of the clinical factors. Tobacco contains a number of
psychoactive substances, including nicotine which can have
effects on cholinergic receptors. It has been claimed, for
example that people who smoke tobacco have an altered
risk of dementia risk of dementia (Leibovici et al, 1999;
Merchant et al, 1999; Wang et al, 1999). Thus, it may not be
unexpected to find cerebral metabolic change in association
with smoking. Despite this, the association with cerebellar
grey matter density remains unexplained.
Three other regions had grey matter changes unrelated to any of the
clinical factors examined- the hippocampi, the rostral
anterior cingulate and the precuneus. The rostral anterior
cingulate (Brodmann area 24) reductions only appeared in
the CTRD group, suggesting that it could be a state-
independant marker of treatment non-response, as
suggested by Mayberg (Mayberg et al, 1997). Interestingly,
in the patients who had recovered, there was a trend
positive correlation between number of ECT and rostral
anterior cingulate grey matter density. Hippocampal
change in T1 values were also unrelated to any clinical
facotrs and were found only in the CTRD group, suggesting
that these changes may be state independent and a marker
of treatment resistance and chronicity. The correlates of the
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hippocampal changes will be examined in the next chapter.
Ultimately, however, the large changes in precuneus remain
unexplained.
5.4.4 Defining chronicity and treatment resistance
The patient sample was chosen to be extreme examples of chronicity
and 011 a continuum of treatment responsiveness (Bonne et
al, 1996), and to maximise the likelihood of having a sample
which exhibited cerebral abnormalities. Two years of
continuous symptoms was chosen to define chronicity as
the rate of recovery more or less reaches a plateau after
about eighteen months of illness (Keller et al, 1982; Keller et
al, 1984), suggesting the remaining patients form a stable,
unchanging cohort of patients. In fact, the sample of CTRD
patients examined well exceeded two years of active illness,
having a mean episode duration of 197 weeks (almost 4
years of continuous illness).
The definition of treatment resistance is necessarily arbitrary, and
varies considerably in the literature, most noticeably with
country. The criteria that were used in this study for
judging the adequacy of antidepressant dose and duration
was based on British National Formulary recommended
maximum doses, ensuring that the sample would be
considered as being treatment resistant by most British
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psychiatrists. In fact, the sample far exceed the minimum
criteria of treatment resistance, having had trials of multiple
adequately dosed antidepressants for sufficient periods of
time (Appendix 5.1).
Patients may be divided into having relative and absolute treatment
resistance depending on whether an adequate dose and
duration of antidepressant had been prescribed. However,
it could be argued that inadequate treatment itself may
predispose to cerebral change, if persistent hypercortisolism
mediates the neuronal damage. This is further supported
with the finding that chronicity is predicted by longer
duration of illness prior to treatment (Scott, 1988),
suggesting a progressive damaging effect of untreated
illness. Such a model may not be fully adequate to explain
how treatment resistant patients can still effect full
recoveries.
5.4.5 Measuring cumulative illness severity, total illness
duration and duration of illness before adequate
treatment.
Accurately measuring time related illness features requires a
longitudinal study. This study has the disadvantage of
being cross-sectional. Thus, measurements of lifetime
illness duration, severity over time and duration of illness
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without treatment may have varying reliability, dependent
on the quality of retrospective information from casenotes.
Fortunately, full clinical documentation was available on
both patient sample groups.
The advantage of using number of ECT treatments, total number of
hospital admissions and total duration of in-patient stay as
indices of cumulative illness severity is that these data could
be accurately measured. As hospital admission and ECT are
usually reserved for patients who are severely disabled with
illness, or for those with intractable illnesses requiring
assessment and treatment, it is not unreasonable to use
these indices as measures of illness severity over time. In
contrast, the estimate of lifetime illness duration has to be
regarded with caution as it is more dependant on patients'
recollections and the quality of clinical documentation. An
acceptably accurate estimate of duration of illness prior to
adequate treatment could not be obtained, as it was greatly
dependant on patients' recollections of distant events, which
itself could be subject to distortion by their present mental
state. Such an estimate requires accurate assessment and
documentation at first presentation and ideally,
corroboration by third parties at the time. As these were
not reliably available, an estimate of illness before treatment
had to be abandoned.
5.4.6 Alternative interpretations of the data
Although the groups were very closely matched, it could be argued
that the changes were related to treatment, specifically to
ECT. Whether such as association is causal, and if so in
which direction is not clear. However, there is little
evidence that ECT causes significant damage to
hippocampal or other brain tissue (Coffey et al, 1988;
Devanand et al, 1994; Scott et al, 1995), or changes cognitive
function greater than those produced by depression.
Further, there were no grey matter difference between
controls and the recovered patients, some of whom were
on psychotropic medication and had previously received
ECT. Also, ECT may be expected to produce prominent
hippocampal atrophy, as it is the most vulnerable to the
effects of seizure related hypoxia. However, there was no
correlation between ECT and hippocampal grey matter in
this study. This was underlined when the CTRD and RD
groups were compared controlling for the number of ECT
given- grey matter density reductions in the left
hippocampus were still found in the CTRD group. Further,
there was a positive correlation between total illness
duration and bilateral hippocampi after controlling for
cumulative severity. Because of this, and, as the total
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number of ECT administered, total duration of in-patient
stay and total number of hospitalisations were very closely
intercorrelated it seemed reasonable to regard the total
number of ECT administered as being an index of
cumulative severity. Efowever, the possibility of having a
treatment, or ECT related effect cannot be finally
discounted. Longitudinal studies are therefore required to
determine whether cortical atrophy predates particularly
severe illnesses which require ECT, or whether ECT causes
such changes.
It could also argued that motor slowing was a consequence of
repeated ECT particularly in those with later onset illnesses.
However, later onset CTRD patients had not received more
ECT than younger patients. Further, such enduring
cognitive effect has not yet been reported in the literature.
It is more likely that patients with motor retardation
received ECT, this being a factor predicting a good response
to ECT.
It could also be argued that the RD patients were still depressed.
However, the RD group had insufficient symptoms to reach
defining criteria for illness. Further, eighteen of the twenty
had returned to work, the other two being unemployed not
through the effect of illness and only of this group needed
psychiatric follow-up, for medication monitoring purposes
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only, suggesting symptomatic and functional recovery.
It could also be that the impairments seen were attributable to
medication. Although none of the CTRD patients were
drug free, about half of the recovered patients were
medication free. There was no difference in symptoms or
motor retardation between medicated and unmedicated
recovered patients.
Finally, it may also be that the brain changes, as with dexamethasone
suppression status, resulted from the effects of restricted
food intake and weight loss, often exhibited by depressed
patients. However, it is not clear why such changes should
be localised or lateralised to the left side. Such




1. Only patients with CTRD had changes in all three brain tissues in
limbic and subcortical areas. RD patients and controls did
not differ.
2. The CTRD patients had neocortical reductions in temporal and
frontal regions, which correlated with the severity of illness
over time, and therefore, possibly acquired.
3. The CTRD patients had right sided fronto-striatal atrophy,
confirmed on conventional volumetric analysis, which was
not present in the RD group. Both patient groups had age-
related reductions in fronto-medial grey matter (Brodmann
areas 9 and 10) which were also correlated with increasing
severity of motor retardation in the CTRD group, and with
age of onset in the RD group. The RD group continued to
have residual motor retardation, despite good
symptomatic, functional and social recovery. Thus, the
results suggest that later onset depression, which show
more endogenous features, is associated with acquired
fronto-medial structural change, with clinical and structural
features similar to a form of "sub-cortical" or "striato-frontal"
dementia becoming more prominent with older age. There
was some evidence that cumulative severity and older age
interacted, so that the most pronounced fronto-medial
reductions would be expected in the severely unwell, older
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patients. Although similar results are found in the elderly
depressed, these results suggest a relationship between
structural change and age in a mainly middle aged group.
4. Hippocampal and rostral cingulate reductions were not related to
cumulative severity, motor retardation, age of onset or to
any of the other clinical factors measured. It may be that
reduced grey matter density in these areas are markers for
treatment resistance.
5. Other influences, such as cigarette smoking history may have
pharmacological effects with secondary effects on cerebral
water distribution.
6. The increased grey matter density in the precuneus could not be
presently explained.
7. The form of voxel based analysis used in this study, SPM '96,
provided a more detailed and anatomically precise
examination of the MRI data. SPM analysis predicted right
fronto-striatal atrophy in the CTRD group, which was
confirmed on conventional volumetry. This effectively
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CHAPTER 6: CHRONIC, TREATMENT RESISTANT DEPRESSION
- MRI CORRELATES OF COGNITIVE IMPAIRMENTS.
6.0 Abstract
The pattern of cognitive impairments often found with depression
suggest temporal and frontal lobe dysfunction. Functional
and structural imaging studies also suggest temporal and
frontal dysfunction or atrophy, even on recovery,
particularly in the elderly. The patients we examined with
CTRD exhibited MRI changes in grey matter in frontal and
left temporal regions. It is therefore possible that impaired
cognitive function is associated with these structural
changes and is a marker for chronicity.
The profiles of cognitive function of twenty patients with CTRD,
twenty controls and twenty recovered patients were
compared using a battery of neuropsychological measures.
The scores from the neuropsvcholoeical tasks and the erevST j o c/ j
matter density of the different subject groups were
correlated using voxel based analysis to localise impaired
function to grey matter changes. Specifically, it was
predicted that verbal memory impairment would be
associated with reduced left temporal (hippocampal) grey
matter densitv, and measures of motor retardation would
j '
be associated with reduced prefrontal grey matter density.
An exploratory analysis was also performed of the clinical
correlates of the cognitive impairments, to distinguish state
dependant, accumulative and age-related cognitive
impairment.
Patients with CTRD were markedly impaired on verbal memory and
psychomotor speed dependant tasks, suggesting a
combined temporal and fronto-striatal functional deficit, but
were also impaired on almost all other neuropsychological
measures. They also showed a disparity between
educational years and predicted premorbid IQ. Recovered
patients showed significant slowing in reaction time
measures only, compared to controls.
As predicted, impaired verbal memory was associated with reduced
left hippocampal grey matter, and measures of
psychomotor slowing were associated with diminished
prefrontal cortex in the CTRD group. NART score also
correlated with medial prefrontal cortex in the CTRD group
only.
The exploratory analysis suggested that psychomotor slowing was
associated with increasing age, current and cumulative
illness severity in both patient groups. This suggests that
the prefrontal grey matter changes associated with motor
slowing were acquired and indicated an interaction between
age and cumulative severity. A prospective, longitudinal
study would be required to test this hypothesis.
The results help validate the differences in grey matter density found
in the CTRD group, the differences being associated with
the underlying dimension of function. The results also
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challenge the notion that depression related cognitive
impairment is fully reversible and suggest that it may be
associated with an age related, acquired, prefrontal





Over the past fifteen years, a wealth of evidence has confirmed that
even mild depression may be associated with cognitive
deficits in several domains. Miller (Miller, 1975) reviewing
the evidence, found that depression was associated with
deficits in a number of domains including the cognitive,
motor and perceptual. Further, Brown et al. (Brown et al,
1994), classifying depressed patients according to degree of
global cognitive impairment into unimpaired, borderline or
impaired groups, on the basis of performance on the
CAMCOG (a measure of global cognitive function), found
that even the unimpaired depressed patients showed clear
cognitive deficits on sensitive measures of language,
memory, attention and executive function compared to
controls, and that global cognitive function and degree of
neuropsychological impairment varied across the groups
despite the three depressed groups having identical mean
Hamilton depression rating scores. They concluded that
cognitive dysfunction could not be considered as an
"epiphenomenon of depressive symptomology" (Brown et
al, 1994). Numerous studies thereafter have demonstrated a
similar range of depression related cognitive deficits (Brown
et al, 1994; Beats, 1996; Elliott et al, 1996; Austin et al, 1992a;
Weingartner et al, 1981; Roy-Byrne et al, 1986; Austin et al,
1999).
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6.1.2 The importance of cognitive impairment in depression
Depression associated cognitive impairment is important for a
number of reasons. Firstly, although the exact causal
relationship between neuropsychological impairment and
depressive symptoms is unclear, it is known that
neuropsychological impairment per se, is a risk factor for
depression (Post, 1968; Devanand et al, 1996). This is
illustrated when examining patients with suspected
Alzheimer's disease- cognitive impairment can be
sufficiently severe to make the differentiation between early
Alzheimer's dementia and depression from clinical and
neuropsychological profile difficult. Not only can dementia
initially present with depressive symptoms, but a significant
proportion of patients (up to 10%) initially thought to have
an organic dementia, are later rediagnosed as having major
depression (Huppert & Beardsall, 1993; a "pseudodementia"
presentation). Thus, the type of marked cognitive
impairment, once thought to be the hallmark of dementia,
are frequently displayed by severely depressed elderly
patients.
Secondly, enduring cognitive impairment may be an indicator of
poor prognosis in a number of psychiatric illnesses. This is
best established in schizophrenia (Breier et al, 1991; Gold &
Harvey, 1993) where there is greater breadth of impairment
compared to depression(Goldberg et al, 1993) associated
with brain morphological changes (Goldberg et al, 1994).
1 7 A
The prognostic value of cognitive impairment in depression
has been shown in the elderly (Harvey et al, 1997) and
patients with bipolar affective disorder (MacKay et al, 1995).
Harvey et al. (Harvey et al, 1997) for example, compared
cognitive function in poor-outcome hospitalised geriatric
patients with affective disorders and hospitalised patients
with chronic schizophrenia and found no group differences,
suggesting that severe cognitive impairment may
characterise chronicity, regardless of diagnosis. Enduring
impairment in the elderly depressed may be a marker of
structural brain change potentially as a result of vascular
disease. Such "organic" depressions appear to be associated
with greater treatment resistance, greater morbidity and
mortality. In younger patients too, impaired cognitive
function may be associated with poor outcome (MacKay et
al, 1995). Thus, if younger patients also exhibit pervasive
cognitive impairment, it may argue in favour of structural
brain change.
6.1.3 Characteristics of cognitive impairment in depression
Apart from mood change, severely depressed patients often
prominently complain of lack of concentration,
forgetfulness, lack of motivation and a physical and mental
"slowing up", which can be as functionally disabling as
pathological mood change.
These impairments are confirmed when patients perform
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neuropsychological tests. Depressed patients exhibit
prominent deficits in episodic memory, particularly verbal
but also visuo-spatial memories (Austin et al, 1992a; Ilsley et
al, 1994). Additionally, patients consistently demonstrate
impairments on measures involving motor speed, decision
making and problem solving (Austin et al, 1992a; Moffoot et
al, 1994; Elliott et al, 1996), although the evidence for
impairment in measures involving short term memory or
attention is equivocal. Thus, patients demonstrate a wide
range of cognitive deficit, and not a specific pattern
attributable to the dysfunction of a single discrete neural
system, making it difficult to offer a viable hypothesis
explaining cognitive dysfunction both in terms of the
biological substrate and psychological mechanisms.
The problem may be in suggesting a unitary neuronal system
explantation encompassing the mood, motor and cognitive
changes seen in depression. It would not be unexpected if
the biological substrate for cognitive impairment differed in
hospitalised elderly men, particularly with late onset
depression whose depression may have a more vascular
cause (Krishnan et al, 1997), than for out-patient middle
aged women, whose depression may have a completely
different aetiology. Motivational deficits, for example, has
been advocated as a diagnosis-specific abnormality present
even on recovery, producing cognitive impairment (Elliott
et al, 1996; Elliott et al, 1997). Elowever, this has not been
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reproduced by others (Shah et al, 1999), possibly as a result
of selecting depressed patients with differing clinical and
aetiological characteristics, suggesting a diversity of
mechanisms producing cognitive impairment.
6.1.4 Major depression and subcortical dementia
Neuropsychological deficits in depression have previously been
conceptualised in terms of subcortical dementia. The
cognitive impairments seen in basal ganglia disorders such
as Parkinson's disease (PD) and Huntington's disease (HD),
which form the archetype for subcortical dementia, have
similarities with depression related cognitive impairment
(Elliott et al, 1996), with problems with attention,
bradyphrenia (ie slowed cognitive speed), problem solving
difficulties, visuospatial abnormalities, and marked
abnormalities of mood and affect being common to both
(Cummings, 1986; Cummings, 1992). Both also differ from
traditional cortical dementia (e.g. Alzheimer's disease) by
the absence of aphasia and apraxia. Further, patients with
PD and HD commonly develop depression (Cummings,
1992; Robbins et al, 1992), suggesting that disruption of
frontro-striatal connections could lead to affect
dysregulation. Hence it has been advocated that depression
is associated with a fronto-subcortical or fronto-striatal
dementia (Robbins et al, 1992).
1 7Q
6.1.5 Residual neuropsychological impairment on recovery
from depression.
Considering that there may be structural brain change in depression,
particularly fronto-subcortical, it is important to enquire if
neuropsychological function completely normalises on
recovery from depression. Full recovery would suggest
that cognitive performance was state dependant,
proportional to eg mood change. Further, if severity of
depression and cognitive impairment were independent of
each other, it may point towards different underlying
neural substrates.
A number of studies have examined this, finding that motor speed
tasks may be independent of mood (Moffoot et al, 1994),
may not fully recover with symptomatic resolution (O'Brien
et al, 1993) (Abas et al, 1990) and may be associated with
structural change, particularly in the elderly (Abas et al,
1990). Moffoot et al. (Moffoot et al, 1994) examined the
neuropsychological impairments in melancholically
depressed in-patients during the 'trough' and 'peak' of their
diurnal mood state. Measures of attention and
concentration, working memory, and episodic memory
varied with mood state, but impairment in motor speed
tasks did not, suggesting that motor impairment may
partially be independent of mood state and have a distinct
neurobiological basis.
Abas et al. (Abas et al, 1990) examined elderly depressed patients
i so
before and after recovery and found that recovery left
some depressed patients (about 30%) with residual motor
slowing and some memory impairment. Further, the
residual cognitive impairment was significantly correlated
with increased ventricular brain ratio measured on
computerised tomography scans. The authors felt that the
persisting impairments were not due to subclinical
depression or possibly dementia, but suggested that
repeated relapses were associated with increasing cognitive
decline and increasing cerebral atrophy.
Finally, O'Brien (O'Brien et al, 1993) examined young (in their 30's),
medication free patients with seasonal affective disorder
(SAD) during and on recovery from depression, using the
CANTAB. The scores on most tests improved on recovery,
except on response latency to a spatial memory recognition
task. This continued impairment correlated with the
severity of residual depressive symptoms. However, unlike
the elderly depressed patients in the study by Abas et al
(Abas et al, 1990), no significant relationship was found
between any measure of cognitive function and ventricular
brain ratio.
Thus, it appears that, although most measures of cognitive function
improve on recovery from depression, there may be
residual cognitive impairment mainly in psychomotor
speed but also some aspects of memory, and most
prominently in the elderly. Such residual cognitive
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impairments may be related to permanent changes in brain
morphology, possibly in striato-frontal regions, particularly
in elderly patients.
6.1.6 Aims of this study
The main aim of this study was to profile of neuropsychological
deficits in CTRD and recovered patients and establish the
functional associations of reduced grey matter density in the
CTRD group - specifically, it was predicted that measures of
episodic verbal memory would correlate with hippocampal
grey matter, and measures of retardation (such as measures
of reaction time) would correlate with basal ganglia and
prefrontal grey matter. These correlations would
effectively confirm the biological significance of any
observed group differences, as these differences would then
be not only categorical, but also related to the underlying
dimensions of function.
The other aim was to explore the clinical correlates of
neuropsychological impairments. The most consistent
finding from previous studies is of fronto-striatal atrophy,
and of enduring motor slowing even on recovery from
depression, particularly in the elderly. However, it is not
known if these changes are acquired, or preceded the
development of illness. It may be that depression results in
structural change reflected in residual slowing on recovery.
If such an effect was accumulative, the degree of motor
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slowing may be expected to reflect illness duration or
cumulative severity, and be independent of current overall
severity. Alternatively, if structural changes preceded the
development of depression, neuropsychological measures
may not be correlated with clinical variables. However, as
this is a cross-sectional study, this analysis has to be
regarded as exploratory.
6.2 Methods
6.2.1 Subjects, MRI technique and Statistical methods
Please see sections 5.2.1, 5.2.3 and 5.2.5 for details of the three groups
examined, MRI sequences and statistical comparison
methods. Group comparisons of neuropsychological test
scores were identified using one-way ANOVA, with post-
hoc t-tests for individual measures. Non- parametric
correlations were performed between test scores and
clinical variables as the clinical variables were not normally
distributed.
6.2.2 Neuropsychological and clinical assessment
All subjects were interviewed using the lifetime version of the
Schedule for Affective Disorders and Schizophrenia (SADS-
L) (Endicott & Spitzer, 1978). All available casenotes were
reviewed in detail, providing RDC diagnoses and allowing
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lifetime histories of psychiatric illness to be determined.
Treatment histories were re-constructed from casenotes and
from interview. The total number of hospitalisations,
cumulative length of psychiatric hospitalisation and
cumulative number of ECT treatments were ascertained
from case notes and were used as indices of cumulative
illness severity.
All subjects underwent neuropsychological and clinical testing in a
standardised environment, within a two day period.
Symptom severity was measured using the HRSD
(Hamilton, 1960) and the severity of psychomotor
retardation using the observer rated Widlocher scale
(Widlocher, 1983). Subjects also performed the following
battery of neuropsychological tests in the order specified
below:
1. Handedness scale (Annett, 1970): scoring between +24
(extreme righthandedness) and -24 (extreme
lefthandedness).
2. Maximal voluntary contraction (MVC): Following Cohen
et al (Cohen et al, 1982), who demonstrated that depressed
patients exhibited motor performance deficits in proportion
to the severity of depression, each subject squeezed a
dynamometer as hard as possible. This was repeated three
times for each arm. The three trial for each arm was
averaged to give a measure of maximum voluntary
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contraction.
3. National Adult Reading Test-Revised (NART, (Nelson &
Willison, 1991)), a conventionally accepted reliable estimate
of pre-morbid IQ.
4. The Adult Verbal Learning Test (AVLT (Rey, 1964; Lezak,
1983)); a test of new verbal learning ability, immediate and
short term memory recall and recognition. A fifteen item
list is presented verbally and needs to be recalled imediately
after five consecutive repetitions. After 30 minutes free
recall and recognition are both tested. The test minimises
any possible effect of poor attention span by repeated
presentations, and thus may be useful in depressed patients
(Sweeney et al, 1989).
5. Digit span forwards and backwards (DSF, DSB): a test of
concentration and immediate recall. This was presented and
scored as in the Weschler Memory Scale-Revised (Wechsler,
1987).
6. Trails-making A and B (Army Individual Test Battery,
1944): this tests attention, concentration and psychomotor
speed. Trails-B also requires the ability to shift cognitive set
and is therefore more demanding a task.
7. The STROOP (ref) task, a measure of motor speed and of
set shifting, and thus, of executive (frontal lobe) function.
8. Verbal Fluency (Borkowski et al, 1967): this task is
regarded as a test of frontal lobe function and consists of
generating as many words beginning with the letters F,A
1
and S as possible in 3 sixty second periods.
9. Reaction time tasks from the CANTAB computerised
psychometric testing battery (Sahakian & Owen, 1992),
which allow for a separate determination of the response
initiation and movement times.
10. Simultaneous and delayed match to sample (SDMS) test
from the CANTAB computerised psychometric testing
battery (Sahakian & Owen, 1992); a measure of visuo-spatial
memory also yielding measures of response latency to
making a choice. This involves identifying the matching
design to a complex pattern presented at four different
times after the presentation of the index pattern.
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6.3 Results
The comparison of demographic and clinical variables is shown in
table 5.1 and has already been described in section 5.3.1.
6.3.1 Group comparison of neuropsychological test scores
Table 5.1 and 6.1 summarises the comparison of test scores.
6.3.1.1 NART score
Although the three groups were matched for years of eduction, the
NART score was lower in the CTRD group compared to
controls, with a trend difference compared with the
recovered group. This was reflected in the correlational
analysis- years of eduction and NART score were, as
expected, closely correlated in the recovered and C groups,
but were not in the CTRD group (Table 6.2).
6.3.1.2 Verbal memory and motor speed tasks
Overall, the CTRD group exhibited large impairments in almost all
tests compared to both recovered and C groups, except in
simple tests of concentration and attention (Digits forwards
and backwards) and in the measure of effort or central
motivational state (maximal voluntary contraction). The
largest differences seen in the CTRD group were in verbal
memory measures (AVLT) and measures explicitly
involving response speed (reaction time, Stroop test, and
Trails A and B). There were smaller impairments in the
visuospatial memory task, the verbal fluency task and a test
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(n-18) (n=20) (n=20) ^2/57
Right arm 40.0 (13.2) 39.9 (10.8) 38.3 (14.7) 0.11 (0.90)
Left arm 37.5 (9.8) 38.2 (10.4) 37.4 (12.3) 0.03 (0.97)
Verbal
memory
(n=19) (n=20) (n=20) ^2/58
AV5 9.68 (2.26) 12.4 (1.87) 13.1 (1.39) 18. 4 (<0.0001) CTRD<RD,C
AVT 40.5 (13.5) 52.7 (8.3) 54.8 (7.7) 11.35 (0.0001) CTRD<RD,C
AVB 4.68 (1.38) 5.55 (1.70) 6.55 (1.76) 6.4 (0.003) CTRD<RD,C
AV6 8.05 (3.27) 11.45 (2.35) 11.1 (2.34) 9.4 (0.0003) CTRD<RD/C














Reaction time (n=18) (n=20) (n=20) ^2/57
"Thinking"
latency
670 (223) 549 (91) 483 (62) 8.6 (0.0006) CTRD>RD>C
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(n=13) (n=17) (n=19) ^2/48
MST(S) 8.9 (1.2) 9.4 (0.9) 9.5 (0.9) 1.45 (0.25)
MST(O) 7.7 (2.0) 8.6 (1.2) 8.6 (1.0) 1.83 (0.17)
MST (4) 7.3 (1.8) 8.6 (1.4) 8.7 (1.2) 4.20 (0.02) CTRD<RD,C
MST (12) 5.9 (1.9) 7.4 (1.9) 7.4 (1.2) 4.02 (0.02) CTRD<RD,C
MST (Total) 29.8 (5.6) 33.9 (4.1) 34.3 (2.6) 5.58 (0.007) CTRD<RD,C
Stroop (n=19) (n=18) (n=18) ^2/54
STRPW 111 (3.2) 112 (0) 112 (0) 0.9 (0.4)
STRPP 21.5 (27.4) 58.5 (37.7) 70.8 936.0) 10.7 (0.0001) CTRD<RD,C
STRPT 68.1 (23.0) 52.9 914.7) 53.4 (6.1) 5.2 (0.009) CTRD>RD,C
STRPWC 35.6 (23.1) 11.8 (12.5) 8.8 (13.4) 12.9 (<0.0001) CTRD>RD,C
Trails A and
B
(n=19) (n=20) (n=20) ^2/58
Trails A 46.6 (17.4) 31.3 (12.0) 31.6 98.1) 8.8 (0.0005) CTRD>RD,C
Trails B 111.3 (35.9) 66.5 (24.2) 59.3 (11.7) 23.3 (<0.0001) CTRD>RD,C
Verbal
fluency
(n=19) (n=20) (n=20) ^2/58
Total of
three letters
36 (12.8) 44 (10.2) 48 (12.5) 5.2 (0.008) CTRD<RD,C
of strategy (six elements test), thought to examine the
integrity of the frontal lobes, where response speed was not
important.
1 RQ







In verbal memory, the CTRD patients had impaired learning,
delayed active recall of material and impaired passive
recognition of words previously presented. The CTRD
patients did not differ on the index of "forgetting" compared
to both the recovered and C groups. Recognition was
particularly impaired - there was better passive recognition
than active recall in the recovered patients (13.4 (1.4) vs 11.3
(2.2); t= 5.29, p<0.001) and controls (12.2 (2.8) vs 11.1 (2.9); t=
2.71, p=0.01) groups, but not in the CTRD group (mean= 8.2
(SD=4.8) vs 8.1 (3.9); t=0.25, p=0.8).
The recovered patients did not differ in any of the
neuropsychological measures except for reaction time, a
relatively pure measure of motor retardation. Within the
reaction time test, the greatest impairment in both CTRD
and recovered groups was movement latency time. This
was not related to medication status, as there was no
difference in reaction time or any other motor speed or
i on
memory related task between medicated and unmedicated
recovered patients.
6.3.2 Exploratory correlation between grey matter density and
neuropsychological measures.
6.3.2.1 Correlation with NART score
NART score showed positive correlations with grey matter density in
bilateral orbito-frontal/ medial frontal cortex and left
occipital (figure 6.1), and a negative correlation with
bilateral cerebellar grey matter density in only the CTRD
and not the recovered and control groups. Because of the
group difference in NART score, the grey matter group
comparisons were repeated controlling for NART score
(figure 6.2). The CTRD patients still had reduced grey
matter density in left hippocampus and left temporal
neocortex, compared to the combined recovered and C
group, though the frontal neocortical reductions in grey
matter density disappeared.
6.3.2.2 Correlation with verbal memory scores
As predicted, verbal memory performance correlated with left
hippocampal grey matter density in the CTRD group
(figure 6.3). Delayed recognition from the AVLT was
chosen, as it was particularly impaired in the CTRD group.
Left hippocampal grey matter density was not related to the
1 Q1
Figure 6.1. Positive correlation between grey matter density and NART score in
CTRD.
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Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
9,63,-6 (4.17)






R. infero-medial frontal (11/ 43)
R. inferior frontal (43)
4629 <0.001 (0.02)
-46, -76, -10 (4.40)
-51, -68, -10 (4.24)




L. medial occipital (19)
L. medial occipital (19)
L. medial occipital (19)
4136 <0.001 (0.03)
-46, 43, -10 (3.69)
-12, 64, -2 (3.66)




L. fronto-medial (10/ 47)
L. superior frontal (10)
L. superior frontal (11)
2826 0.001 (0.09)
33, -70, -8 (4.0)
22, -62, -10 (2.86)










Figure 6.2. Reductions in grey density in the CTRD vs combined controls and RDs, controlling
for the effects of age and NART score.
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
-64, -23, 8 (3.81)





L. superior temporal (42)
L. precentral (4)
L. superior temporal (22)
3626 <0.001 (0.039)
-30, -18, -18 (3.64)
-34, -14, -26 (3.16)









Figure 6.3. Positive correlations between grey matter density and AVRC score (delayed
recognition of previously learnt words), controlling for age and NART score.
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Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
-35, -9, -30 (4.19) <0.001 (0.16) L. inferior temporal (20) 1741 0.009 (0.25)
-32, -28, -14 (2.70) 0.003 (1) L. hippocampus
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Figure 6.4. Negative correlations between grey density and total reaction time in CTRD.
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
26, -3,-24 (3.51) <0.001 (0.81) R. parahippocampal (35) 1461 0.017 (0.42)
36, 29, -20 (3.43) <0.001 (0.88) R. inf. frontal 47)
23, 5, -16 (3.16) 0.001 (0.99) R. inf. frontal (47)
-10, 10, -12 (3.13) 0.001 (0.99) L. subcallosal ant. cing. (25) 1306 0.022 (0.49)
-20, 11, -20 (2.99) 0.001 (0.99) L. inf. frontal (47)
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Figure 6.5. Negative correlations between grey density and total reaction time in CTRD
controlling for age.
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Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-
voxels (Z-statistic) value (corrected) (Broadmann area) (voxels) value (corrected)
23, 38, -20 (3.29)
34, 31, -18 (3.29)




R. sup. and med. frontal (11)
R. sup. and med. frontal (11)
R. sup. and med. frontal 11)
1570 0.013 (0.36)
-25, 46, -16 (3.64)
-10, 55, -18 (2.68)




L. medial frontal (11)
L. superior frontal (11)




Figure 6.6. Negative correlations between grey density and Trails B time in CTRD, controlling for
age.
Co-ordinates of peak uncorrected p- Anatomical region size of cluster uncorrected p-







R. inf. frontal/ sup. temporal
R. inf. frontal/ sup. temporal
R. inf. frontal/ sup. temporal
1407 0.018 (0.072)
-4, 24, -16 (3.49)
-3, 37, -10 (3.33)




L. medial frontal (25)
L. medial frontal (25)
R. medial frontal (25)
964 0.044 (0.71)
9, 61,10 (3.42)
8, 59, 18 (3.27)
















































































































































































































































































































































the number of ECT previously administered (see section 5.3.3.2).
6.3.2.3 Correlation with measures of motor speed
There was a negative correlation between total reaction time and
right orbito-frontal cortex in the CTRD group (figure 6.4)
but no correlation in both the controls and recovered
patients. This negative correlation remained after
controlling for age (figures 6.5). Time taken for the Trails B
task in the CTRD group negatively correlated with grey
matter density in right inferior frontal/ superior temporal
cortex (figure 6.6).
6.3.3 Clinical correlations of neuropsychological measures
Tables 6.3 and 6.4 show the Spearman correlations between
neuropsychological task scores and clinical variables in the
three groups.
6.3.3.1 Clinical correlations of NART score
In the CTRD group, NART score correlated with none of the clinical
variables, including cumulative severity (number of ECT)
and total duration of illness, and was not related to the
current severity of depression or retardation.
6.3.2.2 Clinical correlations of verbal memory (table 6.3 and 6.4)
In the CTRD group, the most impaired verbal memory measures,
delayed recognition (AVRC) and verbal learning (AV5),
?nn
were negatively correlated with measures of cumulative
severity (number of ECT, and number of hospitalisations)
and not with current symptom severity. The recovered
group showed no impairment in verbal memory and no
correlation with residual symptom severity or motor
retardation.
6.3.2.3 Clinical correlations of motor speed dependant tasks
(table 6.3 and 6.4)
In both the CTRD and recovered groups, measures with explicit
motor speed demands (reaction time, Stroop, and Trails
tasks) correlated with clinically rated motor retardation
(Widlocher score), thus providing validity for the Widlocher
scale. In both groups, motor tasks also correlated with the
HRSD score and the number of ECT previously
administered, suggesting that motor slowing reflected both
current and cumulative illness severity.
Performance on motor speed tasks slowed with age in both patient
groups, but not in controls. Greater motor slowing was
also associated with older age at onset of first and last
episodes. Age and age at first onset were positively
correlated in both patient groups, suggesting older patients
in this study had had a later first onset of illness. Thus, the
results suggest that both a later onset of illness, and a more





The main findings of this study were that:
a. Patients with CTRD had severe neuropsychological
impairments, particularly in episodic verbal memory and
motor speed tasks. As predicted, verbal memory
impairment correlated with reduced left hippocampal grey
matter density, and measures of motor slowing correlated
with prefrontal grey matter reduction. The results thus
support the notion that medial temporal and fronto-striatal
function is impaired in chronic depression and, suggest that
the functional correlate of right prefrontal atrophy found in
the CTRD patients is motor retardation.
b. Recovered patients had residual motor retardation,
measured clinically and objectively (using the reaction time
measure), but did not have fronto-striatal atrophy. The
degree of slowing was not related to medication.
c. CTRD patients had a reduced NART score, which
correlated with reduced medial prefrontal grey matter
density, suggesting performance on the NART was
sensitive to focal grey matter changes.
d. An exploratory analysis suggested that the degree of
verbal memory impairment in the CTRD group reflected
the cumulative severity of illness and not current severity of
symptoms. The degree of motor slowing on relatively pure
measures of speed reflected the current severity of
?n?
symptoms, cumulative illness severity and older age in both
patient groups. NART score did not correlate with any
clinical factor.
e. The form of voxel based analysis used, SPM'96, was a
valid form of analysis in correlating structure with function
on Tl-weighted MRIs.
6.4.2 Pattern of neuropsychological impairments
The chronic, treatment resistant depressed patients were particularly
impaired on episodic verbal memory tasks and tasks
involving psychomotor speed, but showed
neuropsychological impairments on almost all tasks, except
in those measuring attention, concentration and motor
effort. They also exhibited a disproportionate reduction in
NART score compared to that expected on the basis of their
educational years.
6.4.2.1 Verbal memory
Delayed recognition of previously learnt verbal material was the
most impaired verbal memory measure. Recent studies
have found that verbal recognition is impaired in
depression, particularly in those with melancholic
symptoms (Austin etal, 1992a; Austin et al, 1999), memory
impairment being proportional to the severity of
depression. There is also evidence that verbal memory is
dependent on the integrity of the temporal lobe.
Recognition has been found to depend on intact temporal
lobe function, whereas recall depends on working memory,
a pre-frontal cortical function (Goldman-Rakic, 1995).
Lesion experiments in animals (Squire, 1992; Squire et al,
1992) and clinical studies (Baxendale, 1997; Mayes &
Downes, 1997) also indicate the need for temporal integrity
for memory function.
6.4.2.2 Motor slowing
The CTRD patients showed prominent motor slowing on all tests
involving speed. However, only the reaction time task was
impaired in both patient groups, a task which has
previously been found to be a sensitive measure of motor
retardation (Shah et al, 1996). Further, of all the
neuropsychological tasks involving motor speed, it most
closely reflected the severity of clinically rated motor
retardation (Widlocher score) and symptoms in both patient
groups. The results suggest that the reaction time task may
be a sensitive measure of psychomotor retardation. Hence,
it is not unexpected that, of all the neuropsychological
measures, reaction time measures correlated with reduced
prefrontal cortex.
The reaction time task was also the only one in which recovered
patients continued to be impaired, the degree of
impairment correlating with the clinically rated measure of
motor retardation. This is in keeping with previous
?na.
evidence which has shown recovered patients to have
residual slowing after recovery from depression (O'Brien et
al, 1993) (Abas etal, 1990). Interestingly, structural change in
recovered patients has been found only in the elderly
(O'Brien et al, 1993) (Sheline et al, 1996)- we found no
significant structural differences in our sample of middle-
aged recovered patients.
The results of the exploratory correlational analysis were in keeping
with the findings outlined in chapter 5- objective measures
of motor slowing in both patient groups, particularly
reaction time, reflected both the current severity of
depressive symptoms, cumulative severity and age (see
section 5.4.3 (B) for further discussion). The conclusions
from this analysis have to be considered as hypothesis
generating, given the relatively small numbers of subjects in
the groups in comparison to the number of comparisons
made.
6.4.2.3 Premorbid IQ
Although the groups were matched for total number of years in full
time education, the CTRD group showed a mismatch
between educational years and predicted premorbid IQ
derived from the NART score. As NART scores and
educational years are usually closely correlated, and as the
NART score reduction in the CTRD group was unrelated to
any of the clinical factors, it suggests a non-progressive,
?n^
acquired effect. NART scores are traditionally regarded as
being resistant to pathologies associated with general
intellectual decline and has become the standard measure of
premorbid IQ. However, there is evidence that NART
scores may be dispropotionately reduced in patients with
melancholic depression and may be sensitive to focal brain
changes. Austin et al (Austin et al, 1999) examined a large
sample of depressed patients referred to a specialised mood
disorders clinic and found that patients with melancholic
depression had a lower NART derived premorbid IQ than
non-melancholic patients, despite being matched for years
education. Further, in patients with chronic schizophrenia,
who also exhibit broad cognitive impairment, NART may
not accurately measure premorbid IQ (Crawford et al, 1992)
and may be affected by left temporal lobe atrophy. Also,
patients particularly with left temporal lobe tumours
(Ebmeier et al, 1993) also exhibit a dissociation between
educational years and NART scores. The present results
suggest that NART score may also be sensitive to changes
in medial prefrontal cortex, which is part of the "dorsal
cognitive loop" involved in the regulation of a number of
executive functions.
6.4.3 Grey matter correlations
Although episodic verbal memory and tasks involving motor speed
were equally impaired, deficits in these tasks mapped to
?f>f3
different areas of the brain- verbal memory impairment
was associated with left hippocampal grey matter changes,
and motor slowing was associated with prefrontal grey
matter.
Thus, the results suggest that a pure fronto-striatal dementia model
may be insufficient to account for all the cognitive deficits
seen in depression. This is in broad agreement with the
findings from previous functional neuroimaging studies
(Bench et al, 1993; Curran et al, 1993; Dolan et al, 1993)
which find both frontal and temporal hypoperfusion during
depression, and neuropsychological studies (Elliott et al,
1996; Austin et al, 1992a; Austin et al, 1999; Greenwald et al,
1996) which show both mnemonic and psychomotor
impairments, again suggesting frontal and temporal lobe
impairment. Elliott et al (Elliott et al, 1996), for example,
tested the fronto- subcortical dementia hypothesis by
comparing the neuropsychological profile of depressed
patients with Alzheimer's disease, PD and HD using the
CANTAB battery of neuropsychological tests. As the
depressed patients were impaired on almost all tests, they
concluded that the impairments may be attributable to
combined fronto-striatal and temporal dysfunction. Austin
et al (Austin et al, 1992a) examined forty depressed patients
dichotomised into endogenous and neurotic groups on the
basis of the Newcastle score. They found that patients with
an endogenous symptom profile were particularly impaired
?07
on tests involving motor or cognitive speed. They also
found the depressed patients exhibited memory
impairment, suggesting medial temporal lobe involvement.
Fronto-subcortical dementia pattern may not be present in all
depressed patients. Massman et al. (Massman et al, 1992)
used discriminate function analysis to compare the
neuropsychological profile of patients with unipolar
depression, bipolar depression, Huntington's disease,
Alzheimer's disease, and normal controls. About half the
depressed patients had a normal memory profile, 30% a
subcortical dementia profile, and none a cortical dementia
profile. The patients with a subcortical dementia pattern
were most impaired on speed-dependent information
processing tasks such as the WAIS-R Digit Symbol Score,
Digit Symbol Incidental Recall Score, Trail Making B
performance, and Category Fluency, ie tests in which
patients with subcortical dementia have significant
impairment.
Greenwald et al (Greenwald et al, 1996) reported left medial temporal
atrophy to be correlated with cognitive impairment in late
onset depression, and Ebmeier et al (Ebmeier et al, 1997;
Ebmeier et al, 1998) reported reduced left temporal
perfusion in late onset depression. Finally, correlation of
left hippocampal volume with verbal memory performance
has been found in patients with schizophrenia (Goldberg et
al, 1994), who also have reduced hippocampal size (Suddath
?ns
et al, 1990; Lawrie & Abukmeil, 1998; Velakoulis et al, 1999).
Functional imaging studies have so far only provided
equivocal evidence (Fletcher et al, 1997).
Thus, fronto-subcortical involvement in depression may be most
applicable to patients exhibiting an endogenous symptom
profile with prominent psychomotor impairment, as has
been found in this study, with temporal lobe involvement
being present in patients with significant cognitive or
memory impairment.
6.4.4 Structural changes, chronicity and cognitive impairment
As the hippocampal changes were found only in the CTRD group,
and were associated with reduced episodic verbal memory,
it suggests that memory impairment may be a risk factor
for (continuing) poor outcome.
There is supportive evidence from the literature that cognitive
impairment is associated with chronicity- McKay et al.
(McKay et al, 1995) have found that patients with chronic
bipolar affective disorder suffer substantial cognitive
impairment. Harvey et al. (Harvey et al, 1997) found no
difference in cognitive function between poor-outcome
hospitalised geriatric patients with affective disorders and
hospitalised patients with chronic schizophrenia, suggesting
that chronic illness may be associated with severe cognitive
impairment, regardless of diagnosis. Importantly, their
?HQ
patients with chronic affective disorder suffered comparable
levels of negative symptoms as younger patients with
chronic schizophrenia, suggesting an overlap of symptoms
common to chronicity in both conditions.
There are also parallel findings in patients with other chronic
psychiatric diagnoses. Hippocampal atrophy has also been
found in patients with schizophrenia (Woodruff et al, 1997;
Lawrie & Abukmeil, 1998; Velakoulis et al, 1999) as well as
in severe PTSD (Bremner et al, 1995). Thus, it has been
suggested that left hippocampal changes may be markers of
chronicity, regardless of diagnosis (Velakoulis et al, 1999).
Interestingly, left hippocampal volume may be reduced in
patients with first-episode psychosis (Velakoulis et al, 1999),
suggesting the presence of a neurodevelopmental
abnormality. The results of this present study also show the
left hippocampal grey matter changes are not related to
illness duration or severity, although verbal memory
impairment was worse with increasing cumulative illness
severity. Clearly, the aetiological relationship between
memory impairment, hippocampal changes and chronicity
cannot be resolved in a cross-sectional study such as the
present one, and requires longitudinal study.
6.4.5 Correlational analysis using SPM'96 provided valid
results
The pattern of correlation of grey density reductions with cognitive
?in
impairments were consistent with findings from previous
functional and structural imaging studies (Bench et al, 1993;
Dolan et al, 1993; Curran et al, 1993) and help validate the
use of this form of voxel based analysis in analysing MRI
images. The validity of voxel based analysis in analysing
MRI images has also been shown in a study by Wright et al
(Wright et al, 1995) who were able to reproduce the findings
from volumetric analysis in a sample of patients with
schizophrenia. The form of voxel based analysis used here
(SPM '96) is more sophisticated than the one used by Wright
et al (SPM '95) (Wright et al, 1995) as tissue densities in the
latter had binary values (0 or 1), whereas in this study, the
range of signal intensities was preserved, with density
values ranging from 0 to 1). It is, therefore likely that voxel
based analysis may be usefully employed in analysing MRI
images, and may provide a more complete and sensitive
analysis than traditional volumetry.
6.4.6 Limitations of study
A limitation of the study, is that it was cross-sectional in design.
Thus, although the clinical correlations of cognitive
impairments may provide clues as to whether the
impairments were acquired, accumulative or trait
dependent, the exact causal relationship cannot ultimately
be ascertained in this study, emphasing the need for
longitudinal studies.
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A further criticism of the study could be the lack of correction for
multiple comparisons in the correlational analysis between
neuropsychological and clinical measures. This part of the
analysis has to be regarded as exploratory and aimed to
generate as opposed to testing hypotheses. Nevertheless,
the relationship between both clinically rated and
objectively measured motor retardation, medial frontal
cortex and age or age of onset is robust, and consistent with
the established evidence, as is the relationship between
episodic verbal memory and left hippocampus. However,
further studies would be needed to directly test the
hypotheses generated by this study.
A final criticism is the relatively small numbers involved in each
group. Small group size would increase the likelihood of a
type 2 error ie. incorrectly accepting the null hypothesis. In
this circumstance, only large differences or strong
associations would be detected.
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6.5 Summary
1. Patients with CTRD showed marked impairments in episodic
verbal memory, speed dependant cognitive tasks and
measures of general cognitive ability compared to both
controls and recovered patients. They were also impaired
in tasks of executive function to a lesser degree, but not
impaired in measures of attention and working memory.
2. Impaired episodic verbal memory correlated, as predicted, with
left hippocampal grey matter density, thus providing
validity for the group difference, as it correlated with
underlying function. Hippocampal grey matter change and
verbal memory impairment were found only in the CTRD
group. Thus, hippocampal change may be markers for
chronicity, a conclusion supported by similar findings in
patients with chronic schizophrenia.
3. Objectively measured motor slowing correlated, as was predicted
from the existing evidence, with reduced grey matter in
inferior prefrontal cortex. The relationship between
clinically rated retardation, age and prefrontal cortex was
broadly reproduced using objective measures of retardation
in both patient groups. Patients who had recovered from
depression were impaired on reaction time measures which
were the most sensitive to motor retardation. The results
are in concordance with the findings from chapter 5.
4. NART scores were dispropotionately reduced in the CTRD group
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compared to that expected on the basis of years of
education. This reduction correlated with reduced grey
matter density in medial prefrontal cortex, implicating this
area in broader, cognitive processes.
5. The particular type of voxel based analysis used, SPM'96, produced
results localising episodic verbal memory and motor
slowing to left hippocampus and inferior prefrontal cortex
respectively, as was predicted on the basis of the existing
literature. This provides validity for the use of voxel based
analysis in analysing MRI data.
6. There are striking similarities in the cognitive deficits in patients
with chronic depression and chronic schizophrenia, together
with a convergence in the brain areas involved in the
pathology of both conditions. It therefore suggests a







The thesis starts by reviewing evidence from recent functional imaging studies
which confirm that limbic and subcortical structures are involved in the
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temporal regions. These changes should be associated with functional
change- the evidence reviewed suggests that frontal hypometabolism
may be associated with motor slowing and disruption in executive
tasks (Austin et al, 1992a; Moffoot et al, 1994; Elliott et al, 1996; Austin
et al, 1992b; Curran ei al, 1993; Dolan et al, 1994), such as planning, and
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evidence also suggests that VBA is a valid method of analysing
metabolic and perfusion data (Friston et al, 1995a; Friston et al, 1995b),
allowing the localisation of functional changes in depression to be
defined in a more spatially precise manner.
7.2 Striatal dopaminergic activity in depression
The primarv ouestion in the first experiment was if there was evidence of
l /I i
reduced striatal dopaminergic activity in those with depression. Using
r ' -IBZTvl, a SPET ligand with high D2/' 3 receptor specificity and
moderate affinity, there was evidence of increased specific uptake of
the ligand at the right striatum in depressed patients, suggesting
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1996; Ebert, 1998). Striatal IBZM uptake normally depends on both
receptor density and competition with endogenous ligand. SPET
imaging cannot allow absolute quantification of receptor density.
Therefore, it is not possible to state unequivocally that increased
uptake represents reduced endogenous dopamine release, but, several
lines of evidence suggest that this is the correct interpretation of the
findings. Further, increased binding (reduced endogenous dopamine
release) correlated with objective measures of motor retardation,
strengthening the evidence for a striato-frontal involvement in
depression, the manifestation being motor retardation. This is
consistant with functional, structural and neuropsychological studies
suggesting a fronto-striatal deficit in depression.
7.3 Personality correlates of dopamine receptor availability
Although the effect si/e of the between group comparison was relatively large
(about 0.8), the within-group variation in IBZM binding was
unexplained. Both animal studies and indirect human studies suggest
that the striatum may be involved in complex behaviours which may
form the basis for temperament or personality. The dimension scores
from three personality inventories were correlated with the specific
striatal uptake ratios. Scores from Eyscnck's psychoticism and
neuroticism dimensions, and Cloninger's reward dependance
dimension correlated in predicted directions with striatal IBZM uptake.
Parallel PET and SPET data(Gray et al, 1994; Farde el al, 1997) also
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provide supportive evidence that the normal variation in receptor
density may be associated with variation in temperamental
behaviours. Thus, dopamine receptor imaging may help identify the
neurobiological substrate of personality traits and help elucidate the
biological basis of temperament.
7.4 Functional vs structural striatal changes in depression
Because this first experiment was cross-sectional in design, it was not possible to
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differences. On the one hand, SPET studies of striatal dopamine
receptor availability before and after response to either medication
(Ebert el al, 1996) or total sleep deprivation(Ebert, 1998) suggest a
reversal of motor retardation and increased 1BZM uptake. On the
other hand, structural studies of patients with unipolar depression
suggest fronto-striatal volume reductions (Soares & Mann, 1997).
Longitudinal studies of combined structural and receptor imaging are
required to examine if the substrate of striato-frontal volume
reductions is reduced fronto-striatal dopaminergic neurones.
7.5 Review of structural brain changes in depression
What is the evidence that structural differences may be present in depressed
patient? If so, are these differences acquired or predisposers to
depression? The evidence related to these questions are reviewed in
chapter 4. The review concludes that structural change is more evident
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in the elderly with late onset (aged 60+) depression. The increasing
effects of vascular disease with age may partially explain structural
changes. These changes may be associated with treatment resistance
and chronic!tv. It is suggested that temporal lobe change specifically
may predispose to chronicity.
As hypercortisoiism is frequently found in severe depression, one prediction is
that depression should be associated with hippocampal atrophy, a
structure known to be susceptible to the effects, amongst others, of
Cortisol. High resolution MRI techniques have already shown that
patients recovered from recurrent depression exhibit reduced
hippocampal volumes, suggesting just such a mechanism of
neurotoxicity.. The review also concludes that fronto-striatal volume
reductions have been the most consistant observations in patients with
unipolar depression, particularly in the elderly and associated with
motor slowing. Therefore, it would be predicted that CTRD,
presumably associated with continuing hypercortisoiism should
exhibit hippocampal changes proportional to the total duration or
severity of illness. Further, it may be expected that patients with CTRD
would exhibit structural changes in fronto-striatal and temporal
regions.
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7.6 MR I changes in patients with CTRD
Do middle aged patients with CTRD and RD show structural changes, ana if so,
are they acquired., state dependant or markers of illness? These were
the subject of the second experiment where high resolution brain MRI
images were examined. Fronto-striatal atrophy was found in CTRD
patients, using both SPM analysis (voxel based analysis) and
conventional volumetry. Additionally, VBA revealed a combination of
grey matter reductions and white matter increases in left hippocampus
and rostral anterior cingulate regions, suggesting a change in the
behaviour of water in these regions. Finally, there were extensive
fronto-temporal grey density reductionds in the CTRD group, which
appeared to be acquired, as they correlated with with measures of
iilness severity, such as the total number of FCT received, in contrast,
hippocampal and rostral cingulate changes did not relate to total iilness
duration, present and previous severity, suggesting that these changes
may be markers of chronicty or treatment resistance. The present
results support the notion that rostral anterior cingulate
hypoperfusion may be a marker of treatment resistance.
Both depressed groups showed reductions in medial prefrontal grey matter
density (including Brodmann areas 9 and 10) with older age, an
association not present in controls. Increasingly severe depressive
symptoms and psychomotor retardation were both associated with
reducing grey matter density in medial prefrontal cortex, particularly
in Brodmann areas 9 and 10. In both patient groups, the degree of
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clinical psychomotor slowing appeared to reflect the severity of
preceding illness. This could indicate that, in a sample of middle aged
patients, older patients may* be more susceptible to prefrontal changes
than younger patients or that older patients with melancholic
depression suffer a fronto-striatal degeneration in proportion to the
severity of the illness. It is tempting to speculate that melancholic
depression associated with motor slowing may be associated with
acquired, partially irreversible medial prefrontal grey matter
reductions, accentuated by* age, the degree of reduction dependant on
age and severity.
7.7 Cognitive function in CTRD.
What is the pattern of cognitive deficits in patients with CTRD and RD, and do
the deficits relate to structural change? These were the subject of
chapter 6. Patients with CTRD were particularly impaired on episodic
verbal memory and motor speed dependant task, but generally had a
wide range of cognitive impairments,. General cognitive ability, as
assessed by the NART, also showed deterioration in the CTRD group.
The RD group exhibitedcontinued impairment in reaction time, but
were otherwise unimpaired in other neuropsychological tasks. This
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rated motor slowing.
Neuropsychological impairments were associated with grey density reductions
in two areas. Psychomotor retardation and general cognitive ability
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impairment both appeared to be related to frontal grey density
reductions, particularly involving Broadman areas 9 and 10, but also
inferomedial prefrontal cortex. Episodic verbal memory impairment
related to reduced left hippocampal grey matter density. As the
hippocampal grey matter was not related to any of the illness
characteristics, it suggests that hippocampal structural change,
together with memory impairment may represent a marker for
chronicity and / or treatment resistance.
7.8 Psychomotor retardation in depression
The two experiments both suggest a central position for psychomotor
retardation in the symptomatology of melancholic depression, as has
been suggested by others (Widlocher, 1983; Parker etal, 1993; Austin
& Mitchell, 1995), and suggests that a frontostriatal correlate for motor
slowing. It could be speculated that there is loss of striato-frontal
dopaminergic neurones accounting for residual motor retardation on
recovery and for striatofrontal atrophy in depression. This cannot be
convincingly tested in cross-sectional studies such as the present ones.
7.9 Temporal lobe dysfunction and chronicity
The results also suggest that disrupted left temporal lobe integrity is associated
with chronicity and treatment resistance. One limitation is that the
studies have been cross-sectional. Therefore, it is not possible to rule
out that these changes are state dependant. However, in
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schizophrenia(Waddington, 1993) (O'Callaghan et al, 1995), obstetric
complications may be linked to neurodevelopmental brain
abnormalities, in particular left temporal lobe volume reduction and
less pronounced cerebral lateralisation. Further, obstetric
complications may be more frequent in patients with early onset
depression or with bipolar disorder (Kinney et al, 1993) (Guth et al,
1993) (Done et al, 1991). It is, therefore, possible that
neurodevelopmental abnormalities in patients with unipolar
depression, particularly affecting the left temporal lobe, may
predispose to chronicity.
Thus, it is not clear if the changes in the CTRD patients are, state dependant,
related to the illness or its treatment, represent permanent anatomical
differences or a combination of all these factors.
7.10 Validity of the voxel based analysis of structural MRIs.
Voxel based analysis of the MRIs produced results consistent with findings from
previous functional and structural imaging studies. The results of VBA
correctly predicted finding right fronto-striatal atrophy in patients with
CTRD using volumetric analysis. However, VBA also revealed
evidence of other MRI changes, probably representing local change in
water content and not anatomical change, thus not detectable by
conventional volumetry.
VBA is, therefore, a valid method of analysing "structural" images. VBA is
operator independent, time efficient, unrestricted by a priori
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hypotheses if necessary, and provides amore complete analysis of all
aspects of the MRI data. VBA therefore promises to be a useful and
efficient way of analysing MRIs in detail, particularly in psychiatric
disorders.
7.11 Future directions
The challenge now is to characterise the natural history of the observed
structural and functional brain changes in depression. If having a
chronic illness leads to the development of structural changes, this will
increase the pressure to treat depressed patients as quickly and
effectively as possible. On the other hand, if these changes are
antecedents of depression, it would be important to identify if they are
related to birth trauma or abnormal neural developmental in utero.
Ultimately, these findings support the idea that depression may appear
clinically homogeneous, but severe refractory depression and late
onset depression are indeed brain diseases.
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Appendix 5.3- An example of the results from the automated















APPENDIX 5.4: Volumetric analysis
1. Preparation of MR images
The MR images were analysed using the ANALYSE program running on
a Unix-based Sun workstation (Sun Microsystems). Images were
initially converted to 8-bit images. Non- brain tissue such as
meninges, skull and scalp were removed by ascertaining the
threshold voxel intensity between grey matter and CSF. Tissue
below this threshold (surrounding CSF) and exterior to this rim of
CSF (skull, scalp and meninges) were excluded. Where
meningeal tissue abutted on cerebral tissue, this was manually
removed using an anatomical atlas as a guide.
Although the images were, as far as possible, acquired perpendicular to
the AC-PC line, visual inspection confirmed that some images
had small amounts of tilt (rotation around the x-axis), roll
(rotation around the y-axis) and/or yaw (rotation around the z-
axis). All images were re-orientated correcting for these. A one-
bit template was produced for each image, and both this template
and the original image were resliced in the correct orientation in
Analyse. Trilinear interpolation was used for the original image,
but nearest neighbour interpolation was used for the one-bit
template. This ensured that partial volume effects would not be
introduced at the exterior edges of cerebral tissue in the one bit
template. After reorientation, the original image and 1-bit
256
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template image were multiplied, thus removing extra volume
added to the original image as a result of partial voluming at the
exterior edge of cerebral tissue. The total cerebral volume thus
remained unchanged after re-orientation.
2. Landmarks used to delineate the structures.
A number of studies were reviewed (Appendix 5.4(1)- Appendix 5.4(2))
examining landmarks that other researchers have previously
used to delineate structures. On the basis of this, the criteria in
Appendix 5.4(3) were devised. The hippocampus was divided into
anterior and posterior portions, using the presence of the
mamillary bodies as a landmark. No attempt was made to
measure amygdala volume separately. The caudate and putamen
were measured bilaterally, as well as prefrontal tissue (frontal
tissue anterior to the genu of the corpus callosum), "posterior
frontal" tissue (frontal tissue between the anterior edge of the
genu of the corpus callosum and the slice in which the anterior
commisure presented most medially and horizontally), and the
temporal lobes.
3. Segmentation of MRIs.
Two investigators underwent training to accurately identify landmarks
and to reliably segment images into the areas mentioned above.
MR images were then anonymised by a third investigator. Half
257
the images from each subject group were randomly chosen to be
flipped so that left and right sides were reversed. The two
investigators who segmented the MR images were thus blind to
the left-right orientation and diagnostic group membership of the
images. Five random images were chosen to be analysed by both
investigators independently, allowing a measurement of inter-
rater reliability. One of the investigators performed a repeat
analysis of the same five images two months later, producing a
measure of intra-rater reliability. These measurements are shown
in Appendix 5.4(4).
The two investigators each independently analysed the images from half
the total subjects.
4. Statistical analysis
The results of preceding voxel based analysis predicted volume reductions
particularly in the right prefrontal and basal ganglia regions. VBA
also indicated smaller reductions in left prefrontal and basal
ganglia regions. The greatest differences were comparing controls
with the CTRD group. Thus, one-tailed t-tests were used (SPSS for
the Macintosh v4.0), as the direction of change was predicted, and
no correction for multiple comparisons was used, as there were
specific hypotheses about the regions showing volumetric
reductions. As the total cerebral tissue volume did not differ
258
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between the three groups (Appendix 5.4(5b)), controlling for total
volume in the group comparison was not required.
5. Result
As predicted, the CTRD group had reduced right caudate and right
prefrontal tissue volumes compared to controls (Appendix 5.4(5a
and 5b)). In comparison to recovered patients, the CTRD group
had bilateral caudate volume reductions, but no change in
prefrontal volume. As predicted by VBA analysis, there were no
other volume changes in any other region. These results
effectively validate the findings of right fronto-striatal atrophy
found using VBA.
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Clinical and psychometric correlates of dopamine D2
binding in depression
P. J. SHAH, A. D. OGILVIE, G. M. GOODWIN AND K. P. EBMEIER1
From the MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Edinburgh
ABSTRACT
Background. Single photon emission tomography (SPET) with the dopamine D2/3 ligand 123I-IBZM
gives a semi-quantitative estimate of dopamine binding. In depressed patients, we predicted
evidence of reduced function, i.e. increased binding, particularly in more retarded patients.
Methods. Fifteen depressed patients with major depressive illness and 15 healthy, age- and sex-
matched volunteers were examined with a clinical and neuropsychological test battery and high
resolution IBZM-SPET. Estimates for specific binding were computed by averaging striatum to
whole slice or frontal uptake ratios over 8-10 scans acquired from 70 min after tracer injection.
Results. Using whole slice as reference, left striatal uptake ratios did not significantly differ for
patients from controls. Right ratios were significantly higher in patients than controls (F = 0-03).
There were significant correlations between IBZM binding in left and right striatum and measures
of reaction time and verbal fluency.
Conclusions. Increased IBZM binding in striatum probably reflects reduced dopamine function,
whether due to reduced release of dopamine, or secondary up-regulation of receptors. The observed
abnormalities may be trait or state related, an issue that needs to be addressed with longitudinal
study designs. The possible role of medication as a confounding variable requires further
exploration.
INTRODUCTION
The role of serotonergic and noradrenergic
neurotransmitter systems in the pathogenesis of
depression is widely accepted, but several lines
of evidence also point to an involvement of
dopaminergic mechanisms. First, a reduced
turnover of dopamine, determined by the
measurement of homovanillic acid in cerebro¬
spinal fluid, has been demonstrated in depressed
patients, particularly if motor retardation is
present (van Praag & Korf, 1975; Jimerson,
1987). Secondly, many antidepressants, such as
tricyclics, monoamine oxidase inhibitors, nom¬
ifensine, bupropion and electro-convulsive
treatment, exhibit direct or indirect dopamine
enhancing effects. Moreover, some agents with
mainly dopaminergic effects, amphetamine,
1 Address for correspondence: Dr K. P. Ebmeier, MRC Brain
Metabolism Unit, Royal Edinburgh Hospital, Morningside Park,
Edinburgh E10 5HF.
pirebidil and bromocriptine, may have anti¬
depressant action (Diehl & Gershon, 1992).
Thirdly, the mesolimbic dopaminergic system
with its projections to medial frontal cortex has
been implicated in depressive behaviour in
humans and in animal models of reward-seeking
behaviour (Fibiger, 1993). In the human brain,
the anterior cingulate is densely innervated by
dopaminergic neurones. Parkinson's disease is
associated both with (anterior cingulate)
dopaminergic depletion and a high rate of
depression (Cummings, 1992). Finally, studies
of cerebral perfusion have implicated the cingu¬
late gyrus, the fronto-orbital cortex and basal
ganglia in the recovery from depression after
pharmacotherapy (Goodwin et al. 1993) and
ECT (Lerer et al. 1994; Scott et al. 1994).
Three single photon emission tomography
(SPET) studies have examined dopamine func¬
tion more directly in depression, by using 123I-
IBZM (123I-3-iodo-methoxybenzamide), a benz-
amide derivative with high D2/3 receptor sel-
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ectivity (Verhoeff et al. 1992), but moderate
affinity to dopamine receptors. Its specific
binding, therefore, reflects receptor binding and
any partial displacement by endogenous ligand
(Laruelle et al. 1995). Specific IBZM binding in
the striatal regions of interest (ROIs) was
increased in the depressed group compared with
controls, suggesting either a reduction in the
competition from endogenous dopamine or an
up-regulation or increased affinity to IBZM of
D2/3 receptors (D'haenen & Bossuyt, 1994). A
second study could not statistically confirm this
group difference for the depressed patients
examined, but found IBZM binding to be
specifically higher in patients with clinically
rated psychomotor retardation (Ebert et al.
1996). IBZM binding was reduced after suc¬
cessful pharmacological treatment and a con¬
comitant improvement in motor retardation
(Ebert et al. 1996). The same pattern of change
in IBZM binding was found in depressed patients
with a successful antidepressant response to
total sleep deprivation (Ebert et al. 1994).
Ebert et al. (1996) dichotomized patients by
the presence or absence of retardation, but they
did not specifically investigate the cross-sectional
relationship between IBZM binding in
depression and more objective measures of
speed, reflecting motor and cognitive com¬
ponents of retardation. We designed this study
to compare IBZM binding in the basal ganglia
in a depressed group with matched healthy
volunteers, predicting a significant excess of
binding in the patients, which was likely to be




The design of the study was approved by the
local research ethics committee and the ap¬
propriate committee at the Department of
Health (ARSAC). Written informed consent
was obtained from all participating subjects.
Fifteen in-patients (nine males and six females)
from the Royal Edinburgh Hospital who fulfilled
DSM-III-R criteria (American Psychiatric As¬
sociation, 1987) for a current major depressive
episode with or without melancholic or mood-
congruent psychotic features and 15 healthy
volunteers were entered into the study. The
groups were matched for age, sex, and pre¬
morbid IQ.
Two of the depressed patients had a bipolar
affective disorder. Eight patients were on anti¬
depressant medication (including lithium) only,
three were on benzodiazepines only. The re¬
maining four were free of all medication at the
time of scanning. For at least 3 months prior to
the investigation, patients had not received any
medication that acted directly on the dopamine
system, such as neuroleptics. The severity of
symptoms was assessed using the 17-item
Hamilton Depression Rating Scale (Hamilton,
1960) and the patient's position on the neurotic/
endogenous continuum was measured by the
Newcastle scale (Carney et al. 1965).
Controls were screened for the presence of
psychiatric disorders using the Schedule for
Affective Disorders and Schizophrenia (SADS)
(Endicott & Spitzer, 1978) and they were free of
any medication. Both patients and controls were
required to be in good physical health, par¬
ticularly with no evidence of alcohol or substance
misuse, significant neurological illnesses or brain
trauma. All patients were right-handed, two of
the controls were predominantly left-handed.
Imaging protocol
Subjects were imaged with a 12 detector, brain
dedicated SPET camera, with an in-slice and z-
axis resolution of approximately 8-5 mm (full
width half maximum), and a sensitivity of
520 cps in a head-sized phantom filled with
1 kBq/ml (Ebmeier et al. 1991).
All subjects took oral doses of potassium
iodate to ensure thyroid saturation with iodine
and to prevent its excess exposure to radiation,
170 mg each on the night before and the morning
of the scan, 85 mg after the scan. All scans were
performed in the morning. An in-dwelling
catheter was inserted into an arm vein 15-30 min
before the injection of 185 MBq of 123I-IBZM
over a period of 30 s. During and for 5 min after
injection, patients were required to lie still and
silent wearing eye patches with ears unplugged,
with background noise kept to a minimum. The
subject's head was then placed in a moulded
headrest, positioned with the help of two crossed
light beams, and fixed with two pressure pads
over the zygomatic arches.
Slices were acquired parallel to the orbito-
meatal line (OML). During the first hour, a full
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scan of the brain was carried out, followed by a
short sequence of scans around the level of the
basal ganglia, allowing the operator to choose
the slice position with maximum activity from
the striatum, approximately 4 cm above the
OML. Single slices were then acquired at this
level in a time series from 80 min to 140 min
post-injection. IBZM studies in healthy
volunteers have found specific activity to be at a
steady state during this period (Verhoeff et al.
1992).
Analyses of the scans were carried out by a
physics technician who was blind to the clinical
details. Regions of interest (ROIs) were drawn
in advance from the transaxial slice at the level
of the anterior and posterior commissure taken
from a standard brain atlas (Talairach et al.
1988), outlining left and right frontal cortex,
striata and brain slice hemispheres. The complete
templates were linearly re-positioned, re-sized
and deformed, so that the outlines of the
hemisphere ROIs fit over the cortical rim, as
defined by the 20 % isocontour line of the scan
(Ebmeier et al. 1991). The striatal ROIs were
then re-positioned and centred over the maxi¬
mum striatal activity by hand if necessary, but
were not further re-sized. Once the template
position had been determined for each subject
for the first scan, no further adjustment of the
template was permitted. Following the previous
studies, a regional uptake ratio was calculated as
the ratio of the striatal ROI activity to reference
ROI. With this approach, striatal activity (pre¬
sumed to represent specific + non-specific
binding + free ligand) is compared to a back¬
ground region (non-specific binding + free
ligand), providing a functional index of specific
binding of IBZM to D2/3 receptors. The choice
of the reference region may affect results,
particularly if it includes the basal ganglia. For
example, the use of whole slice ratios may
reduce the power of comparisons by including
areas with high specific binding in both nu¬
merator and denominator (Ebert et al. 1996).
On the other hand, using a smaller reference
region may increase the variability of the uptake
ratios (Ebmeier et al. 1991). Finally, it has to be
considered that non-specific binding may not be
the same for different subjects and thus may
confound group comparisons (Laruelle et al.
1995). For comparison purposes, we chose two
reference regions - whole slice and frontal cor¬
tex. Regional uptake ratios were calculated for
each scan in the time series and were then
averaged across 8-10 scans to remove noise. The
mean time of the scans was well matched for the
two groups (118 (s.d. = 5) min in controls v. 121
(s.d. = 8) min in patients post-injection).
Neuropsychological testing
All subjects were tested under standardized
conditions. On the morning prior to the scan
subjects performed the National Adult Reading
Test revised (Nelson & Willison, 1991) to
measure pre-morbid IQ, the auditory verbal
learning test (AVLT; Rey, 1964; Lezak, 1983),
the Digit Symbol Substitution Test (DSST;
Wechsler, 1981), Trail-making A and B from the
Army Individual Test Battery (Army Individual
Test Battery, 1944), the FAS-Verbal Fluency
test (Borkowski et al. 1967) and the reaction
time tasks from the CANTAB computerized
psychometric testing battery (Sahakian & Owen,
1992), which allow for a separate determination
of the response initiation and movement times.
On the morning of the scan, subjects per¬
formed a maximum voluntary contraction
(MVC) task. Each subject was asked to squeeze
a dynamometer as hard as they could, and the
average of three trials with the right hand was
used for analysis. This follows the work of
Cohen et al. (1982) who demonstrated that
deficits in motor performance in depressed
patients was proportionate to their level of
depression and also Moffoot et al. (1994) who
found a reduction in performance in melan-
cholically depressed patients sensitive to diurnal
variations in mood. It has been suggested that a
reduced performance may reflect a generalized
reduction in central motivational state or in
effort. Subjects also completed the
Befindlichskeitskala (BFS; von Zerssen et al.
1974), an adjective check list of 28 word-pairs
reflecting their present state of mind. The scale
has two subscores, one for the degree of fatigue
experienced, the other for the degree of de¬
pression felt. Finally, the Alderly Park State
Anxiety Questionnaire (APSAQ; Walker, 1990)
was used to assess the subject's level of state
anxiety just after the injection of the ligand.
A subgroup of the healthy volunteers com¬
pleted the Eysenck Personality Questionnaire to
determine extraversion, neuroticism and psycho-
ticism (Eysenck & Eysenck, 1975).
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Statistics
Data were analysed with SPSS (version 4) for
the Apple Macintosh. Since clear hypotheses
existed for the direction of group differences,
comparisons were made by one-tailed Mann-
Whitney V tests. For correlations between
Hamilton scores, psychometric tests and striatal
tracer uptake, Spearman's one-tailed correlation
coefficients were computed. Non-parametric
tests were used consistently, because some
variables were not normally distributed. Ex¬
ploratory correlations are descriptive, or at best
hypothesis generating. Univariate 95% con¬
fidence intervals (CI) were computed for the
correlation coefficients to provide a more prac¬
tical description of the effect. However, corre¬
lations of measures of psychomotor retardation
with striatal IBZM uptake were planned, hy¬
pothesis testing, and therefore do not require
correction for multiple comparisons.
RESULTS
As Table 1 shows, patients and controls were
well matched for age and sex. There was a trend
for depressed patients to have fewer years of
education than controls, but this was not
reflected in their NART IQ. The average 17-
item Hamilton score was 23-5 (s.d. = 7-6, range
= 8-45) in the depressed group, the mean
Newcastle score 6-9 (s.d. = 2-28, range = 2-11).
Four of the 15 patients had obvious retardation
(Hamilton score of 2 + ). One patient was not
able to co-operate with the whole scanning
sequence, and was, therefore, not included in the
analysis of imaging data.
Psychometric testing
As expected, patients reported more depression
and fatigue than controls (Table 1). Patients
were weaker than controls in the hand grip task,
and tended to be slower for total reaction time,
response initiation time, and movement time.
There were no differences between patients and
controls for state anxiety and for neuro¬
psychological tests, apart from a trend for poorer
verbal fluency in patients.
IBZM binding and diagnosis
Fig. 1 shows that depressed patients had higher
right striatal activity than controls, using whole
slice as a reference region (mean: 1-68 (s.d. =
Table 1. Descriptive and clinical variables in
depressed patients and healthy volunteer controls
Depressed Controls Mann-
(N= 14) (N= 15) Whitney
Variable Mean (s.d.) Mean (s.d.) U test P
Age (years) 45 (14) 41 (10) 0-54*
Sex (M/F ratio) 9/6 9/6
NART IQ 112 (10) 116(7) 0-24*
Education (years) 13(3) 15(2) 007*
APSAQ 9(8) 5(4) 0-24
BFS
Total 26 (14) 9(8) 0002
Mood 6(5) 1 (2) 001
Fatigue 6(5) 2(3) 0004
Isometric contraction (kg) 34 (15) 45 (14) 0-03
Total reaction time (ms) 684 (227) 571 (63) 006
Response initiation time (ms) 524 (168) 449 (47) 0-09
Movement time (ms) 488 (353) 330 (58) 0-05
Digit symbol substitution 10(2) 11 (2) 0-15
test
Trails A (s) 32 (7) 32 (9) 0-49
Trails B (s) 90 (108) 54 (17) 0-25
Verbal fluency 39 (20) 48 (10) 009
(words/3 min)
AVLT total (5 trials) 49 (15) 55 (8) 0-24
Delayed recall 10(4) 12(3) 0-31
Recognition 12(6) 13(3) 0-29
* Two-tailed P values.
0 08) v. 1-62 (0-07), Cohen's <7=0-8; Mann-
Whitney U test: Z = 1-8, P = 0-03). There was
no significant effect on the left side (1-66 (0-08) v.
1-63 (0-09), of = 0-4; Mann-Whitney Utest: Z =
0-7, P = 0-23). Frontal uptake indices produced
essentially identical, albeit slightly more pro¬
nounced, group effects (right: T88 (0-13) v. 1-77
(1-00), Cohen's <7= 10; Mann-Whitney U test:
Z = 2-3, P = 0-01; left: 1-88 (0-18) v. 1-80 (012),
Cohen's <7=0-5; Mann-Whitney U test: Z =
1-6, P = 005). The near significant group
difference for frontal IBZM uptake ratios of the
left striatum together with the increase in effect
size from whole slice to frontal ratios for both
sides, suggests that left striatal increases in
IBZM binding are a real effect that requires
larger samples to be statistically confirmed.
IBZM binding and potential confounders of
diagnosis
Across both groups, women had higher striatal
(whole slice) uptake ratios compared with men
for both the left (1-68 (s.d. = 0-07) v. 1-61 (s.d. =
0-08), d= 0-9) and the right side (T69 (s.d. =
0-06) v. 1-62 (s.d. = 0-09), d = 0-9). Although
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Fig. 1. Right (♦) and left (O) whole slice and right (#) and left (O) frontal striatal uptake ratios for IBZM in depressed patients
(D) and healthy volunteer controls (C).
Table 2. Spearman"s rho correlations with right and left whole slice striatal uptake ratios of
IBZM in depressed patients
Right Left
Rho 95% CI Rho 95% CI
Age -0-22 -0-62 to 0-27 -0-24 -0-63 to 0-25
NART IQ 0-15 -0-33 to 0-57 0-13 -0-35 to 0-56
Hamilton scale -0-20 -0-60 to 0-29 -018 -0-59 to 0-31
Newcastle scale 003 -0-44 to 0-48 0-00 — 0-46 to 0-46
APSAQ 000 — 0-46 to 0-46 -0-07 -0-51 to 0-40
BFS
Total -0-09 -0-53 to 0-39 -011 -0-54 to 0-37
Mood -005 -0-50 to 0-42 -011 -0-54 to 0-37
Fatigue -012 -0-55 to 0-36 -006 -0-51 to 0-41
Isometric contraction 000 — 0-46 to 0-46 001 -0-45 to 0-47
Retardation (HAM) 0-21 -0-28 to 0-61 019 -0-30 to 0-60
Reaction time (total) 0-27 -0-22 to 0-65 0-26 -0-23 to 0-64
Response initiation 0-04 -0-43 to 0-49 003 -0-44 to 0-48
Movement time 0-59** 018 to 0-83 0-60** 0 19 to 0-83
DSST -0-04 -0-49 to 0-43 -0-04 -0-49 to 0-43
Trails-A -0-08 -0-52 to 0-39 -004 -0-49 to 0-43
Trails-B -0-05 -0-50 to 0-42 -007 -0-51 to 0-40
Verbal fluency -0-56** — 0 81 to -013 -0-52* -0-80 to -0-09
AVLT (total) 0-14 -0-34 to 0-56 018 -0-31 to 0-59
Delayed recall 0-24 -0-25 to 0-63 0-30 — 0-19 to 0-67
Recognition 001 -0-45 to 0-47 -0-01 -0-74 to 0-45
*P < 0 05; **P < 0 02.
this effect of sex appeared to be greater in significant diagnosis by sex interaction (F4 22 =
healthy volunteers (</= 09-1 -5) than in de- 049; P = 0 75). Since both groups had equal
pressed patients (d = 01-0-4), there was no ratios of males to females, sex was ignored as a
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confounding variable for the group comparison.
Female patients were more retarded than male
patients (1-8 (s.d. = 098) v. 0-75 (s.d. =0-71;
Mann-Whitney U test, P = 0 04), but otherwise
male and female patients were well matched for
the items and the total score of the Hamilton
scale, the Newcastle scale and age.
We examined the effect of concomitant medi¬
cation that could potentially decrease dopa¬
minergic activity in an indirect fashion (such as
antidepressants and benzodiazepines), by com¬
paring ten patients on medication with the four
patients off medication. There was no significant
effect, although the actual effect sizes observed
were large (d = 0-85-0-95) with higher IBZM
binding in medicated patients, and therefore
deserve further investigation as a possible con-
founder of diagnosis. Not surprisingly, a com¬
parison of patients on (N — 7) and off (N = 7)
antidepressants (including lithium) yielded very
similar results (d = 0-80-0-99).
Correlations between clinical and
neuropsychological scales
There were positive correlations of total reaction
time (p = 0-77, P = 0-001, 95% CI = 0-50 to
0-90), response initiation time (p = 0-74, P =
0-001, 95% CI = 0-44 to 0-89), and movement
time (p = 0-48, P = 0-04, 95 % CI = 0-05 to 0-76)
with endogenicity of the depressive illness, as
measured by the Newcastle scale. Reaction times
did not correlate with depression severity, as
estimated by the Hamilton scale total. Total
reaction time (p = 0-47, P = 0-04, 95 % CI =
0-03 to 0-76) and response initiation time (p =
0-51. P = 0-03, 95% CI = 0-09 to 0-78) were,
however, positively correlated with retardation
on the Hamilton scale. Maximal isometric
contraction also correlated with the Newcastle
scale (p= —0-56, P = 0-02, 95% CI = -0-80 to
— 0-16). Finally, performance on the verbal
fluency task showed a trend towards negative
correlation with retardation on the Hamilton
scale (p = —0-39, P = 0-08, 95 % CI = —0-71 to
0-06).
Correlation between IBZM uptake and
psychometric variables
Table 2 shows the correlations of clinical and
psychometric variables with striatal whole slice
uptake ratios. We found positive correlations
between movement time and regional uptake
ratios, as well as negative correlations between
verbal fluency and regional uptake ratios in the
depressed group. Other measures of clinical
retardation, such as the Hamilton-retardation
score, response initiation time, and other timed
neuropsychological tests were not significantly
correlated with IBZM uptake in depressed
patients. Notably, there were no correlations
between uptake and severity of depression as
measured by the Hamilton scale, type of
depression as measured by the Newcastle scale,
or age of the patient.
An exploratory analysis of the Hamilton items
showed that there was a strong negative cor¬
relation between the suicide item and IBZM
uptake (right p = —0-70, P = 0-002, 95% CI =
-0-88 to -0-35; left p=-0-63, P = 0008,
95% CI = —0-85 to —0-24), suggesting that
high suicidality was associated with more normal
striatal IBZM uptake. Interestingly, in a sub¬
group of 11 controls, there were positive
correlations between neuroticism and striatal
IBZM uptake (right p = 0-56, P — 0-035, 95%
CI = 0-05 to 0-84; left p = 0-22, P = 0-26, 95%
CI = —0-34 to 0-67) and negative correlations
with psychoticism (right p = —0-48, P — 0-06,
95% CI = -0-80 to 0-06; left p = -0-75, P =
0004, 95% CI = —0-91 to -0-37), but no
correlations with extraversion (Eysenck &
Eysenck 1975), thus partially confirming results
previously published by Gray and co-workers
(1994). These correlations were repeated using
frontal regions as a reference area. The results




We were able to confirm that there is higher
IBZM binding in the right striatum of depressed
patients compared with healthy volunteers.
There was a smaller difference in the left
striatum, which did not quite reach statistical
significance, even if a frontal reference region
was used. Importantly, in depressed patient^
higher IBZM binding was correlated wijf!^
measures sensitive to reduced speed of motbr
performance, such as movement time and verbal
fluency. Binding was not correlated with mood
per se, grip strength or memory function.
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That 1BZM binding is higher in the right
striatum of depressed patients has some support
from Ebert's studies (Ebert et al. 1994, 1996),
which showed that (retarded) patients had higher
right-sided specific activity during a depressive
episode, which normalized with drug treatment
and with clinical response to sleep deprivation.
The effect size of the group comparison was very
similar to that reported in previous studies
(Ebmeier & Ebert, 1996), suggesting a moderate,
but robust effect. This finding has interesting
parallels with SPET cerebral perfusion studies in
depression. We have found a lower perfusion of
basal ganglia structures in depressed patients
compared with controls (Austin et al. 1992),
which normalised on recovery (Goodwin et al.
1993).
IBZM binding differed between the sexes,
with women having higher binding. This effect
was statistically independent of diagnosis and
did not confound the comparison of the sex-
matched diagnostic groups. Because the sex
effect appeared at least as pronounced within
the control the main effect across diagnostic
groups was not caused by the chance inclusion of
more female retarded patients. A previous study
has reported plasma homovanillic acid levels 10-
70 % higher in female than in male schizophrenic
patients and controls, an effect that appeared
more pronounced in patients acutely after
receiving oral fluphenazine (Koreen et al. 1994).
Pilowski et al. (1994) have found greater left
than right striatal uptake of IBZM in female,
but not in male healthy volunteers. This
difference was absent in schizophrenic patients,
who showed greater left striatal uptake in both
sexes. Animal studies (Kazandjian et al. 1987;
Hafner et al. 1993) and limited human investi¬
gations have suggested modulation of dopamine
function by oestrogen levels (Wieck et al. 1991;
Best et al. 1992). The explanation of our findings
in terms of reduced pre-synaptic release of
dopamine or increased post-synaptic expression
of receptors must remain tentative but merits
further study.
The difference between depressed patients and
controls could be, equally, related to state or
trait differences between the groups, or a
combination of both. There is previous evidence
that striatal IBZM uptake in depression may be
state dependent (Ebert et al. 1994, 1996). A state
effect on the occupancy of D2/3 sites by IBZM
could be due to reduced striatal dopamine release
or to an up-regulation of D, receptor density.
A number of in vivo binding studies with
benzamides have shown that decreased dopa¬
mine D2 receptor occupancy can be the acute
result of increased dopamine release or turnover
(Hall et al. 1990; Logan et al. 1991; Laruelle et
al. 1995) and the evidence from sleep deprivation
suggests a similarly acute effect not likely to be
produced by change in receptor number.
None of the subjects received medication
directly acting on dopaminergic receptors, but
there is some evidence of interactions of other
neurotransmitter systems with dopamine func¬
tion. Serotonergic agonism reduces extrastriatal
dopamine concentration, while acute sero¬
tonergic blockade increases concentrations
(Dewey et al. 1995). Acute antidepressant treat¬
ment with a serotonin reuptake inhibitor or a
less specific drug, could therefore be responsible
for increased IBZM binding in depressed
patients. Similar effects on dopamine ligand
binding have been demonstrated using drugs
acting specifically on cholinergic and GABA-
ergic transmission (Schloesserg et al. 1996).
Although there were no significant differences
in IBZM binding between medicated and
unmedicated patients, and an initial investi¬
gation of the effects of antidepressant treatments
showed a decrease rather than the predicted
increase in IBZM binding (Ebert et al. 1996),
we can not exclude the possibility at this stage
that the diagnosis effect may be confounded
by serotoninergic, benzodiazepine, or anti¬
cholinergic action of the medication prescribed.
Clinical correlations
Only four of the patients were clinically clearly
retarded but there were still measurable psycho¬
motor differences between depressed and control
patients, most strikingly in movement time and
isometric contraction. There were trends (P <
0T) also in other reaction time measures and
verbal fluency. Maximal isometric contraction,
response initiation and movement times were
correlated with endogenicity and clinically rated
retardation correlated with reaction time and
weakly with fluency. These findings accord with
the view that motor signs and, specifically,
measures of performance may be more dis¬
criminating than subjective symptoms for identi¬
fying endogenous patterns of illness. It relates to
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a long standing tradition that places clinical
retardation as the core symptom in depressive
illness (Widlocher, 1983; Parker et al. 1993).
Correlations with IBZM uptake
IBZM uptake correlated most strongly with
relatively pure measures of motor function
(speed of movement in the reaction time task)
rather than clinical measures of mood, fatigue,
grip strength or even retardation. This was
despite the much greater group difference and
within group variance for the patients compared
with controls in the latter measures. This finding
provides the first direct evidence suggesting that
reduced receptor occupancy by endogenous
dopamine in the basal ganglia has a primary
effect on motor function in depression, although
some limited evidence already exists to suggest
acute reversibility of IBZM binding in de¬
pression (Ebert et al. 1996). IBZM uptake was
also correlated with verbal fluency and showed a
trend with DSST performance. These are also
tests which depend upon speed of motor
performance and showed trends towards im¬
pairment in the depressed group. Performance
of Trails A and B was neither impaired in the
patient group nor correlated with IBZM binding.
Since the patients in this study did not on
average display major psychomotor impairment,
the correlations that did emerge were striking.
Significant correlations could only be expected
for the most sensitive of the measures or for
those most directly related to striatal function.
In this regard the failure of mood to correlate
with striatal IBZM binding is very interesting.
The strong negative correlation of IBZM
uptake with suicidality could not be explained
by sex differences and was otherwise unexpected.
It could reflect the anecdotal clinical observation
that activated depressed patients are at increased
risk of suicide; this occurs classically after
alleviation of psychomotor retardation by treat¬
ment, without an improvement of affect. Finally,
the finding of relatively abnormal IBZM uptake
in controls with high neuroticism and low
psychoticism is of interest, because neuroticism
is a strong predictor of later depressive break¬
down (Hirschfeld & Klerman, 1979; Angst &
Clayton, 1986; Hirschfeld et al. 1986). It means
that the potential contribution of trait differences
to increased IBZM binding should not yet be
discounted for depressive illness. We were also
able to replicate the result of Gray et al. (1994),
who found a significant negative correlation of
psychoticism with IBZM binding in left and
right striatum, which they suggest may be due to
an association between increased dopaminergic
activity with receptor down regulation and
psychosis-prone normal individuals. This in¬
terpretation is somewhat at variance with the
reported increase in Bmax for N-methyl-spiperone
binding in psychotic bipolar patients during
positron emission tomography (Pearlson et al.
1995). This discrepancy could be due to a variety
of causes ranging from the different spectrum of
DA receptors labelled by benzamides and
spiperone, to relative displacement by the en¬
dogenous agonist dopamine, to the effect of
diagnosis (healthy versus manic-depressive;
'pre-psychotic' versus psychotic), and least likely
to previous medication, because all but three of
Pearlson's 14 patients were neuroleptic naive
(Pearlson et al. 1995).
CONCLUSION
This study has identified a difference in the
specific binding of IBZM in striatum between
males and females. In previous studies of
depression, the samples have either been all male
(D'haenen & Bossuyt, 1994) or of unequal sex
ratios (Ebert et al. 1994, 1996). Sex will,
therefore, have to be controlled for as a
confounder in future studies. Depressed patients
showed a modest but significant percentage
increase in striatal binding of IBZM. Increased
binding is probably associated with a reduction
in dopaminergic function either reflected in
reduced dopamine release and/or dopamine
receptor up-regulation. Striatal binding in the
depressed patients was correlated with motor
slowing and not with mood, fatigue or hand
grip. The observed associations between
dopamine receptor binding and the motor
slowing of the depressed state may, at least in
part, reflect a more stable trait of depressed
patients.
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Cortical grey matter reductions associated with
treatment-resistant chronic unipolar depression
Controlled magnetic resonance imaging study
PREMAL J. SHAH, KLAUS P. EBMEIER, MICHAEL F. GLABUS
and GUY M. GOODWIN
Background The aetiology of
treatment-resistant major depression
is little understood; its apparent
intractability may reflect brain
abnormality.
Method Magnetic resonance images
ofthe brains of 20 subjects with major
depression lasting for two years or more
were compared with 20 healthy control
subjects and 20 other subjects who had
completely recovered from depression.
Subjects were individually matched for
age, gender, years ofeducation and
premorbid IQ.Grey matter was
segmented from the images, and
compared between groups on a
voxel-by-voxel basis.
Results Subjects with chronic
depression showed reduced grey matter
density in the left temporal cortex
including the hippocampus.There was also
atrend for reduction in the right
hippocampus. Left hippocampal grey
matter density was correlated with
measures of verbal memory, supporting
the functional significance ofthe observed
magnetic resonance imaging changes.
Conclusions Our results potentially
challenge the accepted view ofdepression
as afunctional and fully reversible illness,
implying instead that more permanent
brain changes may be associated with
chronicity.Confirmatory longitudinal and
prospective studies are required to
determine whether these differences
pre-date the onset ofdepression or are
the result ofthe chronic illness process or
its treatment.
While major depression is generally re¬
garded as a reversible psychiatric illness
without lasting changes in the brain, it
actually follows a more chronic, treatment-
resistant course in up to 20% of subjects
(Keller et al, 1982). Such a course implies
that some permanent changes to the brain
may have occurred, but previous neuro-
imaging studies have either ignored the
issue or provided only limited evidence for
biological correlates (Morinobu et al,
1991). Hippocampal atrophy has been
found in the aftermath of highly stressful
life periods, and notably in a small cohort
of elderly depressed subjects with recurrent
depression (Bremner et al, 1995; Sheline et
al, 1996; Stein et al, 1997). In our present
study we use a novel voxel-based analysis
of magnetic resonance imaging (MRI) scans
to compare cortical grey matter density
between younger subjects with treatment-
resistant chronic depression, matched




Twenty subjects with treatment-resistant
depression, aged between 21 and 65,
fulfilling DSM-IV (American Psychiatric
Association, 1994) criteria for major
depressive disorder (chronic) were recruited
from general adult in-patient units and
from out-patient clinics in Lothian. The
subjects also fulfilled Research Diagnostic
Criteria (RDC; Spitzer et al, 1978) for a
primary major depressive disorder. Chroni¬
city was defined by a diagnosis of major
depressive episode (DSM-IV) lasting for
two or more years continuously. Treatment
resistance was assumed if the subjects did
not respond to at least two treatments from
the following four different pharmacologi¬
cal regimes employed for at least four
weeks:
(a) 150 mg of imipramine or an equivalent
tricyclic antidepressant;
(b) 60 mg of phenelzine or an equivalent
monoamine oxidase inhibitor;
(c) 40 mg of fluoxetine or an equivalent
selective serotonin reuptake inhibitor;
(d) six treatments with electroconvulsive
therapy (ECT) with seizures >20
seconds each.
All the subjects with chronic depression
were on a stable medication for at least two
weeks prior to the study, as it was not
possible to study the subjects medication
free. The subjects with chronic depression
had not received electroconvulsive therapy
(ECT) for at least three months. Twelve
subjects had required at least one psychia¬
tric admission.
Twenty subjects who had recovered
from depression previously fulfilling the
DSM-IV criteria for a major depressive
disorder, and 20 normal healthy volunteer
subjects (recruited from hospital secretarial
and nursing staff, as well as community
volunteers) were also examined. Subjects
from both these groups were individually
matched with the subjects with chronic
depression for age, gender, intelligence and
years of education. Subjects who had
recovered from depression were matched,
for age of onset and for onset of the index
episode, with the chronic depression group.
Recovery was defined as scoring five or less
on the 17-item Hamilton Depression Rat¬
ing Scale (HDRS; Hamilton, 1960) for at
least three months prior to the study. The
subjects who had recovered from depres¬
sion were either on a stable medication for
at least two weeks prior to the study, or
were medication free.
All subjects were interviewed using the
lifetime version of the Schedule for Affec¬
tive Disorders and Schizophrenia (SADS-L;
Endicott & Spitzer, 1978). Case notes were
reviewed in detail, providing RDC diag¬
noses and allowing lifetime histories of
psychiatric illness to be determined. Treat¬
ment histories were re-constructed from
case notes and from interview. Healthy
volunteers had no lifetime history of
significant psychiatric illness, using the
SADS-L interview schedule. Exclusion cri¬
teria for all groups were: previous manic
episodes; organic cerebral pathology; neu¬
rological illness; significant alcohol or
substance misuse; head injury associated
with significant loss of consciousness;




All subjects gave informed written
consent following a protocol approved by
the local research ethics committee.
Neuropsychological and clinical
assessment
All subjects underwent neuropsychological
and clinical testing in a standardised
environment, within a two-day period.
Symptom severity was measured using the
HDRS and cerebral dominance indexed
using a handedness scale (Annett, 1970).
Subjects performed the revised National
Adult Reading Test (NART; Nelson 8c
Willison, 1991) to measure premorbid IQ,
and a battery of neuropsychological tests,
including the Auditory Verbal Learning
Test (AVLT; Lezak, 1983), a measure of
verbal learning and memory. A dexametha-
sone suppression test was given to all
subjects within the week after all clinical,




Analysing structural scans usually involves
laborious slice by slice measurement of
local structures. The use of voxel-based
analysis has only recently been extended to
the analysis of structural MRI (Wright et al,
1995), although it has transformed the
approach to isotope and MRI-based func¬
tional imaging (Friston et al, 1995a,b).
MRI scans of subjects are compared after
spatial transformation into a standard
brain atlas space to remove variation in
overall brain position, size and shape.
Subsequent to segmentation of the images,
grey or white matter compartments may be
compared between groups on a voxel by
voxel basis. The technique for spatially
transforming and segmenting images into
different tissue types is fully automated and
operator-independent.
All subjects were scanned within one
week of the clinical assessment. Magnetic
resonance images were acquired on a
Siemens 1 Tesla system, using a magnetis¬
ation prepared rapid acquisition graded
echo (MPRAGE) sequence, with images
acquired perpendicular to the anterior-to-
posterior commissure line. This sequence
produces high resolution images with good
contrast between white and grey matter
(TR=10 ms, TD=500 ms, flip angle=12°,
block size=240 mm, 128 contiguous slices
with an effective slice thickness of
1.875 mm). Image analysis was performed
on a SPARC workstation (Sun Microsys¬
tems Europe Inc) using ANALYZE (CNS
Software), and SPM '96 for spatial normal¬
isation and statistical parametric mapping
(Friston et al, 1995a,b) running in MAT-
LAB (The Mathworks Inc).
In ANALYZE, images were first cor¬
rected for field inhomogeneities with a
phantom image using image algebra, then
converted to 8-bit images and flipped to
reverse right and left to comply with the
neurological convention. Within the SPM
'96 software, images were first spatially
normalised into standard space and then
segmented into grey matter, white matter,
cerebrospinal fluid (CSF) and skull/scalp
compartments, using an automated and
operator-independent process. Spatial nor¬
malisation involved reading image data in
coronal orientation and linearly deforming
them using a 12-point affine transforma¬
tion to fit a Trweighted template image
which included skull and scalp. Nearest
neighbour interpolation was used to pre¬
serve tissue type boundaries and the
original intensity spectrum of the image.
The normalised image has a voxel resolu¬
tion of 1x1x2 mm. Images were then
segmented using a modified clustering
algorithm based on the maximum like¬
lihood 'mixture model' (Hartigan, 1975)
which allows classification of tissue type,
as well as tissue density. The algorithm
uses a combination of the underlying multi-
normal distribution of Tj relaxation times,
and a series of a priori probability images
for each tissue type, where each voxel
represents the prior probability of tissue at
a location belonging to a particular com¬
partment. The multi-normal distribution
reflects the distinct T, intensity clusters
from different tissue types, with the key
assumption that the range of T, relaxation
times from the image produce a range of
intensities which reflect different tissue
types and, within each distribution, differ¬
ent tissue densities. A priori segmented
probability images provide approximate
spatial distributions of different tissue
types. These were derived from averaging
the spatially transformed segmented images
of grey, white matter and CSF from MRIs
of healthy volunteers. The intensity dis¬
tribution of the probability image ranges
between 0 and 1. The algorithm is iterative
and has the effect of biasing voxel classi¬
fication towards the a priori distribution.
Prior to statistical comparison, the spatially
normalised segments were smoothed with a
12 mm full width at half maximum iso¬
tropic Gaussian kernel to remove variation
due to individual differences in sulcal and
gyral patterns. The segmentation procedure
used in this study is more sophisticated
than the method previously applied by
Wright et al (1995). Grey matter is
classified having continuous values from
0-1 based on probability, whereas the
earlier technique classified tissue only as 0
to 1, in binary fashion. In addition, by
smoothing the data, the partial volume
effect is used to convert differences in the
amount of grey matter locally into differ¬
ences in intensity. For reasons of economy,
only grey matter results are reported in this
paper.
Statistical comparison
An ANCOVA model was applied which
removed global grey matter density for
each subject. This normalises the trans¬
formed and segmented brain image to the
same total amount of grey matter, while
preserving regional differences in grey
matter density. Age-effects were also re¬
moved by ANCOVA. Differences between
groups were displayed as statistical para¬
metric maps (SPMs), with a threshold
probability of 1%. Statistical clusters were
projected on to a Tj-weighted grey matter
density template to facilitate interpretation
of the results. Corrected probability values
were computed which take into account the
whole volume examined, the smoothness of
the data, the size of the cluster with
P<0.01, and the peak effect (Z-value).
Group demographic and clinical data were
compared using univariate ANOVA and
post hoc t-tests to identify specific group
differences. Non-continuous variables were
compared using the Kruskal-Wallis and
Mann-Whitney U and x2 tests, as appro¬
priate. The latter statistics were computed
using SPSS version 4.0 for the Macintosh.
RESULTS
Clinical data
The three groups did not statistically differ in
age, gender, cerebral hemispheric laterality,
years of education, estimated premorbid IQ
and the total number of years smoking
(Table 1), although there was a tendency
for the subjects with chronic depression to
have fewer years of education, a lower
NART IQ and perhaps to be right-lateralised
to a lesser degree. The mean age of onset of
first and most recent episodes of depression
did not differ between the chronic and
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recovered groups. Subjects with chronic
depression had suffered a longer duration
of illness and longer illness episodes. Within
the chronic depression group, all were taking
antidepressant drugs. In addition, 12 sub¬
jects with depression took regular neurolep¬
tic medication, five took lithium and three
benzodiazepines. Fourteen subjects with
depression had received ECT in the past.
Nine of the subjects who had recovered from
depression were prescribed antidepressants,
one also received neuroleptics and one
lithium. Eleven of the subjects who had
recovered from depression had previously
received ECT. Subjects with chronic depres¬
sion had moderately severe depressive symp¬
toms (17-item HDRS, mean 20.6, s.d.=5.3,
range 10-30). Subjects who had recovered
from depression had been well for a mean
period of 136 weeks (s.d.=83; range: 43-
290), 16 had previously required in-patient
treatment. Only one depression-recovered
subject would previously have qualified for a
diagnosis of chronic depression (duration of
episode: 182 weeks). The chronic depression
group performed more poorly on the AVLT
delayed recognition test (mean=8.2,
s.d.=4.8) in comparison with both depres¬
sion-recovered subjects (mean=13.4,
s.d.=1.4) and control subjects (mean=12.3,
s.d.=2.8; F(2,55)=13.29, PcO.OOOl). Post-
dexamethasone morning and afternoon Cor¬
tisol values did not differ between the three
groups. Median values for subjects with
chronic depression, depression-recovered
and control subjects were 16.0, 21.6 and
24.0 nmol/1 (y2=4.1, P=0.13, corrected for
ties) and 16.5, 21.1 and 23.4 nmol/1
(y2=0.3, P=0.85) respectively. Values ran¬
ged between 16.0 and 44.6 nmol/1 (0.58—
1.61 /zg/dl) in the morning, and 16.0 and
Table I Clinical and descriptive measures (s.d.)
82.4 nmol/1 (0.58-2.97 /rg/dl) in the after¬
noon, that is, all subjects were suppressors.
Grey matter density
Fig. 1 shows grey matter density reductions
in subjects with chronic depression com¬
pared with healthy control subjects. Reduc¬
tions were found over large areas of the left
temporal neocortex and left anterior hippo¬
campus (Table 2). Comparison of subjects
with chronic depression with depression-
recovered subjects yielded very similar
results. Subjects who had recovered depres¬
sion and control subjects showed no sig¬
nificant differences in grey matter density.
We also found an apparent increase in
cuneus/precuneus grey matter density in
the subjects with chronic depression com¬
pared with both subjects who had recovered
from depression and the control subjects.
This may reflect the consequences of the left
hemispheric changes on grey matter values
in the former group with relatively normal
cuneus/precuneus grey matter. As there was
an a priori hypothesis linking verbal mem¬
ory with left temporal lobe function, we
correlated grey matter density with perfor¬
mance on the AVLT delayed recognition test
in the chronic group. Left hippocampal grey
matter density was positively correlated
with recall of previously learnt verbal
material (Fig. 2 and Table 3).
DISCUSSION
Grey matter abnormalities in
chronic depression
We were able to demonstrate that middle-
aged unipolar subjects with treatment-resis¬
tant chronic depression had reduced grey
matter density in large areas of the left
temporal cortex, including left anterior
hippocampus, compared with both healthy
control subjects and subjects who had
recovered from depression. Well matched
depression-recovered subjects did not differ
from healthy control subjects. We chose to
examine subjects who were symptomatic for
two years or more, in line with the definition
of chronicity proposed in DSM-IV. In fact,
our sample of subjects with chronic depres¬
sion well exceeded two years of active
illness, having a mean episode duration of
197 weeks. This result adds to the evidence
accumulating that, in elderly patients,
chronicity may be associated with increased
ventricle to brain ratio (Roy-Byrne et al,
1988), with decreased temporal (Altshuler,
1993) and amygdala-hippocampal volume
(Axelson et al, 1993; Sheline et al, 1996), as
well as the observation that chronic or
overwhelming stress may be associated with
hippocampal atrophy (Bremner et al, 1995;
Stein et al, 1997).
Functional correlates of grey
matter abnormalities
In agreement with a previous study in
chronic bipolar illness (McKay et al,
1995), verbal recognition was significantly
impaired in the subjects with chronic
depression in our study and, within the
group, was correlated with reduced left
hippocampal grey matter density. Episodic
memory depends on the integrity of the
temporal lobes (Mayes &C Downes, 1997).
Harvey et al (1997) compared cognitive
function in poor-outcome hospitalised
geriatric patients with affective disorders










Mean age 48.9 (9.8) 47.7 (9.9) 49.3(11.8) 0.89
Handedness score 13(16) 16(13) 19(5) 0.27
Years of education 11.7(2.9) 13.4(3.4) 13.5(2.9) 0.12
National Adult Reading Test IQ 107(12.7) 113(10.2) 115(8.7) 0.06
Male: female ratio 13:7 13:7 13:7
Total years smoking 20(13.6) 12(13.7) 17(3.7) 0.14
Age at onset of first episode 38.9(13.5) 38.2(10.1) 0.89
Age at onset of last episode 45.8(10.1) 44.8 (9.8) 0.76
Longest duration of episode (weeks) 197(125) 46 (36) <0.001
Lifetime total illness duration (weeks) 263 (133) 76 (58) <0.001
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Table 2 Comparison of grey matter density between diagnostic groups





Reduced in chronically Left superior temporal/ -64, -23,6 4.46 (< 0.001) 19.61 0.002
depressed v. control lateral inferior frontal -55, 14, 14 4.07 (< 0.001) (<0.000 1)
subjects gyrus -56, 1, 32 3.99 (<0.00 1)
Left hippocampus/ -29, -18, -16 3.33 (<0.00 1) 4.56 0.14
inferior temporal gyrus -53, -66, -8 3.13(0.001) (0.004)
Right hippocampus 31, -25, -12 2.94 (0.002) 1.40 0.84
(0.08)
Reduced in chronically Left superior temporal/ -58, -16, 38 3.9 (<0.00 1) 11.86 0.009
depressed subjects v. lateral inferior frontal -66, -28, -14 3.7 (<0.00 1) (<0.00 1)
depression-recovered gyrus -64, -23,8 3.6 (<0.00 1)
subjects
Left hippocampus/ -38, -16, -28 4.42 (< 0.001) 5.56 0.08
parahippocampal -25, -30, -8 3.97 (< 0.001) (0.002)
gyrus -32, -20, -20 3.9 (<0.00 1)
Right hippocampus/ 30, -21, -18 3.1 (0.001) 1.36 0.85
parahippocampal gyrus 29, -29, -12 3.0 (0.001) (0.08)
17, -11,-16 2.65 (0.004)
Reduced in control v. Left cuneus/precuneus -8, -72,0 3.92 (<0.00 1) 12.88 0.007
chronically depressed -4, -52, 34 3.72 (<0.00 1) (<0.001)
subjects -16, -86, 24 3.71 (<0.00 1)
Right cerebellum 40, -45, -32 3.37 (<0.00 1) 5.57 0.08
21, -30, -28 3.3 (<0.00 1) (0.002)
29, -31, -26 3.27(0.001)
Left cerebellum -40, -50, -34 3.24(0.00 1) 5.35 0.09
-35, -43, -32 3.24(0.001) (0.002)
-28, -27, -26 3.22 (0.001)
Reduced in depression- Right cuneus/precuneus -12, -89, 22 4.44 (< 0.001) 33.04 0.001
recovered v. chronically -4, -53, 34 4.39 (<0.00 1) (<0.00 1)
depressed subjects - 5, - 73, 24 4.11 (<0.00 1)
Coordinates refer to the voxels with maximum (peak) effect sizes as defined by the brain atlas of Talairach & Tournoux (1988). If multiple coordinates are given, the cluster of
contiguous voxels with an uncorrected P < 0.01 has multiple peak effect sizes. Uncorrected P-values are given for peak effect sizes and for the cluster volumes of contiguous voxel with
uncorrected P <0.01. Corrected P-values have been adjusted for multiple comparisons according to peak effect size, cluster volume, smoothness of data and total volume examined
(Friston etal, 1995b). Results are corrected for age.
Table 3 Regression of grey matter density on performance in delayed verbal recognition (Friston et al, 1995b), controlling for age in the chronic depression group only
(n=l9)
Region Peak Peak Z (uncorrected Cluster volume, cm3 Corrected
coordinates P-values) (uncorrected P-value) P-value
Left hippocampus -35, -9, -32 4.33 (<0.00 1) 8.01 0.04
Parahippocampal -35, -15, -24 3.31 (<0.00 1) (<0.00 1)
Gyrus -30, -9, -22 3.30 (<0.00 1)
Coordinates refer to the brain atlas of Talairach & Tournoux (l988).The multiple coordinates indicate that the cluster of contiguous voxels with an uncorrected P < 0.01 has multiple
peak effect sizes. Uncorrected P-values are for peak effect sizes and for the cluster volume of contiguous voxel with uncorrected P < 0.01. Corrected P-values have been adjusted for
multiple comparisons according to peak effect size, cluster volume, smoothness of data and total volume examined (Friston etal, 1995b)
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Fig. I Statistical parametric maps (P < 0.01) for reductions in grey matter densitities in subjects with chronic
depression compared with healthy control subjects. Effects are controlled for age.
-10 -5 0 5 10
centred verbal memory
recognition performance
Fig. 2 Positive correlation of grey matter density
with delayed verbal recognition, controlling for
age and premorbid IQ in a pixel within the left
hippocampus (— 30 — 9 — 22). Effects are controlled
for age.
schizophrenia and found no group differ¬
ences, suggesting that the severity of
cognitive impairment may correlate with
chronicity, regardless of diagnosis. In sup¬
port of this notion, a correlation of left
hippocampal volume with verbal memory
performance could be demonstrated in
subjects with schizophrenia, who also show
reduced hippocampal size (Goldberg et al,
1994).
Methodological considerations
This is the first application of a new voxel-
based analysis of structural MRI, compar¬
ing patient groups and control subjects.
Voxel-based analysis is generally likely to
be more sensitive to localised differences
which may be a small part of, or overlap,
the structures (object maps) measured in
traditional volumetric approaches (Ebmeier
et al, 1998). Because the results in this
study may, therefore, not be detectable
with the traditional 'gold standard' volu-
metry, an independent replication of the
results using statistical parametric mapping
or another voxel-based method will be
essential. One reason for this is that our
measure of grey matter density is based on
regional ^-relaxation times. Changed T, at
the boundary with other compartments
may be due to partial volume effects in
the presence of structural brain differences,
but local changes in brain chemistry may
also affect Tj. Subjects with depression
often restrict their food intake and suffer
weight loss, which in turn may result in
reversible brain atrophy, similar to that
observed in anorexia nervosa (Swayze et al,
1996), although it is not clear why such
atrophy should be localised or lateralised to
the left side.
Possible aetiologies of grey matter
abnormalities
Grey matter changes can be antecedent to or
consequent upon depressive symptoms or
their treatment. Obstetric complications may
be more frequent in subjects with depression
(Guth et al, 1993). In schizophrenia, left
temporal lobe volume reduction may reflect
reduced neurodevelopmental cerebral lateral-
isation (DeLisi etal, 1991). The subjects with
chronic depression in our study showed a
similar tendency to less lateralisation, imply¬
ing that neurodevelopmental abnormalities
in subjects with unipolar depression, parti¬
cularly affecting the left temporal lobe, may
finally predispose to chronicity.
Alternatively, the chronic illness may be
responsible for temporal lobe atrophy.
Raised levels of Cortisol, which are not
suppressed by dexamethasone may predict
rapid relapse and possibly chronicity (Am¬
sterdam et al, 1983). Animal work suggests
that chronically raised Cortisol can facilitate
hippocampal neuronal death, which in turn
may cause dysregulation of the hypothal-
mic-pituitary-adrenal (HPA) axis (Sapolsky
et al, 1986). Dysregulation of the HPA axis
can also be found in people with schizo¬
phrenia, who have reduced hippocampal
volumes. However, since temporal lobe
damage may cause hypercortisolaemia,
these assoiations do not establish the direc¬
tion of the effect. Interestingly, the subjects
with chronic depression did not exhibit
dexamethasone non-suppression, suggest¬
ing that hypercortisolaemia was not an
important factor maintaining chronicity in
this sample. However, since we did not
obtain baseline measures of Cortisol and this
was a cross-sectional study, the possibility
of present or previous HPA dysfunction
cannot be discounted.
Finally, the treatment of depression
may be responsible for localised tissue loss.
To test this hypothesis, we correlated the
number of ECTs during subjects' lifetimes
with grey matter density in the chronic
depression group. There were no correla¬
tions with hippocampal grey, but there
were some neocortical regions with signifi¬
cant correlations extending over temporal
and frontal lobes. Whether such associa¬
tions are causal, and if so in which direction
is not clear. Longitudinal studies are
required to determine whether cortical
atrophy predates particularly severe ill¬
nesses which require ECT, or whether
ECT causes such changes. Although we
have very closely matched groups, the study
could be criticised for including chronically
depressed and depression-recovered sub¬
jects who were taking medication. There
is no convincing evidence to suggest that
long-term antidepressants or ECT are
responsible for structural brain changes
(Scott et al, 1995) or changes in cognitive
function greater than those produced by
depression. Further, there were no grey
matter differences between control subjects
and the subjects who had recovered from
depression, some of whom were on psycho¬
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